Neutrophil function in S100A9 null mice. by McNeill, E.
R EFER EN C E O NLY
UNIVERSITY OF LONDON THESIS
Degree py>0 Name of Author
C O P YR IG H T
This is a thesis accepted for a Higher Degree of the University of London. It is an 
unpublished typescript and the copyright is held by the author. All persons consulting 
the thesis must read and abide by the Copyright Declaration below.
C O P YR IG H T D E C LA R A TIO N
I recognise that the copyright of the above-described thesis rests with the author and 
that no quotation from it or information derived from it may be published without the 
prior written consent of the author.
Theses may not be lent to individuals, but the Senate House Library may lend a copy 
to approved libraries within the United Kingdom, for consultation solely on the 
premises of those libraries. Application should be made to: Inter-Library Loans, 
Senate House Library, Senate House, Malet Street, London WC1E 7HU.
R E P R O D U C TIO N
University of London theses may not be reproduced without explicit written 
permission from the Senate House Library. Enquiries should be addressed to the 
Theses Section of the Library. Regulations concerning reproduction vary according 
to the date of acceptance of the thesis and are listed below as guidelines.
A. Before 1962. Permission granted only upon the prior written consent of the 
author. (The Senate House Library will provide addresses where possible).
B. 1962 - 1974. In many cases the author has agreed to permit copying upon 
completion of a Copyright Declaration.
C. 1975 - 1988. Most theses may be copied upon completion of a Copyright 
Declaration.
D. 1989 onwards. Most theses may be copied.
This thesis comes within category D.
This copy has been deposited in the Library of  :—
This copy has been deposited in the Senate House Library, Senate House,
LOANS
Malet Street, London WC1E 7HU.
C:\Documents and Settings\lproctor\Local Settings\Temporary Internet Files\OLKS\Copyright - thesis (2).doc

Neutrophil Function in 
S100A9 Null Mice
Eileen McNeill
Cancer Research UK London Research Institute
and
University College London 
September 2005
Supervisors
Dr. Nancy Hogg Prof. Peter Beverley
Cancer Research UK University College London
This thesis is submitted in part fulfilment of the requirements for the degree of 
Doctor of Philosophy at the University of London
UMI Number: U593019
All rights reserved
INFORMATION TO ALL USERS  
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
Dissertation Publishing
UMI U593019
Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author.
Microform Edition ©  ProQuest LLC.
All rights reserved. This work is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346
Abstract
S100A9 and its heterodimeric binding protein, S100A8, are low molecular 
weight calcium-binding proteins of the S I 0 0  protein family that are abundantly 
expressed in myeloid cells. They constitute 40% of neutrophil cytosolic protein 
and 1% of monocyte cytosolic protein. To elucidate the function of this protein 
complex, a study o f the S100A9 null mice, which also lack S100A8, was 
undertaken.
Myelopoiesis in the S100A9 null mice was shown to be normal, with the 
resulting neutrophils and monocytes showing no differences in differentiation or 
activation state. No compensatory upregulation of other S I00 proteins was found 
in S100A9 null neutrophils, which exhibit a significantly lower buoyant density 
than wildtype neutrophils.
The basic calcium homeostasis of the S100A9 null neutrophils was 
normal. However a reduced calcium flux in response to suboptimal levels of 
MIP-2, KC, M IP -la , PAF and C5a but not FMLP was observed. This lesion in 
calcium response was shown to be in the IP3 -mediated calcium release pathway.
Adhesion of the S100A9 null neutrophils along with migration and in vitro 
chemotaxis was normal. In addition no differences in the cytoskeletal 
morphology o f the S100A9 null cells was seen. No defect in in vivo migration of 
neutrophils or monocytes could be seen in a peritonitis model initiated by 
thioglycollate, TNFa or IL-1(3.
Activation of the NADPH oxidase, measured in kinetic and phagocytosis- 
activated studies, was unaltered by the loss of S100A9. There was no effect of 
S100A9 deletion in an in vitro bacterial killing assay or in an in vivo model of 
Streptococcus pneumoniae lung infection.
Expression o f S100A8/9 has been associated with wound healing and 
cancer. No defect in wound healing or injected tumour growth was found in 
S100A9 null mice. However a model of chemical-induced carcinogenesis in the 
S100A9 null mice demonstrated both an increased rate o f papilloma formation 
and increased papilloma multiplicity.
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CHAPTER 1
1 Introduction
1.1 Calcium  signalling
Calcium is a simple ubiquitous cellular signal. From the moment of 
fertilisation, when activation of the egg occurs by introduction of a sperm- 
transported phospholipase C to initiate calcium oscillations, calcium regulates an 
array of diverse cellular processes. As calcium participates in the transduction of 
a variety of signals, a complex network of calcium handling mechanisms exist. 
Calcium levels within the unstimulated cell are held at ~100nM rising to a level of 
~lpM  upon stimulation (reviewed in (Berridge et al., 2000)). The calcium that is 
needed to make up a cellular signal can broadly be either of extracellular origin, 
entering the cell by one of many cell surface ion channels, or released from the 
internal calcium stores through different calcium channels. The activation of 
these processes occurs either by the activating signal directly opening a calcium 
channel, for example the voltage operated calcium channels found in excitable 
cells, or by the production of a calcium mobilising second messenger.
1.1.1 Extracellular calcium entry
Study of calcium entry pathways in non-excitable cells has been a focus of 
intensive research in recent years. Pathways of this type are either directly 
activated by extracellular ligand-gated ion channels, by second messengers, such 
as lipid mediators including DAG and arachidonic acid, or by the depletion of the
17
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intracellular stores. This store operated calcium entry process allows the cell to 
refill depleted intracellular stores. The activation of a family of store operated 
calcium channels on the cell surface by either physical interaction with the 
calcium stores or following production of a diffusible factor is hypothesised to be 
the means by which this process occurs. (Reviewed in (Berridge et al., 2003; 
Hardie, 2003; Spassova et al., 2004)).
1.1.2 Intracellular calcium release
The primary origin of intracellular calcium signals is the endoplasmic 
reticulum (ER). As well as the role of this cellular organelle in protein synthesis, 
the membrane bound sacks or tubes of the ER provide a reservoir of calcium 
within the cell. Calcium levels within the ER are ~100-500pM where calcium is 
held by high capacity buffering proteins such as calsequestin and calretinin 
(reviewed in (Berridge, 2002)). The most well defined intracellular calcium 
release pathways in non-excitable cells are those elicited by the IP3 receptor and 
the ryanodine receptor. Both these receptors are located in the membrane of the 
endoplasmic reticulum in non-excitable cells and act as ligand gated ion channels 
allowing the release of calcium into the cytosol. Calcium release via the IP3 
receptor occurs following ligation by the lipid mediator IP3. This mediator is 
produced by enzymes of the phospholipase C family that hydrolyse the membrane 
lipid PIP2 to form DAG and IP3. The ryanodine receptor gains its name from the 
plant alkaloid ryanodine that was used to define this receptor. Ryanodine has a 
stimulatory activity at low concentrations and an inhibitory function at higher 
concentrations. Along with these better defined second messengers, putative roles 
for NAADP and sphingosine-1 -phosphate (SIP) in releasing calcium are under
Chapter 1: Introduction
study. (Basic program of calcium signalling reviewed in (Berridge et al., 2003; 
Berridge et al., 2000)).
1.1.3 The OFF process
Following elevation of the cytosolic calcium concentration, the signal 
must then be transduced into a specific effect. This can occur by direct activation 
of calcium-sensitive enzymes and ion channels, or be further transduced by 
calcium-binding effector proteins. Along with the activation of the calcium 
driven cellular processes, the calcium signal itself must be terminated and the 
calcium in the cytosol be removed. The clearance of the calcium signal happens 
by activation of calcium pumps that return calcium to the internal stores 
(Sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA) pump), pump 
calcium out of the cell (Na+/Ca2+ exchanger), or facilitate uptake into the 
mitochondria (mitochondrial uniporter). This process is aided by calcium 
buffering proteins that have a high on-rate for calcium binding. They rapidly take 
up free calcium and gradually release it back into the cytosol to be removed in 
keeping with their slow off-rate (reviewed in (Berridge et al., 2003)).
1.1.4 Calcium signal transduction
It is the job of calcium binding proteins to take the basic elemental signal
of increased calcium and translate this into a diverse array of cellular functions.
The most common calcium-binding protein motif is the EF-hand that is shared by
many proteins having calcium buffering or calcium sensor activities. The
classical helix-loop-helix EF-hand motif contains a 12 amino acid ion-binding
pattern: X*Y*Z*y*X**Z  where XYZ are the ligands participating in metal ion
coordination (EF-Hand structural reviews: (Ikura, 1996; Lewit-Bentley and Rety,
19
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2000)). The underlying mechanism by which EF-hand sensor proteins transduce 
their signal is by a large change in conformation following calcium binding, 
altering their interaction with downstream effector proteins.
1.2 S100 proteins
SI00 proteins are a major EF-hand family subgroup with approximately 
19 members. S I00 proteins are so named after their biochemical property of 
being soluble in 100% ammonium sulphate (SI00 fraction). The first member of 
this group, S100B, was identified in the S I00 fraction of bovine brain 
homogenate (review (Donato, 2001)). Proteins of this family show a relatively 
tissue-specific distribution pattern. For example S100A1 is highly expressed in 
cardiac tissue and S100B is highly expressed in neuronal tissue. A summary of 
the tissue distribution and putative functions of the SI 00 family is shown in Table 
1.1. The majority of S I00 family members are clustered on chromosome 1 in 
humans and chromosome 3 in mice. Following the discovery of the chromosomal 
organisation of the S I 0 0  family members, a nomenclature based on the order in 
which they are found in the human chromosome was suggested and generally 
adopted in the late 1990s (Ridinger et al., 1998; Schafer et al., 1995). Genomic 
analysis of the S I00 family has indicated they are absent in Arabidopsis thaliana, 
Drosophila melanogaster, Caenorhabditis elegans and Saccharomyces cerevisiae. 
The most evolutionary primitive organism to express any SI00 protein is Squalus 
acanthius (Spiny dogfish) from the Chondricthyes class (Sharks, Skate and Rays). 
The protein expressed by this organism is most closely related to S100A1, 
indicating this may be the ancestral member of the S I00 family (Ravasi et al., 
2004). The SI00 family demonstrate 50% similarity between members at the
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Human
S100
Family
Member
Ortholog
in
Mouse?
Tissue Distibution 
According to 
Swiss-Prot 
Database 
(Human)
Putative Functions 
(Human and/or Mouse)
References for 
putative functions
S100A1 Yes Highly prevalent in 
heart, also found in 
skeletal muscle and 
brain
Modulates cardiac calcium 
signalling and stimulates 
Ca2+ induced Ca2+ release.
Most et al., 2004; 
Most et al., 2003; 
Treves et al., 1997
S100A2 Yes Subset o f epithelial 
cells including 
human mammary 
epithelial cells and 
keratinocytes
Chemoattracts eosinophils. 
Regulates F-actin- 
tropomyosin interaction. 
Inhibits tumour 
progression
Gimona et al., 
1997; Komada et 
al., 1996; Wicki et 
al., 1997
S100A3 Yes Skin specific None
S100A4 Yes Ubiquitously
expressed
Promotes metastatic 
activity o f tumour cells. 
Modulates cell migratory 
machinery
CNaaman et al., 
2004; Kim and 
Helfman, 2003; 
Taylor et al., 2002; 
Wang et al., 2005
S100A5 Yes Kidney None
S100A6 Yes Ubiquitous Regulates cell-cycle 
progression
S100A7 Yes Fetal ear, skin, 
tongues, highly up- 
regulated in 
psoriatic epidermis
Chemoattracts
lymphocytes.
Anti-microbicidal.
Glaser et al., 2005; 
Jinquan et al., 1996
S100A8 Yes Myeloid cells Chemoattractant. 
Anti-microbicidal and 
apoptosis inducing 
function in complex with 
S100A9.
Regulates neutrophil 
oxidase activity and 
arachidonic acid transport 
in complex with S100A9.
Cornish et al.,
1996; Kerkhoff et 
al., 2005; Kerkhoff 
et al., 2001; 
Steinbakk et al., 
1990; Yui et al., 
1997
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Human
S100
Family
Member
Ortholog
in
Mouse?
Tissue 
Distibution 
According to 
Swiss-Prot 
Database 
(Human)
Putative Functions 
(Human and/or Mouse)
References for putative 
functions
S100A8 Yes Myeloid cells Chemoattractant. 
Anti-microbicidal and 
apoptosis inducing function 
in complex with S100A9. 
Regulates neutrophil 
oxidase activity and 
arachidonic acid transport in 
complex with S100A9.
Comish et al., 1996; 
Kerkhoff et al., 2005; 
Kerkhoff et al., 2001; 
Steinbakk et al., 1990; 
Yui et al., 1997
S100A9 Yes Myeloid cells Chemoattractant. 
Anti-microbicidal and 
apoptosis inducing function 
in complex with S100A9. 
Regulates neutrophil 
oxidase activity and 
arachidonic acid transport in 
complex with S100A9.
Kerkhoff et al., 2005; 
Kerkhoff et al., 2001; 
Ryckman et al., 2003b; 
Steinbakk et al., 1990; 
Yui et al., 1997
S100A10 Yes Connective 
and epithelial 
tissues
Interacts with Annexin II. 
Forms part o f comified 
epithelium.
Broome et al., 2003; 
Eckert et al., 2004; 
Waisman, 1995
S100A11 Yes Haematopoetic
and
reproductive 
tissues (highly 
prevalent in 
sertoli cells)
Interacts with Annexin I. 
Forms part o f comified 
epithelium.
Broome et al., 2003; 
Eckert et al., 2004; 
Seemann et al., 1996
22
Chapter 1: Introduction
Human
S100
Family
Member
Ortholog 
in Mouse?
Tissue Distibution 
According to Swiss- 
Prot Database 
(Human)
Putative Functions 
(Human and/or 
Mouse)
References for 
putative functions
S100A12 No Monocytes and 
lymphocytes
RAGE ligand Hofmann et al., 1999
S100A13 Yes Heart and skeletal 
tissue
Participation in 
fibroblast growth 
factor-1 release
Mouta Carreira et al., 
1998
S100A14 Yes Highly prevalent in 
colon, moderate 
levels in thymus, 
kidney, liver and 
lung.
None
S100A15 No Unknown None
S100B Yes Highly prevalent in 
brain
Modulation of 
neuronal calcium 
signalling. Mediates 
neurite outgrowth
Dyck et al., 2002; 
Huttunen et al., 2000; 
Nishiyama et al., 
2002; Xiong et al., 
2000
SI OOP Yes Placenta None
S100Z Putative
sequence
Spleen and 
leukocytes
None
Table 1.1 Summary of S100 family members showing site of expression and 
putative functions if known.
Sites o f expression according to Swiss-Prot database accessed via www.genecards.ora. Table 
adapted from (Donato, 1999; Marenholz et al., 2004).
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amino-acid-level, although their DNA sequence similarity is less. The regions of 
greatest divergence between family members are in the non-coding regions 
indicating a potential role for these regions in tissue specific control of expression 
(Zimmer et al., 1996).
The gene structure of S100 proteins are highly conserved in humans and 
rodents, consisting of 3 exons, with the coding sequence beginning in exon 2 and 
ending in exon 3 (figure 1.1) (Zimmer et al., 1996). The basic structural unit of 
the SI 00 protein is a symmetrical unit comprising of two EF-hand domains joined 
by a flexible linker (figure 1.1). Most S I00 proteins generally exist as dimers, 
with the formation of homodimers being the most common stoichometry. S I 0 0  
proteins are defined by the presence of an atypical N-terminal EF-hand domain 
consisting of 14 rather than 12 residues. Typically the conformational change in 
the EF-hand induced by calcium binding is small in the N-terminal EF-hand and 
more dramatic in the C-terminal motif. The hydrophobic patch revealed by 
calcium binding to the S I 0 0  protein is relatively shallow and an S I 0 0  dimer 
typically presents two symmetrically opposed hydrophobic zones. It is these 
hydrophobic pockets that appear to allow interaction of the S I 0 0  protein with its 
target (Bhattacharya et al., 2004).
In addition to their ability to bind calcium, S I00 proteins are also reported 
to bind other divalent cations including zinc and copper. The site of binding has 
been shown to be near the dimer interface surface in the crystal structure of 
S100A7, S100B and S100A12. (Recent structural data for S I00 reviewed in 
(Bhattacharya et al., 2004)). The specificity of their effector function is thought 
to be provided primarily by their distinct tissue specific expression and sub- 
cellular localization.
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Figure 1.1 S100 protein and gene structure
A: General structure o f S100 proteins showing the two EF-hand motifs, with EF-hand II having an 
extended calcium binding loop.
B: Typical S100 protein gene structure, with the boxes showing the three exon regions and the 
blue regions indicating the coding sequences. The corresponding mRNA structure is also shown.
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1.2.1 S100 null animals
Numerous functions have been associated with S I00 proteins. Much of 
this evidence comes from in vitro studies and provides a broad spectrum of 
possible functions many of which seem to have no defined mechanism of action. 
To date several S I00 null animals have been produced in order to address the 
function of these proteins in an in vivo biological system. The majority of these 
transgenic animals have been viable and fertile, showing no gross abnormalities (a 
summary of the S100 null animals published to date can be found in Table 1.2). 
Only S100A8 has been shown to have a non-redundant function in development 
to date. The S100A8 null mice are lethal at embryonic day 11.5, possibly 
implying a role in maternal-foetal interaction (Passey et al., 1999). S100A1 is 
expressed at high levels in cardiomyocytes. S 1 0 0 A 1 null mice have a lesion in 
the calcium response to (3-adrenergic stimulation in cardiomyocytes and show 
lack of compensation for increased cardiac work in a model of acute 
hemodynamic stress (Du et al., 2002). The S100B null mice show enhanced 
calcium transients in response to caffeine in astrocyte cell cultures (Xiong et al., 
2000). In addition these mice show an enhanced reactivity in a model of 
experimental epileptogenesis where seizures are induced by electrical stimulation 
of the amygdala, a process known as kindling (Dyck et al., 2002). The S100A4 
null mice have shown an increased susceptibility to spontaneous tumour 
formation (Grum-Schwensen et al., 2005). S100A11 null animals are normal, 
viable and fertile showing no abnormalities to date in the cells that demonstrate 
the highest basal expression of this protein, sertoli cells (Mannan et al., 2003).
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S100 Family 
Member
Phenotype Reference
S100A1 Decreased cardiac contractility and increased Du et al., 2002
susceptibility to haemodynamic stress in vivo
S100A4 Spontaneous tumour formation CNaaman et al., 2004
S100A4 Decreased engraftment o f syngeneic tumour cell-line Grum-Schwensen et
al., 2005
S100A8 Embryonic lethal Passey et al., 1999
S100A9 Decreased chemoattractant-induced calcium signalling Hobbs et al., 2003
in vitro
S100A9 Altered neutrophil migration in vitro Manitz et al., 2003
S100A11 No obvious phenotype Mannan et al., 2003
S100B Enhanced memory function in in vivo behavioural Nishiyama et al., 2002
tests
S100B Enhanced epileptogenesis in an in vivo kindling model Dyck et al., 2002
Table 1.2 Summary of SI00 family knockout mice
Adapted from (Marenholz et al., 2004).
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1.2.2 S100A9
S100A9 is of considerable interest to leukocyte biologists by nature of its 
extraordinarily high expression in neutrophils, constituting 40% of neutrophil 
cytosolic protein in its dimeric form with S100A8 (Edgeworth et al., 1991). 
Originally identified in a number o f studies and given a variety o f names 
including “the cystic fibrosis antigen” (CFA), “migration inhibitory factor-related 
protein 14 (MRP-14), p i4, calgranulin A and LI light chain amongst others 
(reviewed (Hessian et al., 1993)). Cloning of the S100A9 cDNA revealed these 
proteins to be the same entity and latterly it has been given the name S100A9 
according to the new nomenclature of these proteins. Uncharacteristically for 
S I00 proteins, S100A9 exists as a hetero-, rather than homo-, dimer bound to 
another family member, S100A8. The stochiometry o f this complex was 
evaluated by immuno-afflnity chromatography and complexes o f 1 : 1  
S100A8:S100A9 were found in human granulocytes and monocytes along with 
higher order complexes (Edgeworth et al., 1991). Further evaluation of the dimer 
formation revealed that the most favourable conformational arrangement of 
S100A8/9 was as a 1:1 heterodimer, with other S100A9/A9 or S100A8/A8 
hom odim eric com plexes not dem onstrating the unique interface 
complementarities of the heterodimer (Hunter and Chazin, 1998). There are 
several reports of higher order S100A8/9 complexes with the formation of 
calcium-induced tetramers being the most recently reported (Teigelkamp et al., 
1991; Vogl et al., 1999). Yeast two-hybrid analysis also revealed the heterodimer 
to be the preferred conformation for the human proteins with only the murine
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homologs showing homodimerization (Propper et al., 1999). The C-terminus was 
shown to have an important role in dimer formation in that study (Propper et al., 
1999). The relative importance of the C-terminus in dimer formation was not 
confirmed in later deletion studies that showed mutation of both the C- and N- 
termini of S100A9 did not prevent dimer formation with S100A8 in the human 
system (Hessian and Fisher, 2001). The crystal structure of S100A8/9 complex 
has been recently released and is shown in Figure 1.2.
The murine system is often used as a model to evaluate the function of 
proteins and the results obtained applied to the human system. Comparison of the 
murine and human homologs of S100A9 has revealed that both murine S100A9 
and S100A8 share 59% and 64% nucleotide identity with the human proteins. At 
the protein level 59% identity is reported, with the most conserved areas being the 
calcium binding motifs and the most divergent the C-termini (Lagasse and 
Weissman, 1992). Biochemical analysis of murine S100A9 indicated that it 
appears to be the homolog of the human protein and is expressed at similar levels 
to the human protein in murine granulocytes (Nacken et al., 2000).
Phosphorylation o f human S100A9 has been reported following 
ionomycin treatment of both monocytes and neutrophils. The site o f this 
phosphorylation was shown to be the penultimate amino acid in the C-terminus of 
S100A9 (Edgeworth et al., 1989). Phosphorylation of S100A9 also occurs in 
response to FMLP and PMA (Bengis-Garber and Gruener, 1993; Guignard et al., 
1996). The phosphorylation of murine S100A9 has never been published and 
indeed the C-terminal phosphorylation site described in the human protein is not 
conserved in the murine protein (E. McNeill - data not shown).
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Figure 1.2 Crystal structure of S100A8/9 as a heterotetram er at 1.8A 
resolution
Data from RCSB protein databank entry IXK4 fhttp://pdbbeta.rcsb.org/pdb). 1.8A Structure 
released 15th October 2005, as yet unpublished. Authors: Brueckner, F.N.A., Skerra, A., 
Komdoerfer, I.P. Stuctural diagrams produced by Dr Rebecca Kirk (IMP Vienna) using PyMOL 
software (DeLano, 2004). S100A9 shown in green, S100A8 shown in blue. A: S100A8/9 dimer 
crystalised as a alpha helical heterodimer. The predicted biological entity is of a dimer o f dimers 
(B).
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1.2.3 S100A8/9 expression
S100A8/9 is primarily expressed in neutrophils and monocytes. Stratified 
squamous epithelia of the tongue, oesophagus and buccal cells and cells of the 
hair follicle also express this protein in healthy individuals (Brandtzaeg et al., 
1987; Schmidt et al., 2001; Wilkinson et al., 1988). A more widespread 
expression profile for the heterodimer occurs during disease, in particular by 
hyper-proliferative epithelial cells and in squamous cell carcinomas of skin and 
lung (Wilkinson et al., 1988). Expression by epithelial cells during inflammatory 
conditions is also frequently reported. Human epithelial keratinocytes have been 
shown to express S100A8/9 during conditions including psoriasis, lupus 
erythematosus and atopic dermatitis (Gabrielsen et al., 1986; Kunz et al., 1992; 
Saintigny et al., 1992). A subset of human macrophages express S100A8/9 in 
inflammatory and infective conditions such as rheumatoid arthritis and pneumonia 
(Odink et al., 1987) (Buhling et al., 2000).
1.2.4 Subcellular localisation
In resting neutrophils S100A8/9 has a cytosolic localization and treatment 
with activating stimuli such as zymosan causes the protein to move to the 
membrane, illustrated by cell fractionation experiments (Lemarchand et al., 1992). 
Recent studies have demonstrated the membrane localisation of S100A8/9 to be in 
detergent insoluble lipid rafts (Nacken et al., 2004). In human monocytes the 
protein complex translocates completely from the cytosol to the cytoskeletal and 
vimentin-containing structures following treatment of the cell with elevated 
calcium concentrations (Roth et al., 1993). This movement occurs in these cells 
following treatment with the calcium ionophore ionomycin (Burwinkel et al.,
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1994). The preferential translocation of phosphorylated S100A9 to the membrane 
and cytoskeletal fraction of monocytes has been suggested (van den Bos et al., 
1996). An association of S100A9 with the microtubule system and the secretion 
of these proteins under these circumstances are reported (Rammes et al., 1997).
Similarly in keratinocytes expressing S100A8/9, a calcium dependent 
association with the vimentin cytoskeletal fraction occurs (Goebeler et al., 1995).
1.2.5 S100A8/9 -  putative functions
As high extracellular concentrations of S100A8/9 are found in a range of 
inflammatory conditions, a range of extracellular functions as well as intracellular 
functions have been proposed. In particular faecal levels of the S100A8/9 
complex are used as a non-invasive means of assessing inflammatory bowl 
disease (Fagerhol, 2000). High elevated serum levels of S100A8/9 complex were 
first reported in cystic fibrosis patients and the complex at that time was known as 
the Cystic Fibrosis Antigen (CFA). CFA was thought to be key in the 
pathogenesis of this disease prior to the identification of a mutation in the cystic 
fibrosis transmembrane receptor (CFTR), a chloride ion transporter, as being 
causative in this condition. CFA was eventually identified as being a small 
calcium binding protein of myeloid origin (Barthe et al., 1991; van Heyningen et 
al., 1985).
In many cases putative roles for a protein come from observations of 
diseases in which expression o f the protein is absent -  effectively human 
‘knockouts’. No condition of this type has been reported in humans, however, a 
condition comprising of massive elevations in serum S100A8/9 level has been 
described -  hypercalprotectinaemia (Saito et al., 2002; Sampson et al., 2002).
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This condition is associated with serum protein concentrations in the region of 1 - 
6 g/L compared to a standard level of less than lmg/1. The condition manifests 
with serum zinc levels of 77-200pmol/1 compared to basal levels of 1 l-18pmol/l. 
Whether the elevated levels of zinc are a cause or effect of the elevated S100A8/9 
levels is unclear as the zinc was found bound to the protein complex. The patients 
suffer from recurrent infections and systemic inflammation, symptoms that can be 
attributed to elevated zinc levels.
In the following section proposed roles for S100A9 and other S I00 
proteins that could imply a role in neutrophil function will be discussed in context 
of an overview o f the role of neutrophils in innate immunity. Neutrophil 
functions are summarised in figure 1.3.
1.3 Innate im m unity
In order to survive in an environment with constant exposure to potentially 
harmful microorganisms, we must have a means to prevent our bodies being 
invaded to deleterious effect. The body is protected by two arms of the immune 
system the evolutionarily ancient innate immune system and the more recent 
adaptive immune system. The innate immune system is the body’s first line of 
defence against pathogens and is responsible for protecting the body against the 
majority of potentially dangerous microbial insults. The innate immune system 
consists of both the physical barriers of the epithelial surfaces, that act to stop 
pathogenic microorganisms adhering to and entering the body, and cell-mediated 
immunity mediated by phagocytic leukocytes such as macrophages and 
neutrophils. These cells are capable of recognising pathogens, engulfing and
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Phagocytic vaculoes fuse w ith  
cytotoxic granules inside the  
cell and an oxidative burst 
is in itiated.
N eutrophils arrive at th e  sitye o f 
in fection and identify  invading  
pathogens using pa tte rn  
recognition recepotrs and  
opsonic receptors.
N eutroph ils  phagocytose  
invading m icroorganism s, 
generally  opsonized by 
c o m p lem en t or antibody.
N eutrophils  adhere  to  th e  in flam m ed  
vascular en d o th e liu m  and m ove  
in to  th e  surrounding tissue 
fo llow ing  grad ients o f
The neutrop hil cytotoxic  
m achinery kills and degrades
th e  m ic r o o r g a n i s m .
The neutrop hil undergoes  
apoptosis during  th e  resolution  
o f in flam m atio n  and is phagocytosed  
by other leukcytes to  contain th e ir  
destructive capacity.
Figure 1.3 General scheme of neutrophil function
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destroying them whilst at the same time producing chemical signals to activate the 
inflammatory response and stimulate the adaptive immune system.
The first point of protection against pathogens is the continuous surface 
epithelium that forms a physical barrier with the external world. As well as acting 
as a physical barrier, the body’s epithelia act to produce chemical barriers to 
microbial invasion, such as the low pH of the stomach and antibacterial peptides 
produced by the skin and intestine. In addition, the normal gut flora compete for 
nutrients with other pathogenic bacteria, thus preventing their growth. These 
mechanisms of immunity require no specific recognition of pathogens. The 
cellular arm of the innate immune system requires a method of pathogen 
recognition to direct their cytotoxic potential in a focused manner against the 
pathogen not the body itself. One of the first lines of activation of the cellular 
innate system is the complement cascade. (Basic core elements of the innate 
immune system reviewed in (Beutler, 2004; Janeway and Medzhitov, 2002))
1.3.1 Recognising pathogens
Complement proteins circulate the body in blood and tissue fluid. The C3 
component undergoes a constant low-rate hydrolysis into C3a and C3b and 
following adhesion of C3b to a pathogen surface binds to factor B in blood 
allowing recognition and cleavage by factor D cleavage to form the C3 convertase 
complex. The C3 converatse converts more C3 into C3a and C3b allowing large 
quantities of C3b to bind at high density to the microorganism surface allowing 
recognition by complement receptors on leukocytes. As a result the bacteria are 
opsonized and can be recognised and phagocytosed by cells of the innate immune 
system. In addition the complement pathway can also assemble the bactericidal
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pore forming complement complex that punctures bacterial membranes, and also 
produces the anaphylatoxins C3a, C4a and C5a. These attract the cellular 
component of the innate immune system to the site of infection. (Complement 
function reviewed in (Fujita, 2002)).
Another way in which cells recognise invading microbes is by ligation of 
the Toll like receptors (TLRs). This family has been the subject o f intense 
investigation in recent years since their identification. TLRs were identified as 
mammalian homologs of a drosophila protein crucial in allowing these flies to 
sense fungi. There are ten TLRs in humans and nine TLRs (along with two 
additional paralogs) in mice. These cellular receptors are thought to be the major 
mechanism by which mammals sense microbes. The TLRs act as Pattern 
Recognition Receptors (PRRs), receptors that recognise conserved Pathogen 
Associated Molecular Patterns (PAMPs). The identification of TLRs shows that 
PAMPS are specific molecules that are generally unique to microbes. The first to 
be identified in humans was TLR4, which recognises LPS, a heat stable bacterial 
wall component. LPS had been known for more than 100 years as a cause of 
fever and potentially fatal septic shock. In addition to the TLR family other PRRs 
such as Mannose Binding Lectin and f-Met-Leu-Phe Receptor (FMLP receptor) 
recognise terminal mannosyl residues and formylated peptides originating from 
bacteria. (Pattern recognition reviewed in (Beutler, 2004; Gordon, 2002; Janeway 
and Medzhitov, 2002))
1.3.2 The leukocytes of the innate immune system
The first cells to be recruited to the site of infection are neutrophils. 
Neutrophils are short-lived polymorphonuclear leukocytes, also known as
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granulocytes. These have a half-life of around 6  hours in the circulation before 
undergoing apoptosis and are the most abundant leukocyte in blood (although to a 
lesser degree in mice). Neutrophils are specialized to rapidly take up microbes by 
phagocytosis. They have an artillery of cytotoxic machinery to kill and degrade 
the pathogen once it has been phagocytosed. They are capable of producing an 
oxidative burst and contain numerous granules that contain a host of anti­
microbial peptides and protease enzymes. It is the function of these cytotoxic 
leukocytes that is the principle focus of study in this thesis. (Review of neutrophil 
biology (Witko-Sarsat et al., 2000).
Another type of leukocyte that is important in the early phase of an innate 
immune response is the macrophage. Macrophages are a mature differentiated 
form of monocytes, collectively known as mononuclear phagocytes. Monocytes 
are formed in the bone marrow and circulate around the body in the blood and 
become resident macrophages in most tissues. They act as sentinels recognising 
invading pathogens by opsonic receptors or other pathogen recognition receptors 
and produce a range of cytokines that attract other members of the innate and 
adaptive immune system to the affected area.
1.3.3 Neutrophil development
The bone marrow is the principle site for the production of blood cells, 
termed haematopoiesis. Leukocytes and erythrocytes are derived from multi­
potential pluripotent stem cells. Neutrophils arise from these stem cells via the 
“Common Myeloid Progenitor” (CMP) and “Granulocyte-Monocyte Precursor” 
(GMP) in a process termed granulopoiesis. Neutrophils are a terminally 
differentiated cell type and do not under go further cell division. As a result of
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their short life span and in order for the body to respond rapidly to an infection, 
the bone marrow must contain a large reserve of neutrophils to meet the challenge 
of an acute infection. The granulocyte/macrophage lineage is characterised by the 
expression of FcyRII/III during development (Myeloid development summarised 
in (Imhof and Aurrand-Lions, 2004)). In vitro Granulocyte-Colony Stimulating 
Factor (G-CSF) and Granulocyte/Macrophage Stimulating Factor (GM-CSF) have 
been shown to promote the growth of bone marrow cell colonies containing 
neutrophils in methylcellulose cultures. During the maturation of neutrophils, the 
primary granules arise first during the myeloblast to promyelocyte stage. At this 
point cell division ceases and the secondary and tertiary granules arise. Later 
markers of neutrophils maturation include lactoferrin and the Gr-1 surface marker. 
(Neutrophil development reviewed in (Friedman, 2002; Ward et al., 2000; Witko- 
Sarsat et al., 2000))
The study of granulopoiesis has received interest in recent years in terms 
of elaborating the transcription factors involved and their activation by factors 
such as GM-CSF with the objective of understanding the generation of myeloid 
leukaemias. A scheme of required transcription factors for the production of the 
GMP shows a role for induction of high levels of PU-1 via a C/EBP dependent or 
independent pathway. Commitment to the granulocyte lineage requires continued 
expression of PU-1 and C/EBP along with signalling via the Retinoid acid receptor 
(reviewed in (Friedman, 2002; Ward et al., 2000)).
The control of neutrophil release from the bone marrow has recently been
shown to occur via an axis of increased stimulation of the neutrophil mobilising
chemokine receptor CXCR2 and is required to overcome the effects of the bone
marrow homing chemokine receptor CXCR4 (Martin et al., 2003a). It is assumed
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that via this chemokine-induced signalling, the number of neutrophils circulating 
in the blood is tightly controlled.
1.3.4 A role for S100A9 in neutrophil development?
The expression of S100A9 in mature human blood neutrophils has been 
recognised for a number of years, but the precise point at which it arises in 
neutrophil development is less clear. Initial studies of the expression of S100A9 
mRNA by HL-60 cells (a human leukaemic granulocyte progenitor cell-line) 
showed that S100A9 mRNA was induced when the HL-60 was stimulated to 
differentiate to either a monocytic or neutrophilic phenotype (Lagasse and Clerc, 
1988). This study was extended to look at the expression of S100A8 and S100A9 
in murine haematopoiesis. Expression of S100A9 was shown to occur at sites of 
haematopoiesis in both foetal and adult mice. S100A9 expression was shown to 
be coincident with expression of the Gr-1 and Mac-1 myeloid markers in both 
bone marrow, foetal liver and yolk sac at day 11 of gestation (Lagasse and 
Weissman, 1992). Confirmation of the expression of S100A9 by granulocytes 
and monocytes and possibly myelo-monocytic precursors was provided by 
examination of the morphology of bone marrow cells staining positively for 
S100A8/9 expression (Goebeler et al., 1993). A survey of alveolar, resident 
peritoneal and thioglycollate-elicited macrophages showed them all to be 
S100A8/9 negative (Goebeler et al., 1993). This implies the expression of 
S100A8/9 in the monocyte lineage expression is limited to the non-terminally 
differentiated cell types.
S100A8/9 dimer has been implicated in modulating the activity of casein 
kinase I and II. These enzymes phosphorylate topiosomerase I and RNA
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polymerases I and II. That S100A8/9 can potentially modulate the activity of 
parts of the transcriptional machinery could highlight a role for them in the 
differentiation or commitment of cells to the myeloid lineage (Murao et al., 1989).
1.4 Chem okines and the leukocyte adhesion cascade
The correct, controlled trafficking of leukocytes to the site of an infection 
is an essential facet of immune system function. When this process becomes 
uncontrolled pathological inflammatory conditions can develop. In order to 
perform their key function of protecting the body from infection neutrophils must 
be able to leave their site of development/circulation and follow signals to 
wherever an infection is present. These directional signals are provided by 
chemokines and other chemoattractants, which provide both activating and 
directional information to leukocytes. To do this they must be able to follow an 
orchestrated set of signals that direct them to the correct location. If this process 
fails and the neutrophils do not reach the site of infection, as in the case of 
disorders such as Leukocyte Adhesion Deficiency 1 (LAD1), then infections are 
not controlled and can be life-threatening. Similarly if the neutrophils are targeted 
to the wrong location they have the capacity to cause great damage to the body 
due to their inflammatory potential. (Neutrophil disorders reviewed (Lakshman 
and Finn, 2001)).
1.4.1 Chemoattractants and chemotaxis
Chemoattractants can be broadly broken up into 3 distinct groups: 
‘classical chemokines’, other chemoattractant substances produced by the body 
and substances produced by invading microbes.
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Classical chemokines are small (8-10 kDa) constitutive or inducible 
proteins causing homeostatic lymphocyte trafficking to secondary lymphoid 
organs or secreted by cells at the site of infection/inflammation respectively. 
These proteins have defined C-terminal cysteine motifs. They are sub-grouped 
according to this motif as CXC, CC, C or CX3 C chemokines and bind to CXCR, 
CCR, XCR and CX3 CR receptors respectively. These are seven-transmembrane 
spanning G-protein coupled receptors that activate cytosolic calcium elevations 
through a phospholipase C coupled mechanism. (Classical chemokines reviewed 
in (Rossi and Zlotnik, 2000)).
The body also produces small protein and lipid mediators that act as 
chemoattractants for leukocytes. These include C5a, a part of the Complement 
cascade, which is produced following activation of this protective serum protein 
mechanism. In addition the lipid Platelet Activating Factor (PAF) produced by 
activated endothelial cells, and Substance P, produced by sensory neurones also 
act as non-classical chemoattractants. These non-classical host produced 
chemoattractants also ligate G-protein coupled seven transmembrane spanning 
receptors.
The most comprehensively studied chemoattractant produced by invading 
bacteria is the formylated peptide formyl-methionyl-leucyl-phenylalanine 
(FMLP). This is a potent chemoattractant for neutrophils and ligates a G-protein 
coupled seven transmembrane spanning receptor on these cells.
Chemoattractants activate a host of signalling pathways downstream of
activation of their receptors. In general these receptors produce a range of
biologically active lipid mediators such IP3 and diacylglycerol (DAG) and
products o f the enzyme phosphoinositide-3-kinase (PI-3K) (Chemoattractant
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signalling in neutrophils reviewed in (Niggli, 2003)). In addition they activate 
various protein kinase families and small Rho-family GTP-binding proteins. 
Whilst the role of Rho-family proteins appears to have a clear role in cell 
morphology changes associated with a migratory phenotype, the role of the lipid 
mediators is more unclear (reviewed in (Vicente-Manzanares and Sanchez- 
Madrid, 2004) and (Wu, 2005)). The most perplexing of these is the role of the 
IP3 mediated calcium signal. IP3 is generated by phospholipase C (PLC). Studies 
of PLC(32/3 null mice show that these molecules are entirely responsible for 
chemoattractant induced calcium signalling in murine neutrophils. However, in 
an in vivo model of peritonitis the chemotaxis of the PLC|32/3 null neutrophils 
was unimpaired (Li et al., 2000b; Wu et al., 2000). This seems to imply that both 
the directional and migratory aspects required for chemotaxis do not require this 
calcium signal. No global elevations or persistent gradients of calcium were 
found in neutrophils migrating on glass towards an FMLP stimulus, again finding 
no correlation of calcium signalling with chemotaxis (Laffafian and Hallett,
1995). Indeed the ability of neutrophils to produce a gradient of calcium within 
the cell, which would be required to provide a directional signal, is questionable 
given the release of calcium following chemoattractant stimulation has been 
shown to come from a central store within the cell (Pettit and Hallett, 1998). (The 
potential role of calcium in chemotaxis is reviewed in (Tian et al., 2004)).
1.4.2 Leukocyte adhesion and migration
In order to circulate around the body in the blood stream in the absence of 
inflammatory stimuli, neutrophils need to be kept in a non-adhesive state. This 
circulating pool of neutrophils provides a reservoir of cells for a rapid response to
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a danger signal. The neutrophil receives this signal in the post-capillary venules 
where the slower flow rate allows the cell to interact with the activated 
endothelium. The process of leukocyte adhesion is summarised in figure 1.4. The 
interaction of selectins and their glycoprotein ligands mediate the initial tethering 
and rolling of the neutrophils along the activated endothelium. P-selectin can be 
rapidly mobilised to the endothelial cell surface and interacts with P-selectin 
glycoprotein ligand-1 (PSGL-1) expressed on neutrophil microvilli. This 
interaction is strengthened by the interaction of E-selectin, expressed with slightly 
less rapid kinetics by the activated endothelium, with PSGL-1. The neutrophils 
themselves express L-selectin constitutively, and the binding capacity of this 
ligand is greatly enhanced following leukocyte activation. This molecule interacts 
with glycoprotein ligands upregulated by the endothelium. These tethering 
interactions slowdown the neutrophil allowing interaction with activating and 
directional stimuli such as chemokines and other chemoattractants immobilised on 
the endothelium (Neutrophil adhesion and activation reviewed in (Ley, 2002; 
Witko-Sarsat et al., 2000)).
Following selectin binding and chemoattractant exposure neutrophil |32 
integrins undergo an increase in binding capacity as a result o f “inside-out” 
signalling that leads to clustering of the integrins and a conformational change to 
a high-affmity state. This disengagement of the integrin “safety switch” allows a 
transition to firm interaction with the endothelium. In particular Leukocyte 
function-associated antigen-1 (LFA-1) (aLp2 or CD lla/C D 18) binds to the 
inflammation-induced ligand Intercellular adhesion molecule-1 (ICAM-1) or the 
constitutively expressed ICAM-2. The combination of chemokine activation and
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Figure 1.4 Leukocyte adhesion cascade
In order to migrate to the site of infection neutrophils first become tethered to the inflammatory 
endothelium. The tethering process occurs by binding interaction o f selectins with their 
carbohydrate ligands. This process allows chemokine receptors on the neutrophil surface to bind 
chemokine immobilised upon the endothelial cells. Downstream signalling pathways from 
chemokine receptors cause an increase in the affinity and avidity o f neutrophil p2 integrins 
increasing their binding to ICAM molecules allowing firm adhesion and shape change to occur. 
Neutrophils migrate along the endothelial wall to intracellular junctions where they extravasate 
using PECAM and JAMs. The cells migrate through the extracellular matrix following 
chemoattractant gradients by haptotaxis mediated by pi integrins.
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“outside-in” signals from the engaged integrin allows the neutrophils to spread on 
the vascular wall and gain a motile phenotype.
Having arrested on the vascular endothelium and received activating 
stimuli, the neutrophils must now extravasate out o f the vessel into the 
surrounding tissues to the origin of the inflammatory stimuli. Neutrophil 
transmigration has been shown to occur most frequently at discontinuities in the 
endothelial cell tight junctions. Using Platelet/endothelial cell adhesion molecule- 
1 (PECAM-1) and/or Junctional cell adhesion molecule (JAM), neutrophils pass 
out between the endothelial cells with binding to PECAM-1 causing increased 
expression of a 6 p 1 integrin by the neutrophils and allowing passage across the 
basement membrane (Dangerfield et al., 2 0 0 2 ). Once in the extracellular matrix 
they migrate using p i ,  P2  and p3 integrin-ligand interactions to follow the 
chemotactic gradient to its source by haptotactic movement. (Extravasation 
reviewed in (Nourshargh and Marelli-Berg, 2005; Weber, 2003)).
1.4.3 The cytoskeleton in leukocyte migration
In order for leukocytes to undergo the rapid shape-changes and movement 
required for leukocyte recruitment and cytotoxic functions such as phagocytosis, 
they must be able to intricately re-organise their cytoskeleton. The cytoskeleton is 
an organised network of polymers consisting o f actin microfilaments, 
microtubules and intermediate filaments. The most stable, un-dynamic of these 
are the intermediate filaments, which are primarily formed o f vimentin in 
leukocytes. These seem to play a role in cell rigidity and structural integrity 
rather than in active cellular rearrangement during leukocyte migration (reviewed 
in (Vicente-Manzanares and Sanchez-Madrid, 2004)).
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Microtubules are formed by uni-directional polymerisation, or nucleation, 
of a p  tubulin heterodimers to form hollow tubes. These tubes are dynamic, their 
length being controlled by a process of treadmilling. The interaction of dynesin 
and kinesin motor proteins with the microtubules allows the rapid transport of 
vesicles around the cell. As well as a role in cell migration, these filaments are 
also vital in cell division. In the migrating cell the microtubules organise with the 
microtubule organising centre behind the nucleus away from the direction of 
migration towards the trailing edge (Vicente-Manzanares and Sanchez-Madrid,
2004).
The cytoskeletal element that appears to have the most extensive role in 
leukocyte migration is actin. Monomeric actin nucleates to form micro-filaments 
by treadmilling. An array of proteins modulate this such as the ARP2/3 complex 
that bind to the filaments promoting further actin binding and conformational 
changes in the filament. In a polarised migratory leukocyte, rapid actin 
polymerisation occurs at the lamellipodia in coordination with actomyosin based 
contraction. Rear detachment of the cell requires actinomyosin contraction in the 
absence o f actin fibre extension. (The involvement of the cytoskeleton in 
leukocyte migration reviewed in (Pettit and Fay, 1998; Vicente-Manzanares and 
Sanchez-Madrid, 2004))
1.4.4 S100 protein association with the cytoskeleton
There are numerous reports of different S I00 family members interacting 
with the cytoskeleton, which could translate to playing a role in cell migration in 
rapidly migrating cells such as the neutrophil. Some association of at least 10 of 
the 19 family members with the cytoskeleton seems to indicate a possible
46
Chapter 1: Introduction
conserved role for these proteins in cytoskeletal associated processes (review 
(Donato, 2001)). However, despite numerous S I00 family members having an 
association with the cytoskeleton, there appears to be no consensus concerning 
mechanism of action or association with one particular part of the cytoskeleton. 
Also much of the data comes from in vitro biochemical studies, with the proposed 
functions not being demonstrated in vivo. For example both S100B and S100A1 
have been described to cause the inhibition of microtubule formation by 
sequestration of tubulin, and to confer calcium sensitivity to preformed 
microtubules, yet other members of the family (S100A1, S100A6 and S100A4) 
apparently modulate tropomyosin activity (reviewed in: (Donato, 1999; Donato, 
2001)).
With regard to S100A8/9, much of the evidence presented comes from in 
vitro studies alone or is descriptive rather than mechanistic. S100A8/9 has been 
shown to translocate to the plasma membrane and vimentin intermediate filaments 
in monocytes following the elevation of cytosolic calcium (Roth et al., 1993). 
This translocation is enhanced when S100A9 is phosphorylated (van den Bos et 
al., 1996), it should be noted that phosphorylation of murine S100A9 has never 
been reported. Indeed a “Phosphosite” search of the protein sequence for murine 
S100A9 shows the major human phosphorylation site at the C-terminal of the 
molecule is not conserved in the murine protein, although other probable 
phosphorylation sites are found in the primary structure of the protein (E. McNeill 
-  data not shown). Following phorbol ester stimulation the S100A8/9 complex 
apparently translocates to microtubules in monocytes and macrophages ((Rammes 
et al., 1997)). Recent data has also shown that in vitro S100A9 is capable of
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promoting tubulin polymerisation (Vogl et al., 2004). These putative roles for 
S100A8/9 could clearly translate to a role in cell migration.
S100A4 is associated with cancer metastasis, with its overexpression 
promoting metastatic ability in non-metastatic cell-lines (Levett et al., 2002). A 
transgenic over-expressing S100A4 mouse has also demonstrated a metastasis 
promoting activity (Ambartsumian et al., 1996). The mechanism of action is still 
unclear but S100A4 is found associated with myosin II and localises in the 
lamellipodia of migrating cells (Kim and Helfman, 2003). The ability of S100A4 
to promote a migratory/metastatic phenotype can be reversed by co-transfection 
of S100A1, which has been shown to directly interact with S100A4 in vivo (Wang 
et al., 2005).
In addition to specific evidence of an interaction between S I00 proteins 
and the cytoskeleton, any role of these proteins in calcium signalling or 
homeostasis could translate to a role in neutrophil motility. Cell motility is 
intimately linked with calcium signalling, with calcium necessary for both 
integrin function and for cytoskeletal reorganisation.
1.4.5 S100A8 and S100A9 in cell trafficking
S I 0 0  proteins are unusual in having both intracellular and extracellular 
roles assigned to them. S100A8 and S100A9 have both been described as being 
potent chemotactic agents for neutrophils being secreted in a novel “tubulin- 
dependent” process (Rammes et al., 1997; Ryckman et al., 2004). It is claimed 
non-oxidised recombinant murine S100A8 (also known as CP-10) is chemotactic 
to neutrophils, causing them to undergo F-actin polymerization and shape changes 
without de-granulation, calcium flux or oxidase activity (Cornish et al., 1996;
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Devery et al., 1994; Lackmann et al., 1992). The chemotactic activity of CP-10 
resides in the proteins “hinge-region” (Lackmann et al., 1993). CP-10 was 
identified as an S I 0 0  protein and is now recognised as the murine homolog of 
S100A8 (Lackmann et al., 1992). An interesting phenomena related to the 
function of this protein is its regulation by oxidation (Harrison et al., 1999). Upon 
oxidation, murine S 1 0 0 A 8  was inactive in a chemotaxis assay and not able to 
recruit leukocytes in vivo. The chemotactic function of murine S100A8 is purely 
based on the action of recombinant protein independent of S100A9; S100A8 is 
induced in the absence of S100A9 in fibroblasts and macrophages (Rahimi et al., 
2005; Xu and Geczy, 2000).
Recombinant human S100A8 and S100A9 have been shown to be 
chemotactic for neutrophils in a Transwell chemotaxis assay and in an in vivo air- 
pouch model of inflammation (Hobbs, 2003; Ryckman et al., 2003b). This 
activity in the air-pouch model was shown by the Ryckman publication still to be 
present in the C3H/HeJ endotoxin insensitive mice, showing this activity was not 
due to LPS contamination of the recombinant proteins but not in the Hobbs study 
and is therefore controversial. Blocking antibodies against S100A9 reduced 
infiltration in an LPS-stimulated air-pouch model of inflammation (Vandal et al., 
2003). The release of S100A8/9 from neutrophils by a tubulin dependent process 
upon stimulation with monosodium urate crystals, was shown and hypothesised to 
provide a mechanism for leukocyte recruitment in gout (Ryckman et al., 2004; 
Ryckman et al., 2003a). Other than the chemotactic activity of S100A8 and 
S100A9, S100A7 is chemotactic for lymphocytes and neutrophils using a 
recombinant protein approach in vitro (Jinquan et al., 1996).
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If S100A8 and/or S100A9 do indeed act as chemokines, then this would 
indicate a double role for these proteins in cell motility and chemotaxis, both 
acting within the cell on the cytoskeleton and as part of the chemical signalling 
program required for neutrophil recruitment. Another manner in which S100A8/9 
may affect leukocyte recruitment is by binding to cell surface glycosaminoglycans 
on endothelial cells near to the site of inflammation (Robinson et al., 2002). This 
could provide a mechanism of presenting the S100A8/9 protein to carry out any 
extracellular roles. The association of the complex bound to the cell surface in 
proximity to extravasating leukocytes is strongly suggestive of a function in this 
process (Hessian et al., 1993). Antibodies against a carboxylated A-glycan motif 
present on the surface of endothelial cells, which is shown to bind S100A8/9, 
reduce the recruitment of neutrophils in vivo providing further suggestive 
evidence of a role for these proteins in leukocyte trafficking (Srikrishna et al., 
2001). Treatment of endothelial cells with recombinant S100A9 has also been 
reported to cause a decrease in monolayer integrity and expression of pro- 
inflammatory mediators (Viemann et al., 2005). It should be remembered that 
S I 0 0  proteins are calcium binding proteins and the chelation of extracellular 
calcium causes a decrease in endothelial cell-cell adhesion.
Other than glycans, the Receptor for advanced glycation end-products
(RAGE) has been shown to be a receptor for S I00 family members including
S100A12, S100A1 and S100B. Interaction of these proteins with RAGE regulates
neurite out-growth following stimulation of RAGE expressing neurites with
recombinant S I00 proteins (Huttunen et al., 2000). S100A12 is highly
homologous to S100A8 and S100A9 and is abundantly expressed in human
neutrophils, but is absent in the murine genome (Fuellen et al., 2003; Fuellen et
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al., 2004). S100A12 has been suggested to be central to pro-inflammatory 
functions mediated by RAGE. In vitro S100A12 was shown to cause cellular 
activation of various leukocytes. In models of colitis and footpad delayed type 
hypersensitivity a reduced inflammatory infiltrate was seen following treatment 
with a RAGE blocking antibody (Hofmann et al., 1999). However given the lack 
of S100A12 in the mouse, the ligand of RAGE in the in vivo assays is unclear, but 
has been postulated to be other S I 0 0  family members.
1.5 Neutrophil phagocytosis and m icrobial killing
Once a neutrophil has responded to a chemotactic stimulus and has arrived 
at the site of infection, it must then identify the invading microorganism and 
utilise its cytotoxic killing artillery. Neutrophils recognise pathogens using a 
variety o f surface expressed receptors. Neutrophils predominantly use Fey 
receptors (FcyRIII/CD16 and FcyRII/CD32) or complement receptors (CR1/CD35 
and CR3/CD1 lb/CD 18) to recognise antibody or complement opsonized 
microorganisms. Intracellular signals downstream of phagocytic receptors act in 
concert with activating signals from chemoattractant receptors (eg FMLP 
receptor) and pathogen associated microbial-recognition pattern receptors 
(PAMPs) to cause cytoskeletal reorganisation and engulfment of the opsonized 
particle. This occurs by either the formation of a phagocytic cup or membrane 
protrusions that engulf antibody coated particles, or by a ‘sinking’ of complement 
opsonized particles into the cell. (Phagocytosis reviewed in (Stuart and 
Ezekowitz, 2005; Underhill and Ozinsky, 2002)). A small local release of 
calcium is reported upon complement-opsonized particle attachment followed by 
a larger global increase in cytosolic concentration resulting from calcium influx
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(Dewitt et al., 2003). The global rise in calcium concentration was coincident 
with liberation of (32 integrin from cytoskeletal restraints, which was shown to be 
dependent on the activity of the calcium activated protease calpain (Dewitt et al., 
2003).
1.5.1 Neutrophil granules
The phagocytosed particle sits in a phagocytic vacuole that undergoes 
fusion with neutrophil granules. Neutrophils contain several types of granule, the 
predominant types being the azurophilic and specific granules. The azurophilic, 
or primary granules contain myeloperoxidase (catalyses hydrogen peroxide 
mediated oxidation of halides, which are then thought to have anti-microbial 
activity), neutral proteases (cathepsin G, elastase and proteinase 3), defensins 
(small antimicrobial peptides) and lysozyme (capable of lysing bacteria) amongst 
other antimicrobial proteins. The majority of these proteins are maintained in an 
inactive state by binding to the highly cationic matrix in the acidic pH of these 
granules. The specific granules contain the greatest amount of lysozyme along 
with lactoferrin (copper and iron chelator). The membrane of the specific 
granules contains transmembrane proteins of the NADPH osidase required for 
oxidative burst formation (Neutrophil granule biology reviewed in (Faurschou and 
Borregaard, 2003; Witko-Sarsat et al., 2000)).
1.5.2 Neutrophil oxidase activation
The activation of the oxidase is important to host defence against bacteria 
and fungi. Patients suffering from Chronic Granulomatous Disease (CGD)
PHOXillustrate this. CGD patients have a genetic mutation in one of the gp
proteins that make up the NADPH oxidasethat cause the protein to be absent or
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non-functional. As a result the patients have an increased susceptibility to 
infection (Neutrophil disorders reviewed in (Lakshman and Finn, 2001)).
The oxidative burst occurs as a result of activation of the multi-enzyme 
NADPH oxidase. This machinery consists of the catalytic core, membrane bound 
flavocytochrome b558, which is a heterodimer of p22PIiOX and gp91PHOX proteins. 
This heterodimer is found in both the plasma membrane and in the membrane of 
neutrophil specific granules, before becoming incorporated in the wall of 
phagocytic vacuole upon granule/vesicle fusion. This portion of the oxidase 
machinery acts as a conduit for electron transfer from cytosolic NADPH to 
oxygen in the vacuole. To activate this process the flavocytochrome must interact 
with a complex o f cytosolic proteins: p40PHOX, p47PHOX and p67PHOX. 
Deficiencies in all of these proteins (except the p40PHOX) have been identified as 
varying causes of CGD. The interaction of the small GTPase Rac is vital in 
activating this system, with a patient with a dominantly negative mutation in 
RAC2 having a deficiency in superoxide production. The various components of 
NADPH oxidase machinery have different roles acting either directly as part of 
the catalytic machinery, or to target other members of the complex to the correct 
region (activation of the oxidase machinery reviewed in (Roos et al., 2003; Segal,
2005)):
gp91 phox SUpp0rts the electron transport chain in its entirety. The C- 
terminal region allows NADPH and FAD binding, whilst the N-terminal region is 
capable of haem binding allowing electron transport across the membrane into the 
vacuole.
p22PHOX has a high-affinity binding site for p47PHOX and allows stable
docking of the cytosolic components with the gp91PHOX subunit.
53
Chapter 1: Introduction
p67PHOX binds both NADPH and rac and p47 PH0X in high concentrations. 
p47PHOX is phosphorylated by protein kinases causing a conformational 
change in the cytosolic complex of PH0X proteins allowing them to translocate to 
the membrane. Here it seems to stabilise the association of p67 PH0X with the
P U A V
flavocytochrome by interaction with p22
p40PHOX appears to stabilize the interaction of p47 PH0X and p67 PH0X in the 
cytosol. Any other functions of this protein are as yet unclear.
The chemical reaction that occurs to produce superoxide radicals by this 
complex is essentially:
NADPH + 2 0 2 NADP+ + 2 0 2‘ + H+
The electron transfer into the vacuole occur along the following electron 
transfer chain:
NADPH -» FAD -> 2 Haem 2 0 2
Once formed the superoxide molecule can react with protons, pumped in
to the phagolysosome to compensate for the negative charge occurring following
the introduction of the electrons, to form hydrogen peroxide. The phagolysosome
contains the enzymes myeloperoxidase and catalase following granule fusion,
these enzymes use hydrogen peroxide as a substrate either to produce
hypochlorous acid or water. It has been reported that the pH of the
phagolysosome does fall initially but after only 3 minutes begins to rise to neutral
or slightly above. This observation lead to the identification of potassium
channels playing a key role in microbial killing because if protons alone were
responsible for normalising the electrogenic potential of the NADPH oxidase a
more lasting dramatic decrease in pH would be seen. The activation of a
potassium current, as a part of charge compensation, into the phagolysosome
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prevents the pH dropping. The alterations in pH of the phagocytic vacuole allow 
the cytotoxic proteins of the azurophilic granules to be released from the granule 
matrix and the near neutral pH of the vacuole allows the activation of the neutral 
proteases. This ion flux system is further complicated by the presence of a 
chloride ion flux that also acts as a form of charge compensation ((Ahluwalia et 
al., 2004; Reeves et al., 2002; Segal, 2005)).
In recent years there has been some controversy over the relative 
importance of direct cytotoxic effects of oxidant species and its role in releasing 
and activation antimicrobial proteins from the fused granules. The importance of 
myeloperoxidase in antimicrobial killing has been illustrated by an increased 
susceptibility of MPO deficient mice to yeast infection (Aratani et al., 1999). 
Neutral protease deficient mice lacking elastase and/or cathepsin G show 
decreased survival following challenge with S. aureus or C. albicans (Reeves et 
al., 2002; Segal, 2005). This indicates that protease activity is necessary for the 
killing of some microorganisms and that in these cases oxidant species alone are 
insufficient for this purpose. The elegant proposition of Segal and colleagues is 
that the oxidase activates ion fluxes in the phagocytic vacuole that form an 
environment in which the antimicrobial proteins of neutrophil granules are 
designed to work. This model suggests a complex system of regulation to 
minimise the potential of these cytotoxic moieties to damage healthy tissue when 
released from the neutrophil (Segal, 2005).
1.5.3 A role for S100A9 in neutrophil oxidase activation?
There is a body of literature that appears to identify a key role for S100A9 
in oxidase activation. It has been published that the S100A8/9 complex in
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combination with arachidonic acid can enhance NADPH oxidase activity in a cell- 
free system of neutrophil membranes and cytosolic NADPH subunits (Doussiere 
et al., 1999; Doussiere et al., 2002; Kerkhoff et al., 2005). Its ability to do this has 
been linked to an ability to interact with p67PHOX and Rac-2. A role for 
arachidonic acid in activation of the oxidase has also been highlighted in a study 
where phospholipase A2 was deleted from a myeloid cell-line causing 
inactivation of the oxidase machinery (Dana et al., 1998). The oxidase activity 
could be restored by introduction of arachidonic acid into the system (Dana et al., 
1998). Given the reported properties of S100A9 to bind arachidonic acid 
(Kerkhoff et al., 1999b; Siegenthaler et al., 1997; Sopalla et al., 2002) it seemed 
possible that it acted to supply arachidonic acid to the NADPH oxidase. The most 
recent publication on the phenomenon showed a decreased oxidase activity in 
NB4 cells (a myeloid progenitor cell-line that can be differentiated to a neutrophil 
phenotype by retinoic acid) treated with antisense RNA for S100A9 to block its 
production (Kerkhoff et al., 2005). In addition the kinetics of oxidant production 
by neutrophils from another independent line of S I00A9 null mice were reduced. 
The mechanism of activity was hypothesised to be that S100A9 supplies 
arachidonic acid to the NADPH causing a conformational change in the 
flavocytochrome b558 molecule that then favours NADPH binding.
A more indirect role for the calcium sensor S I00 proteins could be in 
control of oxidase activity via alteration of calcium signalling. Work dissecting 
calcium signals associated with phagocytosis showed, using oxidant-sensitive 
zymosan particles, that the activation of the oxidase upon phagocytosis is 
coincident with a global calcium signal (Dewitt et al., 2003).
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1.5.4 S100A9: antimicrobicidal?
The S100A8/9 complex was isolated from human blood leukocytes and 
used to assess any anti-microbicidal activity of this complex. The complex was 
found to exhibit microbial growth inhibitory activity at concentrations between 4- 
128mg/L against E.coli, Klebseilla sp., S. aureus and S. epidermidis (Steinbakk et 
al., 1990). Further investigation revealed the complex also caused growth 
inhibition of C. albicans (Sohnle et al., 1991). This antimicrobial action of the 
S100A8/9 complex was shown to be zinc reversible by a number of researchers 
indicating that the ability of the complex to chelate zinc appears to be key 
(Santhanagopalan et al., 1995; Sohnle et al., 1991; Sohnle et al., 2000).
The ability of the isolated proteins to bind zinc has been implicated as a 
mechanism for other extracellular functions of S100A8/9. These include a zinc 
reversible inhibition of matrix metalloproteinases, which are enzymes important 
in processes such as wound healing, tumourigenesis and inflammation (Isaksen 
and Fagerhol, 2001). As a factor isolated from rat leukocytes, the complex was 
shown to have the ability to inhibit the growth of a mouse mammary carcinoma 
cell line (Yui et al., 1995a). A related growth-inhibitory/apoptosis inducing 
function on normal fibroblasts was shown to be reversed by elevating zinc levels 
(Yui et al., 1997; Yui et al., 1995b). The relevance of these zinc related functions 
is unclear as the level to which the complex has the capability of bind zinc in vivo 
is unclear.
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1.6 Aim  o f this Thesis
To date almost all the evidence for the function of S100A9 comes from in 
vitro and biochemical assays. A mouse model lacking expression of S I00A9 was 
produced by Richard May in this lab previously. Some basic characterisation of 
the phenotype of these mice has been published recently (Hobbs et al 2003). It is 
the aim of this project to utilise these mice to test some of the many hypothesised 
potential roles for S100A9 in neutrophil function. In addition a range of broader 
in vivo assays will be presented looking in a more generalised and unbiased way 
for a true function of this protein in vivo.
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2 Materials and Methods
2.1 M aterials
2.1.1 Stimulants
Reagent Supplier Stock Solution Storage
FM LP (N -fo r m y l-m e th io n y l- le u c y l-  
phenylalanine)
Sigma 1 OmM in  
DMSO
-20°C
Ionomycin Calbiochem ImM in DMSO -20°C
IP3-AM
G ift from  A. 
C o n w a y  an d  
J.Holmes
As supplied -80°C
KC Sigma 1 mg/ml in PBS -20°C
M IP-la Peprotech EC lO m g/m l in 
PBS
-20°C
MIP-2 Peprotech EC O .lm g/m l in 
PBS
-20°C
Murine IL-ip
Peprotech EC O .lm g/m l in 
PBS
-20°C
Murine TNFa Sigma l Op g / ml  in 
PBS/0.1% BSA
-20°C
PAF Sigma 1 mg/ml in PBS -80°C
PdBu (Phorbol-12,13-dibutyrate) Calbiochem 2mM in DMSO -20°C
PMA/TPA (Phorbol-12Myristate-13-acetate) Calbiochem 2mM in DMSO -20°C
Recombinant Human C5a Sigma 1 mg/ml in PBS -80°C
Recombinant Murine S100A9 Gift from P. Tessier As supplied -80°C
Sodium Arachidonate Sigma Single Use -20°C
Thapsigargin Calbiochem 2mM in DMSO -20°C
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2.1.2 Inhibitors
Reagent Supplier Stock Solution Storage
2 - A P B  ( 2 - A m i n o e t h y l -  
diphenylborinate)
Calbiochem 50mM in Ethanol -20°C
8 -Br-cADPR Sigma S i n g l e  u s e  
Aliquot
-80°C
BIM Calbiochem 2mM in DMSO -20°C
Calphostin C Calbiochem ImM in Ethanol -20°C
DAG Kinase Inhibitor II Calbiochem lOmM in DMSO -20°C
ET-I8 -OCH3 Calbiochem 5mM in Ethanol -20°C
ETYA (5 ,8 ,1 1 ,1 4-eicosatetraynoic  
acid)
Sigma Make fresh -20°C
OAG (1 -oleolyl-2-acyl-sn-glycerol) Calbiochem S i n g l e  U s e  
Aliquot
-20°C
Pertussis Toxin Calbiochem lOOpg/ml in PBS +4°C
RHC80267 Calbiochem 50mM in DMSO -20°C
U73122 Calbiochem S i n g l e  U s e  
Aliquot
Room Temperature
U73343 Calbiochem S i n g l e  U s e  
Aliquot
Room Temperature
2.1.3 Buffers/Serum
Reagent Supplier
E4 Dulbecco’s modified Eagle’s medium (In-house -  Endotoxin 
Free)
FACSfix PBS containing 2% formaldehyde
FACSwash PBS containing 0.2% bovine serum albumin
FCS Foetal Calf Serum
HBSS Hanks Balanced Salt Solution (Gibco-BRL)
HBSS (cation supplemented) HBSS with ImM Ca2+, ImM Mg2+ and IOjiM Znz+
HEPES Gibco-BRL
RPMI Roswell Park Memorial Institute medium (Gibco-BRL)
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2.1.4 Gifts
• DCDHF-coupled Zymosan -  Gift from M.B.Hallett, University of 
Cardiff.
• IP3-AM -  Gift from A. Conway J.B. Holmes, University of 
Cambridge
• Recombinant Murine S100A9 -  Gift from P. Tessier, University of 
Toronto
• Polyclonal anti murine CXCR2 antibody -  Gift from R.M. Strieter 
UCLA
2.1.5 Ceil-lines
B 1 6 g a l v :  Sub-strain of Murine Melanoma Cell line, Cancer Research UK 
Cell-Production Department
3LL: Lewis Lung Carcinoma Cell line, Cancer Research UK Cell- 
Production Department
E.Coli K12: Eschericha coli Gift from J. Edgeworth, St Georges Hospital 
London
2.1.6 Antibodies
Antibody Conjugate Epitope Species Supplier
p i integrin Biotin pi integrin Rat IgG2a BD Biosciences
a4  integrin PE a4 integrin Rat IgG2b BD Biosciences
2B10 None/FITC S100A9 Rat IgG2a CRUK
6A4 None S100A8 Rat IgG2b CRUK
7/4 PE/none Neutrophil/monocyte 
40kDa protein
Rat IgG2a Caltag
Medsystems
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Anti Mouse HRP Mouse Ig Rabbit
Polyclonal
DAKO
Anti Rabbit HRP Rabbit Ig Goat
Polyclonal
DAKO
Anti Rat HRP Rat Ig Goat
Polyclonal
Southern
Biotech.
Associates
Anti-Rat Alexa-633 Rat IgG Goat
Polyclonal
Molecular Probes
Anti-Rat PE Rat IgG Goat
Polyclonal
BD Biosciences
Anti-Rat Alexa-488 Rat IgG Donkey
Polyclonal
Molecular Probes
B220 (RA3- 
6B2)
FITC/CyChrome CD45 on B cells Rat IgG2a BD Biosciences
CD4 (L3T4) FITC CD4 Rat IgG2a BD Biosciences
C D 8 a (53-  
6.7)
PE CD8  a  chain Rat IgG2a BD Biosciences
F4/80 Biotin/Tri-colour M acrophage 160kD a  
glycoprotein
Rat IgG2b Serotec
FcyRII/ni None FcyRII/in Rat IgG2a BD Biosciences
Gr-1 Biotin/FITC Ly-6 C/G Rat IgG2b BD Biosciences
IgG2a FITC/PE/Biotin - Rat IgG2a BD Biosciences
IP3  Receptor None Pan IP3 Recept or  
subtypes
Mouse
polyclonal
Chemicon Intl.
Ly-6 G None/FITC Ly-6 G Rat IgG2a BD Biosciences
Mac-1 PE/Biotin CDllb/CD18 Rat IgG2b BD Biosciences
NH9 None S100A9 Rabbit
Polyclonal
CRUK
Phalloidin Alexa 488, 547 Actin (not
antibody)
Molecular Probes
PLC02 None PLCp2 Rabbit
Polyclonal
S a n t a  Cruz  
Biotech
PLCp3 None PLCp3 Mouse
Polyclonal
C ell Signalling  
Tech.
PyLT None Control IgG2b Rat IgG2b CRUK
Streptavidin Alexa-633 Biotin (not
antibody)
Molecular Probes
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Tubulin Alexa-547 y-Tubulin Mouse Sigma
Y13 None Control IgG2a Rat IgG2a CRUK
2.2 M ethods
2.2.1 Animal husbandry
S100A9 null mice were generated as published previously (Hobbs et al., 
2003). Mixed background 129Sv x C57BL/6J transgenic mice derived from two 
independent embryonic stem cell clones were backcrossed against C57BL/6J mice 
(CRUK in house stock) for ten generations. Heterozygous and homozygous 
offspring were identified within each generation using the following genotyping 
protocol. Wildtype and S100A9 null mice from the same generation of back- 
cross were compared at each generation, until generation ten when in-house 
C57BL/6J control mice were used. Mice were maintained in specific-pathogen- 
free conditions in accordance with UK Home Office guidelines.
2.2.2 Genotyping S100A9 null mice
5mm of tail was cut into an Eppendorf tube and 700pl of tail digestion 
buffer (50mM Tris pH 8.0, lOOmM EDTA, lOOmM NaCl, 1% SDS) was added. 
25pl of a lOmg/ml Proteinase K solution (Sigma) was added and tubes were 
incubated  at 55°C overnight. 700jnl o f  p h eno l:ch lo ro fo rm  
(Phenyl:chloroform:isoamyl alcohol (25:24:1); Sigma) solution was added to the 
digested tail solution and tubes were vigorously shaken on a bench top shaker for 
lOmin. Tubes were centrifuged in a microfuge at full speed for 10 min. The top 
layer was transferred into a new tube and DNA was pelleted by centrifugation at
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full speed in a microfuge for 15 mins at 4°C. The DNA pellet was then washed 
with 70% ethanol and allowed to dry prior to being dissolved in 50pl water.
Alternatively, 80pl sodium acetate 3M (Sigma) and 400pl isopropanol 
were added to 400pl of pre-boiled tail lysate (prepared as above) and gently 
mixed. The solution was centrifuged at full speed in a microfuge at 4°C and the 
supernatant removed. The resulting pellet was washed in 500pl ethanol followed 
by centrifugation at full speed in a microfuge at 4°C. The ethanol was removed 
and the pellet left to air dry prior to resuspension in 2 0 pl water.
Primers
GF1 -  Tm 50.3°C -  AACATCTGTGACTCTTTAGCC 
GB1 -  Tm 50.3°C -  CATCTGAGAAGGTGCTTTGTT 
GNEO -  Tm 56.3°C -  ACCGCTTCCTCGTGCTTTACG
PCR Program
5 min - 94°C
REPEAT FOLLOWING FOR 30 CYCLES:
20s - 94°C
30s - 55°C
60s - 72°C
FINISHING:
5 min - 72°C
HOLD - 12°C
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PCR Protocol
PCR reactions were set up in PCR plates (Cycleplate 24ET, Strip-ease- 8  
caps; Robbins Scientific). The PCR reaction mix consisted of: 1 j L t l  purified tail 
DNA, 125ng of each primer, 1.5U Taq Polymerase (Cancer Research UK) and 
PCR Buffer ( lx  Thermophilic PCR buffer, 1.5mM MgCL, 200pM  
dATP/dGTP/dCTP/dTTP; all Promega) in a final volume of 25 jul. PCR programs 
were run on a Peltier Thermal Cycler PTC-225 (MJ Research).
2.2.3 Agarose gel electrophoresis
Tris-acetate (TAE) buffer
A 50x stock solution was prepared by dissolving 242g Tris base and 
57.1ml glacial acetic acid in dPLO followed by 100ml 0.5M EDTA (pH8.0), with 
the solution then being made up to 1 litre with dTLO.
Electrophoresis
TAE buffer containing 1.8% agarose (Life Technologies) was heated in a 
microwave oven, with intermittent mixing, to dissolve the agarose. The solution 
was allowed to cool briefly prior to addition of ethidium bromide (4pl/100ml; 
Sigma) in a fume hood. The solution was then cast in a mould and allowed to set. 
BlueJuice (Promega) DNA loading dye was added to PCR reaction products at 
1:10 dilution. 25 pi of each sample was loaded per agarose well and DNA was 
electrophoresed at lOOmV in lx  TAE buffer.
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2.2.4 Leukocyte Preparations
Murine bone marrow leukocytes
Murine bone marrow leukocytes were harvested by flushing both femurs 
and tibiae with HBSS containing 0.2% BSA (or relevant assay buffer) using a 
needle and 2.5ml syringe. Cell clumps were dispersed by gentle agitation with a 
plastic pastette prior to passage through a 70pm cell strainer (Falcon). The cells 
were pelleted by centrifugation at 500 x g for 5 min prior to resuspension in 1ml 
hypotonic red blood cell lysis solution (0.144M NH4 CI/O.OI7 M Tris-HCl, pH7.2). 
Red blood cells were lysed at room temperature for 3 minutes at which time the 
cells were washed and resuspended in HBSS/assay buffer. This protocol typically 
yields a population containing 25-35% neutrophils.
Peritoneal leukocytes
3% Thioglycollate (Sigma) solution in PBS was prepared by autoclaving 
twice and resting for at least one week at 4°C. 0.5ml Thioglycollate was injected 
ip into the peritoneum. After 6  hours the mice were sacrificed according to 
Schedule 1 of the Scientific Procedures Act and peritoneal lavage was performed 
with 5ml PBS/5mM EDTA. The harvested cells were passed through a cell 
strainer, pelleted by centrifugation at 500 x g for 5min, washed once and 
resuspended in assay buffer/HBSS. This protocol typically yields a cell 
preparations containing 60-70% neutrophils.
Human neutrophils
Erythrocytes were sedimented from EDTA-anticoagulated whole blood by 
addition of Dextran T500 (Amersham Biosciences) to a final concentration of
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0.6%. After 45 minutes at room temperature the leukocyte-rich plasma was 
layered onto a discontinuous gradient of 70% over 80% isotonic Percoll 
(Amersham Pharmacia Biotech). Following centrifugation at 1137 x g for 15min, 
the neutrophils were harvested from the interface between the 70% and 80% 
Percoll. The neutrophils were then washed three times in HBSS/HEPES 20mM. 
This protocol typically yields a cell population containing 80-90% neutrophils.
2.2.5 RT-PCR
Primers
Primers were designed against the murine cDNA reference sequence for 
S100A8, S100A9, S100A4, S100A1 and S100Z. For all genes except S100A9 
forward and reverse primers were designed to sit in separate exons. All primers 
were designed to have an annealing temperature of 60°C.
S100 A l: GCCCTTCTGTCGAGAATCTG
AAGCACGCTAAAGGGGAAAT 
S100A4: TTGTGTCCACCTTCCACAAA
GCACTATGCTCACAGCCAAC 
S100Z: GCTCAACCACCTTCTTCTGC
TCTTTATTGGCGTCCAGGTC 
S100A9: ACCTGGACACAAACCAAGGAC
GCCATTGAGTAAGCCATTCC 
S100A8: GGAAATCACCATGCCCTCTA
TCCTTGTGGCTGTCTTTGTGT
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RNA Isolation
RNA was prepared from 5xl0 6 bone marrow cells using the Promega SV 
total RNA isolation kit according to the manufacturer’s instructions. RNA yield 
was quantified by diluting the prepared sample 1 / 1 0 0  and measuring the optical 
density at 260nm and calculated by ratio to an optical density of 1 = 40pg/ml.
RT-PCR
The RT/PLATINUM Taq HiFi Mix was used according to the 
manufacturer’s instructions. Briefly, the following reaction mix was prepared in 
thin walled PCR tubes on ice: lx Reaction Mix (as supplied), 250ng template 
RNA, 0.2pM sense primer, 0.2|uM anti-sense primer, 1 -2jLil RT/PLATINUM Taq 
HiFi Mix, water to 50jLil. The following thermocycler setup was used as one 
continuous program for all stages:
cDNA synthesis: 1 cycle of:
50°C for 30 minutes
94°C for 2 minutes 
PCR amplification: 35-40 cycles of:
Denature: 94°C for 15 seconds 
Anneal: 55°C for 30 seconds 
Extend: 6 8 °C for 1 minute 
Final Extension: 1 cycle of:
72°C for 10 minutes
12°C to hold.
PCR products were visualised on 1.8 % agarose gel as before.
68
Chapter 2: Materials and Methods
2.2.6 Protein Analysis
Preparation of detergent soluble leukocyte extracts
Cells were suspended at 5xl07/ml in ice cold lysis buffer (50mM Tris pH 
8.0 containing 1% Triton X-100 (Sigma), 2mM EDTA, 50mM NaCl, 20pg/ml 
PMSF (Sigma), 1 pg/ml aprotinin (Sigma)) and incubated for 30 minutes on ice 
with intermittent disruption with a 25G needle. The solution was then centrifuged 
in a microfuge to remove insoluble material and the supernatant decanted and 
used in assays.
Immunoprecipitation
Aliquots of cell lysate were incubated with 10-20pl/ml mAbs 2B10 or 
Y13 overnight at 4°C under gentle rotation. The mAbs were precipitated by 
incubation with 50pl Protein G sepharose slurry (Amersham Pharmacia Biotech) 
for a further hour. The sepharose was collected by centrifugation and wash by 
resuspension and re-pelleting in lysis buffer five times. The sepharose was then 
boiled in SDS-PAGE sample buffer (as below) for 5 min.
SDSPAGE
A polyacrylamide gel composed o f a stacking gel layered over a 
separating gel was formed. The separating gel was made from 375mM Tris, 
pH8.0, containing acrylamide:bis-acrylamide 37.5:1 solution (Amersham 
Pharmacia Biotech) to give acrylamide concentrations of 15% for S I00 proteins, 
(6 % for IP3 receptor or PLC), 0.1% SDS, 0.04% ammonium persulphate and 
1/5000 TEMED (Sigma). The stacking gel was made of 125mM Tris, pH 6 .8 , 
with 3% acrylamide, 0.08% bis-acrylamide, 0.1% SDS, 0.04% ammonium
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persulphate and 1/5000 TEMED. Proteins for analysis were boiled in sample 
buffer (125mM Tris, pH 6 .8 , 25% glycerol, 2% SDS, 1% 2-mercaptoethanol, 
0.02% bromophenol blue) for 5 minutes. Electrophoresis was performed in an 
Atto Dual Mini Slab Chamber (Genetic Research Instrumentation Ltd) with 
electrophoresis buffer (25mM Tris, 192mM glycine, 0.1% SDS) at 100V through 
the stacking gel and 180V through the separating gel. Rainbow coloured protein 
standards (Amersham Pharmacia Biotech) were run under identical conditions in 
the same gel to allow calibration by molecular weight. Samples not analysed by 
Western blot were visualised using a Silver stain protocol.
Silver stain
Gels were washed twice for 15 minutes in a 50% methanol and 10% acetic 
acid solution, followed by washing in 10% ethanol and 5% acetic acid solution for 
five minutes and a final wash in dtLO. The gels were sensitized in a 20mg/l 
solution of Na2 S2 C>4 for nine minutes. The sensitising solution was exchanged, 
without washing for a 0.1% solution of AgNC>3 in dFLO to which was added 7 5 pi 
37% formaldehye solution per 100ml AgNC>3 solution. The gel was incubated for 
9 minutes with gentle agitation in the solution prior to a 30 second wash with 
dtLO. The stain is developed with a solution of 1 ml/litre 37% formaldehyde in 
0.3% carbonate solution and lg/litre sodium thiosulphate to the required intensity. 
The reaction is stopped by replacement of the solution with a 2.5% acetic acid 
solution.
Western blotting
Following SDS-PAGE, proteins were transferred onto a nitocellulose
membrane (Hybond ECL, Amersham Biosciences) at 60V for 50min (S I00) or
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overnight (PLC/IP3 Receptor) at 4°C in a Transblot Cell (Bio-Rad) containing 
transfer buffer (25mM Tris, 192mM glycine, 20% methanol). The transfer was 
confirmed by staining of the membrane with 0.1% Ponceau S solution (Sigma). 
Following this step the membrane was blocked with PBS/Tween (PBS containing 
0.1% Tween 20 (Sigma)) containing 5% milk powder at 4°C overnight with gentle 
agitation. After washing three times the membrane was incubated in PBS/Tween 
with 5% milk and primary antibody for one-two hours or according to 
manufacturers instructions at room temperature. After washing a further three 
times in PBS/Tween the HRP-conjugated secondary antibody was applied 
(according to the manufacturer’s instructions) in PBS/Tween with 5% milk for 
one hour at room temperature. The membrane was washed a final three times and 
the bound antibody visualised using chemiluminescent substrate (ECL detection 
reagent; Amersham Biosciences) according to the manufacturer’s instructions. 
Excess substrate was blotted from the membrane onto clean tissue. The 
membrane was exposed to film (Hyperfilm ECL; Amersham Biosciences) to 
visualise the protein levels.
2.2.7 Flow Cytometry
FACS staining of leukocyte suspensions
A minimum of 2x l0 5 leukocytes were incubated in 200pl FACSwash 
containing saturating concentrations of antibody on ice in the dark for 15 minutes. 
For larger numbers of samples the leukocytes were pelleted in a 96-well plate and 
resuspended in 50pl of FACSwash containing saturating concentrations of 
antibody. The cells were washed three times with an excess of FACSwash and
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resuspended in 200pl FACSwash (for immediate analysis) or FACSfix (for 
storage ovemight-2 days) and stored in the dark at 4°C.
FACS staining in whole blood
50pl of EDTA-anticoagulated blood was incubated with 50pl of saturating 
antibody solution in a FACS tube (BD Biosciences) for 30 minutes at room 
temperature. The samples were washed in FACSwash and erythrocytes were 
lysed using FACS lysing solution (BD Biosciences) according to the 
manufacturer’s instructions.
Multi-parametric flow cytometry
For multi-parametric flow cytometry the above protocols were followed 
for each successive layer of antibody. For analysis with directly conjugated 
antibody combinations all antibodies were incubated simultaneously. For 
combinations containing un-conjugated or biotinylated antibodies, these 
antibodies were incubated first followed by fluorochrome conjugated secondary 
antibody/streptavidin, finally directly conjugated antibodies were applied. 
Individually stained controls for each fluorochrome were also prepared.
Flow cytometric analysis
Unstained and single-fluorochrome control samples were used to set 
voltages and compensation for each experiment. The fluorescence intensity of 
each fluorochrome in each sample was recorded for in excess of 5000 target cells 
per sample.
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Cell sorting
Cells were stained as for flow cytometry and neutrophils (7/4 Hi + Ly- 
6G/Gr-1 Hi) were sorted using a Mo-Flo cell sorter (Dako Cytomation)
Absolute cell counting
Absolute cell counts were obtained by adding a known quantity of 
calibration bead (CaliBRITE, BD Biosciences) to a known proportion of total 
sample. The number of cells and beads were assessed using a flow cytometer and 
used to calculate the number of cells in the original sample by ratio to the number 
of beads added.
2.2.8 Leukocyte density analysis
Two-step gradient
Bone marrow leukocytes a Lymphoprep gradient was made by carefully 
layering 4 ml of 1.077g/ml Lymphoprep (Sigma) on top of 4ml 1.083g/ml 
Lymphoprep (Sigma). 1ml of bone marrow leukocytes at 2-3x107/ml (prepared as 
described above) in RPMI were then layered on top. Following centrifugation at 
700 x g for 30 minutes, the granulocyte-rich band was collected from the 
Lymphoprep:Lymphoprep interface and the mononuclear cells at the 
RPMLLymphoprep interface.
Continuous Percoll gradient
A 1.097g/ml solution of isotonic Percoll (Amersham Biosciences) in 
0.15M NaCl was prepared and used to create a 9-ml self-generating gradient as 
described by the manufacturer (running conditions: 23° angle-head rotor, 30,000 x
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g, 25°C, 12 min). The gradient was calibrated between 1.018 and 1.138g/ml with 
density marker beads (Amersham Biosciences). Bone marrow leukocytes at
n
5x10 /ml in HBSS were layered onto the preformed gradient at 1 ml/tube and 
centrifuged at 700 x g at 21°C for 30 minutes. The mean buoyant density of the 
cellular bands was calculated with density marker bead calibration, and the 
composition of the bands was determined by flow cytometric analysis.
2.2.9 Measurement of intracellular calcium concentration
Bone marrow leukocytes were prepared in Flux buffer (HBSS: 0.4g/L 
KCl,0.06g/L KH2 P 0 4, 8 g/L NaCl, 0.9g/L Na2 HP04; 0.35g/L NaHC03, 1 g/L D- 
glucose supplemented with ImM Ca2+ and 0.5%BSA) and resuspended at 
lx l0 7/ml in 2.5mM Indo-IAM/Pluronic acid 2.5%. The cell suspension was 
incubated at 30°C for one hour prior to washing in an excess of Flux buffer
n
(30°C). The cells were resuspended at 5x10/ /ml in Flux buffer containing mAbs 
7/4PE and Ly-6G/Gr-1-FITC for 15 minutes at 30°C. Cells were washed one final 
time and resuspended at 5xl0/7/ml and maintained at 30°C prior to use. For 
inhibitor studies requiring pre-incubation aliquots of cells were separated into 
tubes with the inhibitor indicated. Fluorescence was monitored using a BD LSR 
flow cytometer (FL-4 530/30nm BF filter, FL5 424/44 filter, 510LP filter; BD 
Biosciences). Samples were read at a flow rate of 2000-3000 events/sec and 
stimulants were added from lOOx stock solutions at the indicated time points. 
Data was analyzed using Flow Jo software (TreeStar Inc). Results are represented 
as the median Indo-1 ratio for 500-700 neutrophils per second.
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2.2.10 Confocal microscopy
Ethanol cleaned coverslips were coated in 24 well plates with murine 
ICAM-1 solution overnight at 4°C and blocked with 2.5% BSA in PBS for one 
hour at room temperature. Cells were allowed to adhere to the coverslips in 
cation supplem ented HBSS. Adherent cells were fixed with 3% 
paraform aldehyde in PBS at room tem perature for 20mins. The 
paraformaldehyde solution was replaced with 50mM NH4 CI in PBS to quench 
autofluorescence and the coverslips incubated for 10 minutes. The coverslips 
were washed three times with PBS and incubated in 0.1% Triton X-100 (Sigma) 
for 4 mins. Coverslips were washed 2 times in PBS followed by three washes 
with blocking solution (PBS/10% FCS) over five minutes. Primary and 
secondary antibody solutions were applied sequentially and each incubated for 
20/30mins in blocking buffer with 3 washes in PBS between antibody changes. 
Nuclei were stained using DAPI (Sigma) according to the manufacturer’s 
instructions (Molecular Probes). Coverslips were washed 3 times in water and 
mounted onto microscope slides using Mowiol (prepared according to the 
manufacturer’s instructions). The images were taken on a Zeiss Laser Scanning 
Microscope LSM5101.
2.2.11 Adhesion Assay
Fibrinogen (Sigma) was dissolved at 2mg/ml in 0.1 M sodium carbonate 
buffer at 37°C for 30 minutes. 96 well plates (Immulon-1® 96-well plates 
(Dynatech) were coated with lOOpl fibrinogen solution overnight at 4°C. Plates 
were washed twice with RPMI immediately prior to commencement of the assay. 
Bone marrow cells were prepared in RPMI as described and incubated at
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5xl06/ml in 1 jliM  BCECF-AM (Sigma) at room temperature for 30 minutes. Cells 
were washed in RPMI and resuspended at lx l0 7/ml and 50pl of cell suspension 
applied per well. Stimuli were prepared in RPMI at 2x concentration and 50pl 
applied to the wells. The plate pulsed was in a centrifuge for 30 seconds and cells 
left to adhere for 30 minutes. The fluorescence of the well was assessed prior to 
washing using a Cytofluor multiwell platereader (PerSeptive Biosystems; 
excitation: 488nm, emission: 530nm). The plate was washed gently and 50pl 
RPMI added per well and the fluorescence of the well reassessed. The level of 
adhesion was assessed by calculating the percentage of total fluorescence 
remaining following the plate wash step.
2.2.12 Migration assay
Migration assays were performed as detailed by Smith et al with minor 
modifications (Smith et al., 2003). 35 mm glass bottom microwell dishes
(MatTek Corp) were coated at 4°C overnight with 200 pi of murine ICAM-lFc in 
PBS, then blocked with 2.5% BSA in PBS. Bone marrow cells were prepared in 
cation supplemented HBSS and 5xl0 5 cells per dish were allowed to migrate for 
20 minutes at 37°C before rinsing to removed unattached cells. Images were taken 
at 5 second intervals using a Nikon Diaphot 300 microscope and AQM2001 
Kinetic Acquisition Manager software (Kinetic Imaging Ltd).
2.2.13 Chemotaxis assay
Transwell (Coming) plates with a 3pm pore and 6.5mm diameter insert
were pre-incubated with Chemotaxis buffer (HBSS containing 20mM HEPES,
ImM Ca2+, ImM Mg2+, lOpM Zn2+ and 0.1% BSA) at 37°C for one hour. 600pl
Chemotaxis buffer containing various chemoattractant stimuli was placed in the
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plate wells. The Transwell insert was replaced and 5x l06/ml bone marrow 
leukocytes in lOOpl added. The plates were incubated for 2-4 hours at 37°C prior 
to removal of the insert and removal of the buffer from the lower chamber for 
analysis. The lower chambers were washed with ice-cold PBS/EDTA (5mM) 
twice and the recovered cells added to the buffer sample. The harvested cells 
were pelleted and stained in FACSwash to identify the neutrophils, prior to 
absolute cell counting by flow cytometry.
2.2.14 Measurement of oxidant production
Luminol enhanced chemiluminescence
This protocol is adapted from (Dahlgren and Karlsson, 1999). Bone 
marrow leukocytes were suspended at 2xl07/ml in RPMI containing luminol at 
50pM at 37°C. The cell suspension was applied to a 96-well plate at 200pl per 
well. Stimulants were added at lOx concentration immediately prior to placing in 
a heated luminometer (Dynex MLX Luminometer) at 37°C. Readings were taken 
for the whole plate every 17 seconds. The mean light units produced per sample 
per time-point were calculated.
DCDHF-coupled zymosan
Zymosan particles were supplied prepared as detailed in (Dewitt et al., 
2003). 5x10s bone marrow cells (in 50pl HBSS) were mixed with 50pl zymosan 
suspension (2mg/ml) and incubated at 37°C with intermittent gentle mixing. 
Samples taken and washed in ice cold HBSS and resuspended in FACS wash kept 
at 4°C prior to analysis by flow cytometry. For confocal microscopy cells were
77
Chapter 2: Materials and Methods
adhered onto fibrinogen coated coverslips and stained as described using the 
monoclonal anti-S100A9 antibody (2B10).
2.2.15 Bacterial Killing Assays
Human neutrophil assay
Non-pathogenic E.coli K12 were grown to log phase in LB broth at 37°C 
with constant agitation. 2.5xl06 human neutrophils in HBSS were mixed with the 
bacteria at a ratio of 1 0 : 1  and 1 0 % human autologous serum in a final volume of 
lml. A control tube of bacteria alone in HBSS containing 10% human serum was 
also prepared. The samples were incubated at 37°C with constant gentle agitation. 
Samples were removed at indicated time points and the leukocyte population 
separated by centrifugation at 200g for 5 minutes. The cell pellet and supernatant 
samples were diluted in water to lyse the leukocytes and plated onto agarose 
culture plates at 3 different dilutions in duplicate. Culture plates were incubated 
overnight and colonies counted.
Murine killing assay
Non-pathogenic E.coli K12 were grown to log phase in LB broth at 37°C 
with constant agitation. 2.5x105 murine peritoneal leukocytes in HBSS were 
mixed with the bacteria at a ratio of 1 : 1  with 1 0 % murine serum in a final volume 
of lml. A control tube of bacteria alone in HBSS containing 10% murine serum 
was also prepared. The samples were incubated at 37°C with constant gentle 
agitation. Samples were removed at indicated time points and diluted in water to 
lyse the leukocytes and plated onto agarose culture plates at 3 different dilutions 
in duplicate. Culture plates were incubated overnight and colonies counted.
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2.2.16 Air pouch model of inflammation
The protocol was carried out as described by Tessier et al (Ryckman et al., 
2003b). On day 0 and day 3 mice were anaesthetised with halothane and injected 
sub-cutaneously on the back with 2.5ml of sterile air to generate a dorsal air 
pouch. On day 6  mice were anaesthetised and lml of stimulus injected into the 
pre-formed pouch. The stimuli were prepared in PBS containing ImM Ca2+, 
ImM Mg2+ and lOpM Zn2+. At six hours following stimulation the mice were 
euthanised by carbon dioxide exposure followed by cervical dislocation. The 
migrated cells were harvested by flushing the air pouch twice with 2 ml of ice-cold 
PBS containing 5mM EDTA. The cells were counted by flow cytometry. Five 
mice per time point were analysed.
2.2.17 Peritonitis model
Peritonitis was induced by intraperitoneal injection of 0.5ml sterile 
thioglycollate (prepared as described previously), TNFa (10ng) or IL-lj3 (lOOng). 
One hour prior to intraperitoneal injection, opiate analgesia (Temgenic) was dosed 
to each mouse subcutaneously. At a time point 6  hours following stimulant 
injection, the mice were euthanised by carbon dioxide exposure and peritoneal 
cavities were lavaged with 5ml ice-cold PBS containing 5mM EDTA. 
Leukocytes were stained to identify the myeloid cells and cells were analysed by 
flow cytometry. Five mice were analysed per genotype for each sample point.
2.2.18 Streptococcus pneumoniae-induced pneumonia
Mice were lightly anaesthetised with 1.5% (v/v) halthane and 50pl PBS 
containing lxlO 6 CFUs of S. pneum oniae  (D39, serotype 2) was then
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administered into the nostrils of each mouse as previously described (Kerr et al., 
2002). At certain time points mice were sacrificed by cervical dislocation and 
blood samples taken via cardiac puncture. Lung tissue was removed and 
homogenised and viable bacterial counts were determined as described by Kerr et 
al. Four to six mice of each genotype were analysed at each time point.
2.2.19 Wound Healing Assay
Wound healing assays were performed essentially as described in 
(Reynolds et al., 2005). Female mice were anesthetized and the dorsum shaved 
then cleaned with alcohol. Two 3-mm full-thickness cutaneous biopsy punch 
wounds were made either side of the midline of the mouse. Wounds were made 
maintaining the underlying fascia. The wounded tissue was collected on various 
days after injury. Tissue was bisected and fixed in 10% formalin for paraffin 
embedding.
2.2.20 Tumour growth assay 
Maintenance of cell-lines
3LL: Maintained in suspension in RPMI (CRUK in-house) supplemented 
with 5% FCS at 37°C in 5% CO2 . Colonies were split to give colonies containing 
5x10s cells/ml three times per week. For tumour growth experiments the cells 
were harvested and resuspended at 5xl07/ml in PBS.
B 1 6 g a l w  Maintained as an adherent colony in E4 (CRUK in-house) 
supplemented with 10% FCS at 37°C in 5% CO2 . Confluent monolayers were 
harvested using versene and reseeded at dilution of 1:4 or 1:10. For tumour 
growth experiments the cells were harvested and resuspended at 2xl05/ml in PBS.
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In vivo tumour growth assay
Tumour cells were harvested and prepared as above and placed on ice 
immediately prior to the beginning of the experiment. lOOpl of the relevant cell 
solutions were injected sub-cutaneously into the right flank of each mouse. 
Tumour size was monitored by measurement of size in two dimensions every 2-3 
days for 3-4 weeks until a critical threshold of tumour size was reached (1.2cm2). 
Mice were euthanised and tumour excised and weighed.
2.2.21 Chemical induced carcinogenesis
Timed breeding was undertaken to provide mice bom within a four day 
window. The backs of all mice were shaved at 7 weeks of age followed by 
painting of the shaved area with 25 pg DMBA in acetone or acetone alone control. 
The treated skin was painted with 4pg TP A in acetone solution thrice weekly for 
15 weeks beginning 1 week after DMBA treatment. The mice were examined 
weekly and the incidence of benign/non-benign skin tumours noted.
2.2.22 Immunohistochemistry
4pm sections were cut from paraffin-embedded tissues and dewaxed, and 
endogenous peroxidases blocked. Following rehydration the samples were 
microwaved for lOmin at 700W or treated with 1 mg/ml Trypsin (BDH, Merck 
Eurolab) for 15 minutes at 37°C (mAb 6A4 only). Sections were then stained 
with rat mAbs 2B10, Y13, 6A4, PyLT or 7/4 at lOpg/ml in Tris buffered saline, 
pH 7.6 for 40 minutes at room temperature. Biotinylated secondary antibody 
(rabbit anti-rat, Vector Labs) was applied in a similar manner at 1:100. Finally 
StreptABC/HRP was used according to the manufacturer’s instructions (Dako
81
Chapter 2: Materials and Methods 
cytomation) and the slides were exposed to 3,3’diaminobenzidine for 2-3 minutes. 
Slides were counterstained with Harris’ Haematoxylin.
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3 Basic characterisation of S100A9 null neutrophils
3.1 Introduction
The primary site of expression of S100A8/9 is in myeloid cells. In human 
neutrophils the heterodimer is reported to constitute 40% cytosolic protein 
(Edgeworth et al., 1991) and S100A9 to constitute 10-20% in murine neutrophils 
with the dimer presumably constituting 20-40% similarly to the human situation 
(Nacken et al., 2000). Given this expression pattern a logical place to start an 
investigation into the function of this protein is by examining the myeloid cells in 
the S100A9 null animals. By comparing the function of cells that do and do not 
express S100A9 it is hoped that altered cellular function in the S100A9 null 
animals will indicate the functional role of the protein. Early reports on the 
expression of this protein by neutrophils showed it to be expressed during the 
differentiation of neutrophils to their fully mature form (Lagasse and Clerc, 1988; 
Lagasse and Weissman, 1992). S100A9 has been shown to interact with casein 
kinases implicating them in the control of transcriptional machinery giving a 
mechanism by which they could modulate the differentiation process (Murao et 
al., 1989). To ascertain whether this protein does indeed have a role in neutrophil 
development the number of myeloid cells and their expression o f surface 
molecules will be evaluated.
In this laboratory S100A9 null mice were generated using an insertional 
strategy. A Lac Z/Neo cassette was inserted into exon 2 of the murine S100A9
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gene immediately after the ATG translational start codon, preventing transcription
of the S100A9 gene. ES cell clones in which the targeting strategy had occurred
as expected were micro-injected into C57BL/6J blastocysts to create chimaeric
mice (Hobbs et al., 2003). This work was carried out in collaboration with Ian
Rosewell, Mary Ann Jacobs and Stephen Wilson at Cancer Research UK Clare
Hall laboratories. These chimaeric mice were bred with C57BL/6J mice to
produce heterozygous mice with a mixed 129Sv/C57BL/6J background. Two
independent strains were created from the 2G1 and 2E5 ES cell clones and were
maintained independently. The two S100A9 null mouse lines were backcrossed
against C57BL/6J mice for 10 generations, at which time they were considered to
be wholly C57BL/6J in background. The mice used in the preparation of this
thesis are from back-cross generations 5-10. All mice used in the preparation of
this thesis were maintained in Specified Pathogen Free conditions.
Work to characterise the S100A9 null mice has been underway for a 
number of years. The initial observations made on these mice were published in 
2003. At that time the mice had been back-crossed for 3-5 generations onto a 
C57BL/6J background. The initial characterisation of the S100A9 null mice 
indicated that S100A9 was dispensable for the production of neutrophils and 
monocytes in mice. Initial characterisation of the S100A9 null mice showed them 
to be viable, fertile and to live a normal life-span (Hobbs et al., 2003). They 
displayed normal numbers of circulating leukocytes, which appeared to have 
normal morphology by electron-microscopy. The most obvious difference 
between the S100A9 null and wildtype cells was the absence of any S100A8 
protein in the S100A9 null animals. Although S100A8 has been shown to be 
crucial for development, and so is presumably expressed during development in
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the S100A9 null animals, it was totally absent from the mature leukocytes. This 
seems to imply that in the mature animal, in the absence of its heterodimeric 
binding partner S100A9, S100A8 is totally unstable as has been suggested 
previously (Hunter and Chazin, 1998). This finding is in conflict to the reported 
expression of S100A8 in the absence of S I00A9 found in some studies indicating 
that in those studies S100A8 may have another stabilising binding partner 
(Grimbaldeston et al., 2003; Rahimi et al., 2005). The lack of expression of 
S100A8 makes the S100A9 null mice effectively S100A8/9 null animals, making 
interpretation of any phenotype simpler, with the entire heterodimer being absent.
In this section the work contributing to the initial phenotyping of the 
S100A9 null mice is presented as well as further characterisation of the state of 
the S100A9 null neutrophils.
3.2 Results
3.2.1 Neutrophil identification
Studies published to date have found no morphological abnormalities in 
the S100A9 null neutrophils. For comparison a human neutrophil, wildtype and 
S100A9 null mouse neutrophils stained using the Diff-Quik stain are shown 
(figure 3.1A-C). Lobed nuclear architecture characteristic of this cell-type is 
clearly shown by bright purple staining. The cellular morphology in murine and 
human samples is similar, with the murine cells being smaller in size.
Counting neutrophils identified by nuclear morphology as shown in figure 3.1 is a 
common way to enumerate experimental samples. However, for most of the work 
presented in this thesis, flow cytometry was used to identify the neutrophil cell 
population. Myeloid cells can be discriminated by dual staining the cell
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Figure 3.1 Identification of human, mouse and S100A9 null murine 
neutrophils.
Blood leukocytes were isolated from human, wildtype mice and S100A9 null mice. Blood smears 
were prepared and the cells fixed briefly in 100% methanol. Leukocyte morphology was 
visualised using Diff-Quik stain according to the manufacturers instructions. Neutrophils were 
identified by characteristic lobed nuclear morphology (purple) and are shown to the same scale. 
A: Human blood neutrophil, B: wildtype murine neutrophil, C: S100A9 null neutrophil. D: Bone 
marrow leukocytes were prepared as described in Material and Methods and double stained with 
mAbs Ly-6G (FITC) and 7/4 (PE). Neutrophils and monocytes were identified by flow cytometry 
as indicated.
Monocytes Neutrophils
Lv-6C
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population with mAbs 7/4 (PE) and Ly-6G (FITC) (figure 3 .ID) (Henderson et
al., 2003). This staining protocol produces good separation of the monocyte and
neutrophil populations, which is particularly useful when using bone marrow
samples where the populations are less discrete. The neutrophil population is
identified as 7/4 high / Ly-6G high and the monocytes as 7/4 high / Ly-6G
negative.
3.2.2 Neutrophil density
One of the first observations of a difference between the wildtype and 
S100A9 null cells was a difference in partitioning on a two-step Lymphoprep 
gradient. This protocol allows neutrophils to be enriched according to their 
increased density compared to mononuclear phagocytes. When a leukocyte 
suspension is applied to the gradient and centrifuged, the cells separate over the 
gradient with neutrophils sedimenting at the interface between 1.077g/ml and 
1.083g/ml Lymphoprep solutions. While the starting population had equal 
numbers of neutrophils, when an enriching gradient was performed, the S100A9 
null neutrophils were recovered at a lower percentage from the ‘neutrophil’ band. 
This observation was first made by Meg Matthies in this lab. Following on this 
work I repeated the initial experiments with the two-step gradient and observed a 
higher percentage of neutrophils in the ‘monocyte’ layer in the S100A9 null 
samples than in the corresponding wildtype samples (figure 3.2a). Co-ordinately 
a lower percentage of S100A9 null neutrophils were found in the ‘neutrophil’ 
band compared to the wildtype samples. This appeared to indicate that the 
S100A9 null cells had a lower buoyant density and so were partitioning with the 
cells of lower density than would be expected. To try and confirm this
observation a continuous Percoll gradient approach was undertaken.
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Continuous Percoll gradients were formed by ultracentrifugation of a
Percoll solution, which causes Percoll particles of different sizes to be separated
forming a gradient of density through the tube. The continuous Percoll gradient
can be calibrated by inclusion of a range of coloured latex beads of known density
in tubes. The position of the bands formed by the different coloured particles
within the tube can be measured and used to produce a calibration curve of
position of the band in tube relative to buoyant density. Bone marrow samples
from wildtype and S100A9 null mice are then applied to the gradients and
centrifuged at low speed to allow the cells to separate by density through the tube.
The position of the neutrophil rich band and the lymphocyte band were assessed
from wildtype and S100A9 null samples. As lymphocytes do not express S100A9
and so would not be expected to be affected by the deletion of this molecule the
position of this band acts as an internal control to ensure any differences seen in
the position of the neutrophil band are not due to differences in the formation of
the gradient. When the position of the lymphocyte band was compared in the
different samples it was found to have a buoyant density of 1.0439g/ml in both
wildtype and S100A9 null samples. When the neutrophil band was examined it
was observed that the S100A9 null neutrophil band showed a consistently lower
buoyant density (1.081 lg/ml) compared to the wildtype band (1.0836g/ml) (figure
3.2b). The difference was calculated and shown to be significant. The identity of
the neutrophil band was confirmed in both wildtype and S100A9 null samples by
flow cytometry with a myeloid cell identification antibody cocktail and was
shown to contain 80% of the neutrophils (data not shown) loaded onto the
gradient.
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Figure 3.2 Lower density of bone marrow neutrophils from S100A9 null mice
Bone marrow cells were flushed out of femurs and tibias of 6-10 week-old mice. A: The cells are 
applied to a Lymphoprep gradient and cells were recovered cell bands formed at the 1.077g/ml 
and 1.083g/ml Lymphoprep interfaces. The percentage o f neutrophils present before sorting and 
in each cell band were assessed by flow cytometry. The data shown is the mean +/- standard 
deviation for 3 independent samples per genotype and representative o f 3 experiments. B: The 
cells were applied to a calibrated pre-formed continuous Percoll gradient. A band containing 80% 
of the neutrophils loaded on to the gradient was significantly less dense in S100A9 null mice. 
Data, representative o f five experiments, are expressed as mean +/- standard deviation. **, 
P>0.001 using Student’s T test.
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3.2.3 S100 mRNA expression
The difference in density of the two neutrophil populations seems to
indicate that there is not a compensatory up-regulation of proteins to replace the
absent S100A8/9 heterodimer. Extensive 2D gel analysis has been performed on
the S100A9 null bone marrow cells to identify any up-regulation of compensatory
proteins. As published in Hobbs et al, proteomic analysis was performed on
wildtype and S100A9 null bone marrow samples and no differences in any
proteins apart from S100A8 and S100A9 could be detected (Hobbs et al., 2003).
A related issue was whether any other S I00 family members had increased
expression to compensate for the absence of the S100A8/9 heterodimer. To
satisfy reviewers comments for the Hobbs et al publication, RT-PCR studies were
performed. First a literature search was undertaken to identify which family
members were reported to be expressed in neutrophils, as 19 S I00 family
members have been identified to date screening all S I00 proteins seemed
excessive given no gross differences had been observed at protein level. S100A1
and S100A4 have a more ubiquitous distribution or had been reported in
neutrophils respectively (Grigorian et al., 1994). As S100Z, a recently reported
human neutrophil protein, was found to have a putative sequence for expression in
mouse, this was also tested (Gribenko et al., 2001). To detect mRNA expression
of these three S I00 proteins RT-PCR was performed. Primers were designed to
give a product of between 200 and 400 bp with similar annealing temperatures to
allow all samples to be run in the same experiment. As a control for the
experiment primers were designed to detect S100A8 and S100A9. For the
S100A9 protein primers were designed to look for the 3rd coding exon, as a check
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for expression of a truncated mutant, given that S100A9 is targeted with an 
insertional mutation in these animals. Equal quantities of RNA from wildtype and 
knockout bone marrow cells were used in each experiment.
The data obtained from these experiments is shown in figure 3.3. 
Expression of S100A8, S100A9, S100A4 and S100A1 mRNA was detected in the 
wildtype samples. No expression of S100A9 mRNA was found in the S100A9 
null samples as expected. Expression of S100A8, S100A4 and S100A1 did not 
appear to be altered in the S100A9 null bone marrow samples. No S100Z RNA 
was detected in either wildtype or S100A9 null bone marrow samples. As no 
indication of differences in expression was observed, it was decided not to follow 
this line of investigation any further.
This study could have been extended to test primers for all other family 
members and to quantify any suspected differences by performing quantitative 
real-time PCR. The study could also be improved by the inclusion of a control 
primer pair against a constitutively expressed protein such as GAPDH, to confirm 
that equal RNA amounts are included in all samples. Any more subtle differences 
could be more easily picked up in a purified neutrophil population, rather than 
from whole bone marrow. This data along with the 2D gel analysis and western 
blotting data for S100A8 appear to confirm that no compensatory upregulation of 
other proteins has occurred in the S100A9 null animals.
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Genotype +/+ -/- +/+ -/- +/+ -/- +/+ -/- +/+ -/-
Gene S100A9 S100A8 S100A1 S100A4 S100Z
Figure 3.3 Expression of S100 protein mRNA in bone marrow samples from 
wildtype and S100A9 null mice.
Bone marrow leukocytes were isolated from wildtype and S100A9 null mice. RNA was prepared 
and reverse transcribed to cDNA. Primers specific to the DNA sequence of various S100 proteins 
were designed and used in a PCR reaction to form primer specific DNA products. An ethidium 
bromide-stained 1.8% agarose gel of the PCR products generated is shown. Data is representative 
of 3 independent experiments.
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3.2.4 Leukopoiesis
It has been previously published that leukopoiesis is normal in the S100A9 
null mouse (Hobbs et a l, 2003). As this data originates from low back-cross mice 
(generation three), the experiment was repeated on the fully backcrossed 
(generation ten) mice. This was necessary to confirm that no lesion in 
leukopoiesis was revealed on the fully C57BL/6J background that may affect the 
interpretation of both the in vitro and in vivo data. As many assays are performed 
in this study using whole bone marrow, it was vital to know that the percentage of 
neutrophils is the same in both wildtype and S100A9 null samples. Similarly for 
the in vivo assays it must additionally be known that the numbers of circulating 
neutrophils are the same.
To assess the number of different leukocytes, flow cytometry was 
performed with antibodies recognising different leukocyte types (figure 3.4a). 
The number of B cell (B220+), CD4+ and CD8+ positive T cells, neutrophils and 
monocytes per ml of blood were the same in wildtype and S100A9 null blood 
samples. When the leukocytes present in bone marrow (number per femur and 
tibia) were examined, no differences were found in the number of CD4+, CD8+, 
neutrophils and monocytes. In the experiment represented in figure 3.4a a 
reduced number of B cells were seen in the S100A9 null mice. This difference 
was not consistent upon repetition and when subsets of the B220+ population 
were examined no differences were seen between wildtype and S100A9 null mice 
(figure 3.4b). This seems to indicate that, as was observed previously, there is no 
defect in leukopoiesis in the S100A9 null mice.
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Figure 3.4 Leukopoiesis in wildtype and S100A9 null mice
Leukocytes were isolated from blood (shown as cells/ml) and bone marrow (shown as cells/tibia 
and femur pooled) of wildtype and S100A9 null mice. Leukocytes were identified and counted by 
flow cytometry as described in Materials and Methods. Data is from 5 independent samples per 
genotype and displayed as mean +/- standard error o f  the mean and representative of 3 
experiments.
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3.2.5 Myeloid cell development and activation
Having confirmed that the number of myeloid cells is normal in the 
S100A9 null mice, it was also important to check that the differentiation and 
activation state of the cells was also normal. Multi-parametric flow cytometry 
was performed to assess the level of a range of myeloid cell surface molecules on 
the neutrophils and monocytes in both blood and bone marrow. This was 
achieved by examining the expression of adhesion molecules L-selectin Mac-1, 
LFA-1, p i, a4  and the phagocytic receptor FcyRII/III on blood and bone marrow 
neutrophils (figure 3.5) and monocytes (figure 3.6).
Comparing bone marrow and blood neutrophils, it can be seen that the 
levels of LFA-1, Mac-1 and L-selectin are higher on the bone marrow neutrophils. 
The levels of a4  do not appear much higher than background on either bone 
marrow or blood neutrophils. The levels of FcyRII/III and pi appear similar on 
bone marrow or blood neutrophils. The levels of all surface markers studied 
appeared similar on both blood and bone marrow monocytes.. No differences in 
expression of any of the six surface markers studied could be detected when 
S100A9 null mice were compared to wildtype.
This data shows no difference in the differentiation or activation of the 
S100A9 null myeloid cells compared to the wildtype cells. The increased 
expression of Mac-1, LFA-1 and L-selectin on bone marrow versus blood 
neutrophils seems to imply that the bone marrow neutrophils are potentially more 
adhesive, however the activation state of the integrins are not known. The 
increased expression could be due to chemokine signalling causing their retention 
in the bone marrow under normal conditions. The data relating to the up-
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Figure 3.5 Expression of surface markers of differentiation and activation by 
neutrophils
Neutrophils from blood and bone marrow of wildtype and S100A9 null mice were identified by 
staining cells with mAbs 7/4 and Ly-6G. The expression o f cell surface molecules was 
determined by flow cytometry after co-labelling cells with a panel of antibodies as described in the 
Materials and Methods. Data shown is for pooled samples from 5 independent animals per 
genotype.
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Figure 3.6 Expression of surface markers of differentiation and activation by 
monocytes
Monocytes from blood and bone marrow of wildtype and S100A9 null mice were identified by 
staining cells with mAbs 7/4 and Ly-6G. The expression o f cell surface molecules was 
determined by flow cytometry after co-labelling cells with a panel of antibodies as described in the 
Materials and Methods. Data shown is for pooled samples from 5 independent animals per 
genotype.
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regulation of Mac-1 in response to inflammatory stimuli will be presented later in
this thesis.
3.2.6 CXCR4 expression
As a final comparison to confirm that the S100A9 null myeloid cells were 
maturing normally the expression of CXCR4 was examined on these cells. 
CXCR4 levels have been reported to be high on bone marrow myeloid cells, 
acting as a mechanism for their retention at this site until required/mature as the 
CXCR4 ligand SDF-1 is highly expressed in bone marrow (Martin et al., 2003a). 
When the mature cells are released from the bone marrow, it is reported that they 
have a lower CXCR4 level reducing their retention in the bone marrow. Their 
release is thought to occur via an axis of this change in CXCR4 expression and a 
concurrent rise in CXCR2 expression allowing the CXCR2 ligands to mediate 
their entry into the systemic circulation (Martin et al., 2003a).
The expression of CXCR2 is seen to be normal in the S100A9 null bone 
marrow neutrophils (this data is shown in chapter 4 (figure 4.2b)). The expression 
of CXCR4 is similar on neutrophils and monocytes from both wildtype and 
S100A9 null mice in the bone marrow (figure 3.7). The expression of CXCR4 is 
higher in bone marrow than in the blood on both cell types. The expression of 
CXCR4 on blood neutrophils is higher than on blood monocytes. No difference 
in CXCR4 expression on blood myeloid cells is seen between S100A9 null and 
wildtype mice. These data concerning the number and state of the myeloid cells 
in blood and bone marrow show that the development and maturation of myeloid 
cells in the S100A9 null mouse is normal.
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Figure 3.7 Expression of CXCR4 by wildtype and S100A9 null myeloid cells
Myeloid cells from blood and bone marrow of wildtype and S100A9 null mice were identified by 
staining cells with mAbs 7/4 and Ly-6G, The expression o f CXCR4 was determined by co­
labelling cells with mAb anti-CXCR4 as described in the materials and methods. Data is shown as 
mean fluorescence of 5 independent samples per genotype +/- standard deviation.
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3.3 Discussion
3.3.1 Compensation
If we consider the work in the context of the other data gained from the 
characterisation of the S100A9 null mice ((Hobbs et al., 2003)), we have good 
evidence that the S100A9 null mice show no compensatory upregulation of other 
proteins. The findings in our original publication that S100A8 is absent in these 
mice, despite normal levels of message being present, are reflected in the RT-PCR 
data presented. S100A8 RNA levels are unaltered as would be expected as 
normal RNA levels were found by RNAse protection previously (Hobbs et al., 
2003). S100A8 protein is totally absent in the mature animal, as shown by 2D gel 
analysis, immunohistochemistry and western blotting. Those experiments showed 
that when 175 proteins found by 2D gel analysis were compared in S100A9 null 
and wildtype mice the only proteins altered in expression were S100A8 and 
S100A9. It was thought that a more subtle alteration in the expression of other 
leukocyte expressed S I00 family members, or a low level expression of a 
truncated fragment of S I00A9 could be occurring. No obvious differences in the 
RNA levels of the SI 00 proteins examined were found. Taking all these pieces of 
data into account along with the altered density of the S100 A9 null neutrophils it 
seems clear that no compensatory changes in protein expression have occurred.
3.3.2 Normal myelopoiesis
The initial characterisation of the S100A9 null mice provides good 
evidence that S100A9 is not required for the production of normal mature 
neutrophils or monocytes. The first evidence comes from the normal number of
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these myeloid cells being present in blood and bone marrow. This seems to imply
that the steady state numbers being produced are normal in the S100A9 null mice.
That normal numbers are found in the circulation implies that they are responding
normally to signals to retain and release these cells from the bone marrow. A
phenotypic study of the myeloid cells shows that the maturation and activation
state of these cells is normal given that the expression of various surface markers
is normal. Also the levels of CXCR4, a chemokine receptor associated with
retention in the bone marrow, are similar on wildtype and S 100A9 null cells in
blood and bone marrow.
The presence of normal leukopoiesis and the normal differentiation and 
activation state of the S100A9 null neutrophils shows that S100A9 is dispensable 
for this process in mice. The absence of S100A8 protein in the mature animal 
seems to imply that this protein also plays no role in myeloid development in the 
adult animal. This evidence is partially in conflict with data published for an 
independent line of S100A9 null mice (Manitz et al., 2003). In the Manitz study 
no S100A8 protein could be detected by western blot from peripheral blood 
leukocyte, spleen or bone marrow. However, S100A8 reactivity of bone marrow 
cells was detected by immunohistochemical means. More robust evidence of the 
actual presence of S100A8 protein detected by biochemical means at the correct 
molecular size would be needed to confirm this is indeed S100A8.
It was concluded by Manitz et al that there was a shift in the 
myelomonocytic potential of the S100A9 null bone marrow, however the data 
presented is unconvincing. Bone marrow cells were cultured in Teflon bags for 4 
days and the number of cells expressing surface markers including Grl and 
CD1 lb were assessed. It was observed in the publication that slight differences in
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the cell numbers could be seen. The colony formination by bone marrow cells
stimulated with IL-3, GM-CSF, G-CSF or M-CSF was also studied to evaluate the
myelomonocytic potential. In this experiment it was again observed that some
small variation between the potential of wildtype and S100A9 null cells was seen.
Analysis of the data presented for these two experiments does not appear to show
any of these differences to be significant, with wildtype and S100A9 samples
having overlapping error bars in most cases and no statistical evaluation being
performed.
The normal number and developmental status of the S100A9 null 
neutrophils in blood and bone marrow allows the role of the protein in other 
neutrophil functions to be investigated, without any observed effects being a 
possible result of the cells being in a different state. The low number of 
neutrophils in murine blood, and the limited quantities that can be obtained per 
animal makes the use of this source impractical for performing further in vitro 
assays. This leaves the more abundant source of neutrophils in the bone marrow 
as the best to use. Given the difference in density of the S100A9 null neutrophils 
the use of the simple two-step gradient to enrich the neutrophil population will not 
be appropriate to use. The process of forming the Percoll gradient is relatively 
time consuming and there may be different populations of cells contaminating the 
S100A9 null and wildtype bands given their different densities. As such un­
fractionated bone marrow was used in the majority of in vitro studies conducted 
for this publication.
The evidence presented in this section shows no role for S100A9 in the 
development and maturation of neutrophils or monocytes. Despite the expression
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of S100A9 during the development of myeloid cells, as discussed in the
introduction, there appears to be no non-redundant role for it in myelopoiesis.
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4 Calcium signalling in S100A9 null neutrophils
4.1 Introduction
S100A8/9 are low molecular weight calcium binding proteins of the EF- 
hand type. Proteins of the S100 family are assumed to be calcium sensor proteins, 
rather than potent calcium buffering proteins. Upon calcium binding S I00 dimers 
undergo a conformational change exposing a hydrophobic interaction surface, 
presumably mediating their interaction with target proteins (reviewed in 
(Marenholz et al., 2004)). Other S I00 proteins have been highlighted as having a 
role in calcium homeostasis. Lack of S100B causes enhanced calcium transients 
in glial cells, and overexpression of S100A1 causes increased calcium loading of 
the sarcoplasmic reticulum in cardiomyocytes (Most et al., 2003; Xiong et al., 
2000). As calcium binding proteins form part of the cellular calcium signalling 
machinery it seemed logical to investigate the ability of the S100A9 null 
neutrophils to transduce a calcium signal.
There is evidence of almost all neutrophil functions being regulated by 
calcium from phagocytosis and superoxide burst to apoptosis (Reviewed in (Ayub 
and Hallett, 2004; Dewitt et al., 2003)). One of the most well defined stimuli of 
calcium signalling in neutrophils is chemoattractant-induced calcium signalling. 
Despite many years of study the exact mechanism and purpose of the calcium- 
induced signal is still not fully defined. The calcium response to chemoattractants
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provides a simple system to examine whether the S100A9 null neutrophils are 
capable of normal calcium signalling.
The first point to address when designing a system to analyse calcium 
signalling in murine neutrophils is the source of the cells. In the mouse only 5% 
blood leukocytes are neutrophils, and typically only 500-700pl of blood can be 
obtained from a mouse, however murine bone marrow consists of 25-30% 
neutrophils. Although these may not be as ‘mature’ as the circulating blood 
neutrophils they have been shown to exhibit calcium flux upon chemoattractant 
stimulation (Hobbs et al., 2003). Using murine bone marrow as a source of 
neutrophils requires working with a mixed cell population and makes studying the 
calcium properties of the S100A9 null neutrophils more complicated. The 
percentage of neutrophils can be enriched in a bone marrow population, but the 
difference in density of the S100A9 null neutrophils causes differential 
partitioning of the neutrophils in an enriching gradient as discussed in chapter 3. 
Traditional studies often rely on using a cuvette based method where the whole 
population of cells is loaded with a calcium indicator dye and the change in 
fluorescence of the entire population is monitored. Using whole murine bone 
marrow as a source of neutrophils makes this approach inappropriate for a number 
of reasons:
1. The neutrophils make up only 20-30% of the total population and so 
any difference in response to an ‘all-cell’ stimulus in the knockout cell population 
could be masked by the other unaffected cells.
2. Chemokines are a potent stimulus of calcium flux in the neutrophil, and 
many stimuli of this type are specific for neutrophils alone. The response to these
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specific agents may be masked by the majority population, which will remain
unresponsive.
To address these issues it was decided to study the neutrophil calcium 
response by flow cytometry. The murine neutrophil can be readily identified by 
flow cytometry by dual mAb staining with anti-Ly-6G and 7/4 antibodies 
(Henderson et al., 2003). Staining the whole population of bone marrow cells 
with this antibody combination will allow the neutrophils to be identified and 
analysed in isolation from the rest of the cells, eliminating the problems above.
In comparing a population of cells from two different animals it becomes 
critically important that no difference in calcium indicator loading affects the 
results. Although it could be argued that the loading of the two bone marrow 
populations would be controlled by maintaining equal concentrations of indicator 
dye and cells, any differences in the state or number of cells could still 
theoretically lead to differential loading of different batches of cells. The use of a 
ratiometric calcium indicator dye will remove any problems of differential dye 
loading, as ratiometric calcium indicator dye gives a measure of calcium 
concentration within the cell that is largely independent of dye concentration. 
INDO-1 is excited by UV light to emit fluorescence at 2 different wavelengths 
dependent on it being in a calcium-bound or calcium-free state (use of ratiometric 
dyes reviewed in (Hallett et al., 1996; Hallett et al., 1999; Rudolf et al., 2003)). 
The calcium concentration within the cell is proportional to the ratio of these dye 
states. By flow cytometry this ratio can be calculated for every cell and as the 
absolute concentration of dye within each cell does not affect the ratio per se then 
any small differences in dye loading between wildtype and knockout animal will 
have no effect. INDO-1 is also particularly useful as it is available as a lipophilic
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AM-ester. This allows uptake of the hydrophilic dye by the cell after which it is 
cleaved by cellular esterases to release the INDO-1 compound (loading AM-esters 
into neutrophil reviewed in (Hallett et al., 1996; Hallett et al., 1999)).
In this section the basic calcium homeostasis and induced calcium signals 
in the S100A9 null neutrophils will be examined. In order to assess whether the 
deletion of S100A9 has had an impact on the calcium signalling potential of the 
neutrophils it makes sense to look both at their ability to handle calcium and their 
ability to form a calcium flux in response to physiological stimuli. To examine if 
the gross manner in which the cell handles calcium is the same in wildtype and 
S100A9 null cells, the response of the cells to a high level of extracellular calcium 
entry (using the calcium ionophore ionomycin), the loading of the intracellular 
stores (by causing emptying of these stores using thapsigargin which inhibits the 
Ca ATPase causing leaching of the calcium into the cytosol) and the refilling 
mechanism of the intracellular stores by Store Operated Calcium Entry (SOCE) 
were studied. Should all these parameters appear unaffected, it would be 
concluded that there was no gross defect in calcium homeostasis in the knockout 
cells. To test the ability of the cells to mount a calcium response to a 
physiological stimulus, it was decided to examine the response to chemoattractant 
stimulation. It has been previously published by this lab that the S100A9 null 
neutrophils exhibit reduced calcium signalling to sub maximal levels of 
chemokine stimulation (Hobbs et al., 2003). I have followed up this observation 
by investigating the response to a range to different chemoattractant stimuli and 
attempting to elucidate the mechanism of this lesion in the S100A9 null cells.
The aim of this section is to examine the calcium signalling in the S100A9 
null neutrophils and to define and describe any lesion as far as possible. Due to
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the limitations of using primary murine neutrophils to examine cell signalling my 
studies to localise the defect to one particular pathway have relied heavily on 
pharmacological means. The tools available to study calcium signalling in whole 
cells are limited and due to the ‘delicate’ nature of the murine neutrophil, invasive 
means such as micro-injection or DNA construct transfections would not yield 
definitive results.
4.2 Results
4.2.1 Neutrophil calcium homeostasis
Treatment of the S100A9 null and wildtype neutrophils with the calcium 
ionophore ionomycin, which causes calcium influx across the plasma membrane, 
elicited an identical sustained rise in intracellular calcium of similar magnitude 
and kinetics in both groups (figure 4.1a). That the magnitude of the response is 
equal in both cell types implies that S100A8/9 is not acting as a major cellular 
calcium buffer. If an abundant calcium buffer were absent it would be expected 
that the peak of a response would be much greater, with more of the calcium 
being available to bind the indicator dye and less binding to endogenous buffers 
thus higher cytosolic calcium would be registered. This situation is observed in 
the calbindin D28k (a cellular calcium buffer) knockout animal (Airaksinen et al., 
1997). In these animals stimulation of the afferent climbing fibre, a neuronal cell 
expressing high levels of calbindin D28K, causes a higher transient calcium
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Figure 4.1 Normal calcium homeostasis in S100A9 null neutrophils.
Bone marrow leukocytes were loaded with Indo-1 and were identified by labelling with mAbs 7/4 
and Ly-6G. Intracellular calcium concentration was monitored by flow cytometry and was 
expressed as an arbitrary figure, based on the ratio of Indo-1 fluorescence at 424nm and 530nm. 
The median response neutrophil Indo-1 ratio of -500-700 events is plotted every second. The 
response to stimulation, in the presence of extracellular calcium, with lpM ionomycin (A) and 
5pM thapsigargin in the presence/absence of extracellular calcium by chelation with EGTA is 
shown (B and inset). C: Store operated calcium entry is examined by treatment o f the neutrophils 
with 5pM thapsigargin in the absence of extracellular calcium, prior to add-back of calcium at 0.5- 
2pM. All data representative of 3 or more independent experiments.
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spike in heterozygous and null animals compared to wildtype, even though resting 
calcium levels are normal.
Thapsigargin is an inhibitor of the Ca ATPase, an ion channel located on 
the endoplasmic reticulum, causing emptying of the calcium stores by leakage 
through this channel. Treatment of the cells with thapsigargin caused a transient 
increase in cytosolic calcium levels in the absence of extracellular calcium in both 
wildtype and S100A9 null neutrophils (figure 4.1b). The duration and magnitude 
of this response gives an indication of the loading of the intracellular stores, 
which appears equal in wildtype and S100A9 null cells. There was no consistent 
difference in the S100A9 null and wildtype responses. When the cells were 
treated with thapsigargin in the presence of extracellular calcium there was a bi- 
phasic increase in intracellular calcium concentration after which the calcium 
concentration reached a plateau. This response was similar in wildtype and 
S100A9 null neutrophils. The second phase of calcium elevation is caused by 
opening of calcium channels on the cell surface to allow re-filling of the emptying 
stores. This process is called Store Operated Calcium Entry (SOCE). That the 
profiles of cytosolic calcium concentration are similar in wildtype and S100A9 
null cells implies that the SOCE process is working normally. However this can 
be more directly assessed by treating the cells with thapsigargin in calcium free 
buffer to fully empty the calcium stores, then adding back calcium to the buffer 
and observing the profiles of the response. Figure 4.1c shows that SOCE in the 
wildtype and S100A9 null cells is identical over a range of extracellular calcium 
concentrations.
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4.2.2 Reduced MIP-2-induced calcium signalling
The wildtype and S100A9 null cells were stimulated with a titration of the 
neutrophil chemokine MIP-2 in the presence of extracellular calcium, as shown in 
figure 4.2a. At higher levels of chemokine (lOng/ml) no difference in the 
magnitude or duration of the calcium response in the wildtype or S100A9 null 
neutrophils was seen. At lower levels of stimulation (lng/ml and 0.3ng/ml) there 
was a decreased calcium flux response in the S100A9 null neutrophils compared 
to the wildtype cells. This shift in the dose response to MIP-2 could theoretically 
be explained by a lower expression of the MIP-2 receptor (CXCR2) on the cell 
surface. To test this possibility bone marrow cells from wildtype and S100A9 
null animals were immuno-stained with a polyclonal anti-(murine) CXCR2 
antibody (gift from RM Strieter, UCLA) and fluorescent secondary antibody. The 
cells were then further stained with the mAb 7/4 and IA8 cocktail to identify the 
neutrophils as before. Flow cytometric analysis of the neutrophil population 
showed similar expression of CXCR2 on both the wildtype and S100A9 knockout 
neutrophils (figure 4.2b).
4.2.3 Reduced calcium signalling to a range of chemoattractants
To examine the extent of the lesion in calcium signalling in the S100A9 
null neutrophils a range of chemokines were titrated against wildtype and S100A9 
null cells. Figure 4.3 shows that titration of the murine chemokine KC, which is 
also a ligand of CXCR2, showed a similar defect to that seen in response to MIP-
2. Similarly to MIP-2, there was no defect in calcium flux response to high levels 
of KC, but decreased magnitude of the calcium flux response to lower levels of
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Figure 4.2 Reduced calcium response to MIP-2 but normal CXCR2 
expression by S100A9 null neutrophils
Bone marrow leukocytes were loaded with Indo-1 and were identified by labelling with mAbs 7/4 
and Ly-6G. Intracellular calcium concentration was monitored by flow cytometry and was 
expressed as an arbitrary figure, based on the ratio of Indo-1 fluorescence at 424nm and 530nm. 
The median response neutrophil Indo-1 ratio of -500-700 events is plotted every second. A: The 
response o f neutrophils to the chemokine MIP-2. Data representative o f  3 independent 
experiments. B: The cell surface expression of CXCR2 was determined by co-labelling cells with 
antibody as described in the materials and methods. Flow cytometry data presented for pooled 
samples o f 3 independent mice per genotype.
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Figure 4.3 Reduced calcium response to the chemoattractants KC, M IP-la, 
C5a and PAF but not FMLP in S100A9 null neutrophils.
Bone marrow leukocytes were loaded with Indo-1 and were identified by labelling with mAbs 7/4 
and Ly-6G. Intracellular calcium concentration was monitored by flow cytometry and was 
expressed as an arbitrary figure, based on the ratio of Indo-1 fluorescence at 424nm and 530nm. 
The median response neutrophil Indo-1 ratio o f =500-700 events is plotted every second. 
Neutrophils from wildtype and S100A9 null mice were stimulated with KC, M IP-la, C5a, PAF 
and FMLP. Data representative o f 3 independent experiments (2 for PAF).
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KC in the S100A9 null compared with wildtype cells. When the S100A9 null 
cells were stimulated with M IP-la, a decreased calcium flux in the S100A9 null 
cells was seen in response to all concentrations of this chemokine. Although 
M IP-la is a ligand of both the CCR1 and CCR4 chemokine receptors, in the 
murine neutrophil the calcium flux is elicited by stimulation of the CCR1 receptor 
alone (Zhang et al., 1999). The chemoattractants PAF and C5a caused calcium 
flux by ligation of their receptors, PAF receptor and C5a receptor respectively. In 
the S100A9 knockout out cells, the same pattern was observed of no difference in 
calcium flux response at high levels of these stimuli, but a defect at lower levels 
of both these stimuli.
When the neutrophil stimulant FMLP, which stimulates the FMLP and 
FMLP-like receptors on neutrophils, was applied to the wildtype and S100A9 null 
neutrophils no defect in calcium flux response was seen at any concentration of 
stimulus. This data seems to indicate that while the S100A9 null neutrophils are 
compromised in their ability to produce a calcium flux response to a range of 
chemoattractant stimuli, this lesion is not a generalised reduced reactivity, but a 
problem with a specific signalling pathway that is used by some but not all 
chemoattractants.
4.2.4 Defect in intracellular calcium release
To localise the observed deficiency to a particular pathway, the first step is
to study the source of the calcium measured in these responses. The change in
cytosolic calcium concentration in response to a chemoattractant stimulus can be
made up of calcium from two general sources: intracellular calcium release from
the intracellular calcium stores and extracellular calcium entry through calcium
channels on the cell surface. To ascertain which calcium source(s) are being used
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to form the calcium responses seen in this study, the cells were stimulated with 
the various chemoattractant stimuli in the presence of extracellular calcium, as 
before, or in the absence of extracellular calcium (figure 4.4).
When the neutrophils were stimulated with a high concentration of MIP-2 
(2 0 ng/ml) the calcium response has a similar magnitude but decreased duration 
when the cells are stimulated in the absence of extracellular calcium compared 
with the response in the presence of extracellular calcium. In cells stimulated 
with a lower dose of MIP-2 (lng/ml) the response had a similar magnitude and 
duration in the presence and absence of extracellular calcium and the lesion in the 
S100A9 null response is evident in both conditions. This implies that the majority 
of the calcium contributing to this response is coming from the intracellular 
calcium stores, with a minor component o f extracellular calcium entry 
contributing at high levels of chemokine. Removing extracellular calcium does 
not reveal a further lesion in S100A9 null neutrophil signalling and does not affect 
the deficiency seen at the lower level of MIP-2 stimulation. This seems to 
indicate that the lesion is in intracellular calcium release rather than extracellular 
calcium entry. Experiments with similar results were performed with C5a as the 
stimulus. These showed that the majority of the calcium flux response was due to 
intracellular calcium release, but that the magnitude and duration of the response 
to a high level of C5a was reduced in the absence of extracellular calcium. In 
particular the elevated baseline following stimulation with high concentrations of 
C5a is returned to the pre-stimulation baseline in the absence of extracellular
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Figure 4.4 The lesion in calcium signalling in S100A9 null neutrophils is in 
intra-cellular calcium release
Bone marrow leukocytes were loaded with Indo-1 and were identified by labelling with mAbs 7/4 
and Ly-6 G. Intracellular calcium concentration was monitored by flow cytometry and was 
expressed as an arbitrary figure, based on the ratio of Indo-1 fluorescence at 424nm and 530nm. 
The median response neutrophil Indo-1 ratio of ~500-700 events is plotted every second. 
Neutrophils from S100A9 null and wildtype mice were stimulated with MIP-2, C5a and FMLP in 
the presence and absence o f extracellular calcium (calcium removed by chelation with EGTA). 
Data representative of 3 independent experiments.
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calcium. This seems to imply that extracellular calcium entry plays a small role in 
the rapid calcium peak seen and that after this initial reaction calcium channels on 
the surface open, causing a sustained elevation in intracellular calcium. At the 
lower concentration of C5a a slight decrease in the magnitude and duration of the 
response is seen. When the difference between wildtype and S100A9 null 
neutrophils is considered in this experiment, no effect of removing extracellular 
calcium is seen on the relative differences between the 2 groups. This again 
implies that the defect in the S100A9 null cells is in intracellular calcium release, 
rather than extracellular calcium entry.
When the response to FMLP is studied in the presence and absence of 
extracellular calcium, it is seen that at high concentrations of FMLP (lOpM) there 
is little effect on the magnitude of the initial calcium peak of removing the 
extracellular calcium. However, there is a sustained increase in cytosolic calcium 
concentration following the initial calcium flux peak and this sustained 
concentration of calcium is not seen when the extracellular calcium is chelated. 
At lower levels of calcium there is no effect on the magnitude of the response and 
only a slight affect on the duration of the response is evident. This data indicates 
that similarly to C5a, extracellular calcium entry pathways are activated in 
response to FMLP, that allow a sustained elevation of intracellular calcium 
concentration following the initial peak of the response. When the wildtype and 
knockout cells are compared it is seen that removing the extracellular calcium 
does not reveal a lesion in the calcium flux response in the S100A9 null cells. 
This shows that enhanced extracellular calcium entry is not compensating for the 
intracellular calcium release deficiency seen in the other responses in the S100A9 
null cells. To elucidate the intracellular calcium release pathway compromised in
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the S100A9 null cells, a pharmacological study comparing the effect of different 
agents on the FMLP and MIP-2 responses in the wildtype and S100A9 null 
neutrophils was undertaken.
4.2.5 Signalling via a G-protein coupled pathway
Previous studies on signalling by FMLP and IL- 8  (human homolog of 
MIP-2) have shown these proteins to signal by G-protein coupled pathways (Jiang 
et al., 1996; Schorr et al., 1999). To confirm that both the MIP-2- and FMLP- 
induced calcium flux responses occur via a G-protein coupled receptor pathway in 
this system, the cells were pre-incubated in the presence of pertussis toxin (figure 
4.5). This toxin blocks most G-protein activity. When the responses to MIP-2 
and FMLP were compared to responses observed in the presence of PTX it was 
seen that the magnitude of the responses was reduced in both wildtype and 
S100A9 null cells. A long incubation with PTX of 90 minutes at 37°C was 
required to allow this relatively non-cell permeable toxin to pass into the cells.
To confirm if the G protein-coupled calcium release pathways were 
broadly normal in these cells, they were treated with A lFf (figure 4.5). This 
moiety non-specifically activates G-proteins. A lFf had a lag time of around 5 
mins and caused a bi-phasic increase in calcium concentration with an early small 
increase in calcium concentration and a later further, more marked, increase in 
calcium concentration. This response was similar in wildtype and S100A9 null 
cells.
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Figure 4.5 Function of G-proteins in S100A9 null and wildtype neutrophils
Bone marrow leukocytes were loaded with Indo-1 and were identified by labelling with mAbs 7/4 
and Ly-6 G. Intracellular calcium concentration was monitored by flow cytometry and was 
expressed as an arbitrary figure, based on the ratio o f Indo-1 fluorescence at 424nm and 530nm. 
The median response neutrophil Indo-1 ratio o f =500-700 events is plotted every second. The 
bone marrow leukocytes were pre-incubated with lpg/ml pertussis toxin for 90 minutes at 37°C 
prior to stimulation with MIP-2 or FMLP. In addition the cells were stimulated with a solution of 
A1F4' (due to the lag in initiation of a calcium signal data is shown from the initiation of the signal 
at 5 minutes post-stimulation). Data shown was obtained in duplicate in 2 independent 
experiments.
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4.2.6 IP3 mediated calcium release pathway
As discussed in the Introduction, the IP3 -mediated calcium release 
pathway is one of the major calcium release pathways in non-excitable cells. The 
most potent and specific pharmacological inhibitor of the IP3 receptor, a ligand 
gated ion-channel, is heparin. Unfortunately heparin is not a cell-permeable 
inhibitor and so is unsuitable for use in this system. A relatively new tool for 
looking at IP3 receptor activity is 2-aminoethoxydiphenylborate (2-APB) 
(Maruyama et al., 1997). In its effects on intra-cellular calcium release, this 
compound is a highly selective inhibitor of this receptor. More recent 
investigation has indicated that it has a broader range of activity than originally 
thought (Bootman et al., 2002; Peppiatt et al., 2003). The ‘other’ functions of this 
inhibitor are largely related to its effects on extracellular calcium entry pathways 
or to effects on mitochondria following prolonged exposure. As we are primarily 
looking at intracellular calcium release, 2-APB will act selectively to inhibit the 
IP3 receptor in this context. In order to more easily interpret any differential 
effects of 2-APB on the S100A9 neutrophils, the effect of the inhibitor was 
examined at a dose of chemoattractant that gave equal calcium flux responses in 
wildtype and S100A9 null neutrophils. It was seen that applying 50pM 2-APB to 
the cells at the beginning of an experiment caused a large decrease in the MIP-2- 
induced calcium flux response in the S100A9 null cells and had only minimal 
effects on the wildtype cells (figure 4.6a). Other repetitions of this experiment 
have shown that the wildtype response can also be inhibited so is not resistant to 
the effects of 2-APB. That inhibition of the IP3 receptor has a greater effect on
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Figure 4.6 Function of the IP3 receptor in wildtype and S100A9 null 
neutrophils
Bone marrow leukocytes were loaded with Indo-1 and were identified by labelling with mAbs 7/4 
and Ly-6 G. Intracellular calcium concentration was monitored by flow cytometry and was 
expressed as an arbitrary figure, based on the ratio o f Indo-1 fluorescence at 424nm and 530nm. 
The median response neutrophil Indo-1 ratio of =500-700 events is plotted every second. A: Cells 
were exposed to 2-APB (50pM) at time zero prior to stimulation with chemoattractant at the 
indicated time. B: Cells were incubated with a titration o f IP3-AM for ten minutes prior to 
observation o f the Indo-1 signal for the time period shown. C: The expression of the IP3-receptor 
was examined by western blot analysis o f neutrophil lysate as described in the materials and 
methods. Calcium data shown is representative of 3 independent experiments.
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the S100A9 null cells could imply that the lesion in MIP-2 signalling is in the
same pathway. When the same experiment was conducted using FMLP as the
calcium flux stimulus, it was seen that 2-APB had the same effect on both the
wildtype and knockout response. This gives further evidence that the lesion in the
S100A9 neutrophils is specific to some but not all stimuli. That the 2-APB
compound does not show a differential effect on the FMLP response could
indicate that a secondary calcium release pathway is being activated by this
stimulus that is compensating for the lesion in the S100A9 cells.
To check whether the possible lesion in the IP3 pathway could be down to 
differential expression of this receptor, western blotting of a neutrophil protein 
lysate was performed using a pan-IP3 receptor antibody. This revealed no gross 
difference in IP3 receptor expression as shown in figure 4.6c.
To test if the function of the IP3 receptors was grossly normal a small 
amount of a cell-permeable IP3 -ester was obtained. Stimulating the IP3 receptor 
with IP3 itself is not possible in this system as IP3 would not pass through the 
membrane, and is an exceedingly labile substance. The IP3 -ester is more stable 
and passes through the membrane. The ester group is then removed in the cytosol 
and IP3 is released intracellularly (Peppiatt et al., 2003). This was applied to the 
cells at various concentrations. It was found to have a lag period of 5 mins before 
any activity was seen, presumably the time taken to pass into the cell and be 
cleaved. The IP3 ester caused a sustained rise in cytosolic calcium concentration 
at the higher doses tested (figure 4.6b). No difference in calcium release 
following stimulation with the IP3 ester was seen when wildtype and S100A9 null 
neutrophils were compared. This implies that the overall ability of the receptor to 
be activated by its ligand is normal and that S100A8/9 does not play a constitutive
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role in controlling the function of this receptor. It is of interest that a small EF- 
hand protein (CaBP-1) has been reported to interact the IP3 receptor. The 
evidence was provided by alterations in the effect of IP3-AM in the presence and 
absence of the overexpressed CaBP-1 protein (Kasri et al., 2004). We do not 
observe an effect of lack of S100A9 in this similar system but this does not 
absolutely rule out a selective interaction with the IP3 receptor upon stimulation 
by some but not all chemoattractants.
4.2.7 A physical association with the IP3 receptor
There is growing evidence that small calcium binding proteins of the EF- 
hand type are capable of interacting with the IP3 channel and modulating its 
activity either positively or negatively ((Kasri et al., 2004; Yang et al., 2002)). 
S100A1, another family member, is reported to interact directly with the 
ryanodine receptor and modulate its function upon binding ((Most et al., 2003; 
Treves et al., 1997)). Given this information it seems reasonable to hypothesise 
that S100A8/9 could be acting in this pathway by interacting with the IP3 
receptor.
In order to investigate this possibility an immunoprecipitation protocol 
was devised. A monoclonal anti-S100A9 antibody, 2B10, was shown to pull­
down S100A9 from a bone marrow lysate, along with its heterodimeric binding 
partner S100A8. Figure 4.7 illustrates a silver stained gel showing 2 bands of 
approx 14 and 8  kDa pulled down by 2B10 in wildtype lysate, these bands are 
absent in the S100A9 null lysate control and from a control immunoprecipitation
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Figure 4.7 Immunoprecipitation of S100A9
Protein lysates were made from bone marrow samples from wildtype and S100A9 null mice. The 
samples were incubated with 20-30pg/ml o f mAb 2B10, to precipitate S100A9, or an isotype 
control antibody. Antibody bound proteins were isolated using Protein G coupled sparse. Bound 
proteins were removed from the sparse by boiling the sample in SDS-PAGE gel loading buffer. 
A: Samples were run on a 15% SDS-PAGE gel and visualised using a silver-stain protocol. B: 
Western blotting was performed on IP samples using mAb anti-S100A9 (2B10) and polyclonal 
anti-S100A8 (NH9) antibody.
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with a non-specific isotype control antibody in the wildtype and S100A9 null 
lysates. No other obvious bands are seem in the 2B10 immunoprecipitation in the 
presence or absence of elevated cytosolic calcium (following ionomycin 
treatment) that are not present in isotype of S I00A9 null controls. To confirm the 
14 and 8  kDa bands are S100A8 and S100A9 as expected western blotting was 
performed with 2B10 and a rabbit polyclonal anti-S100A8 antibody (NH9). As 
shown in figure 4.7b S100A9 and S100A8 were pulled down by 2B10 as 
expected. Western blotting with the pan IP3 receptor did not produce any 
evidence of the IP3 receptor co-precipitating with S100A8/9; however, the IP3 
receptor antibody was found not to give consistently clear results by western 
blotting. Other IP3 receptor antibodies were also evaluated and also found not to 
give clear results. Immunoprecipitation with a panel of IP3 receptor antibodies 
was also found to be unsuccessful.
4.2.8 Ryanodine receptor signalling
Recent data published by Partida-Sanchez et al showed a role for the
ryanodine receptors in the FMLP-induced calcium flux response in the murine
neutrophil (Partida-Sanchez et al., 2001). In this publication the CD38 molecule
was deleted in mice. CD38 is an ecto-enzyme that catalyses the production of
cADPR from NAD and facilitates its transport into the cell. cADPR is a ligand
for the ryanodine receptor which is a ligand gated ion channel located on the
intracellular stores. In the CD38 knockout neutrophils the response to FMLP was
shown to have a slightly reduced maximum and no secondary peak of calcium.
Although the profiles of the calcium response in this study are different to those
found in the published study (namely no secondary peak of calcium is seen on
stimulation of the bone marrow neutrophils with FMLP in this study), it seems
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possible that this second pathway of calcium release activated by FMLP and 
apparently not other chemoattractants might act as a compensatory pathway in the 
S100A9 null neutrophils.
To test this hypothesis the cells were incubated with 50-lOOpM 8 -Br- 
cADPR, a cell-permeable inhibitor of the ryanodine receptor, in conditions similar 
to those published using this compound (Partida-Sanchez et al., 2001). When a 
range of FMLP concentrations were used to stimulate wildtype and S100A9 null 
neutrophils in the presence and absence of 8 -Br-cADPR at 5 0 jliM , no effect on the 
magnitude or duration of the response was seen in either group (figure 4.8). A 
similar result was found when the experiment was repeated using MIP-2 as a 
stimulant. The experiment was also attempted using Ruthenium Red, another 
inhibitor of the ryanodine receptor, and no effect could be seen in this system 
(data not shown).
As a control for the presence of the ryanodine receptor in this system 
ryanodine was used to treat the cells. Ryanodine activates the ryanodine receptor 
at low concentrations and inhibits its function at higher concentrations but this 
compound is poorly cell-permeable. No effect o f ryanodine was seen in this 
system over a range of doses (data not shown), although it is unclear if this is due 
to the moiety not passing the cell membrane or to absence of the receptor.
Assuming that the 8 -Br-cADPR compound was used at an appropriate 
concentration, it does not appear that the ryanodine receptor pathway is acting as 
a compensatory calcium release pathway in these cells. These results could be
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Figure 4.8 No involvement of 8 -Br-cADPR signalling in FMLP or MIP-2 
induced signalling
Bone marrow leukocytes were loaded with Indo-1 and were identified by labelling with mAbs 7/4 
and Ly-6 G. Intracellular calcium concentration was monitored by flow cytometry and was 
expressed as an arbitrary figure, based on the ratio o f Indo-1 fluorescence at 424nm and 530nm. 
The median response neutrophil Indo-1 ratio of -500-700 events is plotted every second. Cells 
were preincubated for in excess o f 15 minutes with 50pM 8 -Br-cADPR prior to stimulation with a 
titration o f MIP-2 or FMLP. Data shown is representative of 3 independent experiments.
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improved by the use of cell permeable activator of the ryanodine receptor to 
demonstrate their presence or that the inhibitor, used as described, can inhibit the 
receptor in a ryanodine receptor expressing cell type.
4.2.9 Involvement of phospholipase C
To further investigate whether the lesion in the MIP-2 signalling in the 
S100A9 neutrophils is due to an abnormality in the IP3 -mediated signalling 
pathway, an inhibitor of phospholipase C (PLC) was used. As discussed in the 
Introduction the signalling downstream of chemoattractant receptors involves 
activation of the G-protein operated phospholipase C. IP3 and diacylglycerol 
(DAG) are formed by the action of PLC on the lipid precursor PIP2.
U73122 is a cell-permeable inhibitor of PLC. Its relative specificity for 
the various forms of PLC is not completely clear, but there is evidence that it has 
a more potent action on PLC|32 than other isoforms (Hou et al., 2004). 
Surprisingly, when U73122-treated cells were stimulated with either MIP-2 or 
FMLP, the S100A9 null cells showed less inhibition by U73122 (figure 4.9a). 
This is unexpected, as so far the calcium signalling in the S100A9 null cells has 
been compromised and no lesion in FMLP signalling has been observed. With 
the inhibition of the IP3 receptor having a greater affect on the S100A9 null cells, 
the implication is that this pathway is possibly compromised in these cells. It is 
also surprising that the inhibitor reveals a lesion in the FMLP response in the 
knockout cells as inhibition using the 2-APB compound had not revealed any 
disparity between wildtype and S100A9 null cells. A higher 10pM dose of 
U73122 completely inhibits the response to MIP-2 and FMLP in both wildtype
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Figure 4.9 Involvement of PLC in neutrophil chem oattractant induced 
calcium signalling
Bone marrow leukocytes were loaded with Indo-1 and were identified by labelling with mAbs 7/4 
and Ly-6 G. Intracellular calcium concentration was monitored by flow cytometry and was 
expressed as an arbitrary figure, based on the ratio of Indo-1 fluorescence at 424nm and 530nm. 
The median response neutrophil Indo-1 ratio of -500-700 events is plotted every second. A: Cells 
were preincubated for > 15 minutes with 1-lOpM U73122 or 50pM E T -I8OCH3 prior to 
stimulation with MIP-2 or FMLP. Data shown is representative of 3 independent experiments. B: 
The expression o f the PLC|32 and PLC|33 isoforms was examined by western blot analysis of 
neutrophil lysates as described in the Materials and Methods.
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and S100A9 null animals showing again that both responses are dependent on 
PLC-IP3 mediated signalling. An inactive analog of U73122 (U73343) was used 
in this system to control for any PLC independent effects and was found to have 
no effect on either MIP-2 or FMLP signalling in wildtype or S100A9 null cells 
(data not shown). This indicates the effect seen is presumably due to the effects 
of this inhibitor on PLC function.
As this result was quite surprising it was decided to repeat the experiment 
with other inhibitors of PLC. Unfortunately the other published inhibitors of PI- 
PLC are less potent and less specific than U73122. E T -I8 -OCH3 is another 
inhibitor of phosphatidylinositol PLC and this compound did show inhibition of 
the MIP-2 response after a long incubation. No differential inhibition of the 
wildtype or S100A9 null response was seen, with both being strongly inhibited 
(figure 4.9). This again shows that the MIP-2 response appears to be primarily 
due to PLC mediated signalling. It does not provide any further insight into why 
the wildtype response was more strongly inhibited by U73122.
Studies using the PLCp2/3 knockout mice have shown that several 
chemokine responses (FMLP, M IP -la  and IL-8 ) are entirely dependent on 
signalling via a combination of these molecules in the murine neutrophil (Li et al., 
2000b). Studies using the single PLCP2 or PLCP3 animals show that both these 
molecules contribute to different degrees in the signalling by chemokines (Jiang et 
al., 1997; Li et al., 2000b). These experiments showed that PLCP2 was the 
predominant isoform involved in murine chemoattractant calcium signalling, but 
that PLCp3 also performed a minor role and could compensate to some degree for 
the absence of PLCP2. Given the recent data that U73122 may have a different 
potency against PLCP2 and PLCP3 ((Hou et al., 2004)), it could be argued that
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the S100A9 knockout animals have compensated for a lesion in this signalling 
pathway by using a different PLCp family member. If this member were less 
affected by U73122 than the isoform used in the wildtype cells (ie PLCP3 versus 
PLCp2) then the U73122 phenotype could be explained. To test for any 
compensation by upregulation or downregulation of the PLCp family, the levels 
of PLCP2 and PLCp3 were studied by western blotting of a neutrophil lysate as 
before. This experiment found no apparent difference in the expression levels of 
either isoform when wildtype and S100A9 null neutrophils were compared (figure 
4.9b).
As PLCp2 and PLC p3 are activated by G-proteins rather than 
phosphorylation, this makes detecting the level o f activation of these PLC 
isoforms more difficult than studying the phosphorylation activated forms 
(reviewed in (Rhee, 2001; Williams, 1999)). Differences in phosphorylation state 
can be evaluated by immunoprecipitation and phospho-blotting, or by the use of 
phosphorylation specific antibodies. The PLCp family are thought to be 
modulated, rather than activated, by phosphorylation, but the precise site involved 
is unclear (reviewed in(Rhee and Bae, 1997)). Attempts to immunoprecipitate the 
PLCP2 and PLCP3 proteins from the wildtype and S100A9 neutrophil lysates 
were unsuccessful, so any difference in phosphorylation as a cause for the 
differences in wildtype versus S100A9 signalling could not be evaluated.
The only way to test the activity of these PLCp isoforms is to measure the 
level of IP3 produced in response to the stimuli. This, unfortunately, is not an 
easy process. A commercially available kit (Amersham) allows the levels of IP3 
in a sample to be measured using a competitive radio-ligand binding assay to an 
engineered IP3 binding protein. The kit was used in conjunction with an
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immunomagnetic sorted 98% pure neutrophil (Ly-6 G positive) population but 
failed to detect any IP3 in the neutrophil samples, despite using very high cell 
numbers (> lx l0 7 /sample) and inhibiting the degradation of IP3 by including LiCl 
in the stimulation buffer. Data provided with the kit for the production of IP3 by 
neutrophils from rabbit shows that the amount of IP3 produced following IL- 8  
stimulation is very low. This would imply that the problem with my assay may 
have been that the levels extracted were below the limits of detection of the kit, 
particularly as all other parameters and standards were within expected limits.
4.2.10 Involvement of DAG
Data considered so far seems to implicate PLC as a possible site for the 
lesion in the S100A9 null neutrophils. Attempts to evaluate the function of PLC 
with respect to IP3 production have been exhausted but PLC also produces DAG. 
DAG is itself a bioactive moiety, activating PKC and PKC-independent targets as 
well as acting as an activator of extracellular calcium entry via DAG-operated 
calcium channels (Brose et al., 2004; Hardie, 2003; Spassova et al., 2004). If we 
hypothesise that PLC function is somehow altered in the S100A9 null cells then it 
follows that DAG production is also affected.
To investigate any role for altered DAG production in this system the
metabolism of DAG was blocked by using the DAG Kinase Inhibitor II (R59949).
Preincubating the cells with this compound prior to stimulation with MIP-2
showed little effect of the inhibitor on the wildtype response at low or high
concentrations (figure 4.10). However, the S100A9 null neutrophils showed a
considerable inhibition of the MIP-2-induced calcium flux with both the
magnitude and duration of the response being reduced. When the calcium flux
response to FMLP was evaluated in the presence and absence of R59949, little
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effect of the inhibitor was seen on either the wildtype or S100A9 null neutrophil 
response (figure 4.10).
Studies with another inhibitor of DAG metabolism RHC80267, an 
inhibitor of DAG lipase, did not reveal any inhibition of either the MIP-2 or 
FMLP response in wildtype or S100A9 null neutrophils (figure 4.10). This could 
imply that either R59949 is having an effect other than its effect on DAG 
metabolism, or that DAG metabolism occurs primarily via the DAG kinase route 
in neutrophils.
These data show that increased DAG levels have a greater inhibitory effect 
in the S100A9 null cells. These data are also interesting as they show that 
affecting DAG levels seems to inhibit MIP-2 signalling but have no effect on 
FMLP signalling. To confirm that the effect is due to an effect of DAG itself 
rather than an unexpected effect of the R59949, a cell permeable DAG analogue 
was used to see if it has a similar effect.
OAG is a cell permeable DAG mimetic, which can be used to mimic the 
effects of DAG on the cells without the need to affect the entire DAG metabolic 
cycle. Cells were pre-treated with lOOpM OAG, then stimulated with MIP-2 or 
FMLP as before (figure 4.11). When the effect of OAG on the MIP-2 induced 
calcium flux was considered it was seen that some effect of the OAG was seen on 
the wildtype response, but a much more pronounced reduction of the MIP-2
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Figure 4.10 Effect of alteration of DAG metabolism on neutrophil calcium 
signalling
Bone marrow leukocytes were loaded with Indo-1 and were identified by labelling with mAbs 7/4 
and Ly-6 G. Intracellular calcium concentration was monitored by flow cytometry and was 
expressed as an arbitrary figure, based on the ratio o f Indo-1 fluorescence at 424nm and 530nm. 
The median response neutrophil Indo-1 ratio of -500-700 events is plotted every second. Cells 
were preincubated for in excess o f 15 minutes with 20-50pM DAG Kinase Inhibitor II or RHC- 
80267 (an inhibitor o f DAG lipase) prior to stimulation with MIP-2 or FMLP. Data shown is 
representative of 3 independent experiments.
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Figure 4.11 Effect of the DAG analog OAG on neutrophil calcium signalling
Bone marrow leukocytes were loaded with Indo-1 and were identified by labelling with mAbs 7/4 
and Ly-6 G. Intracellular calcium concentration was monitored by flow cytometry and was 
expressed as an arbitrary figure, based on the ratio o f Indo-1 fluorescence at 424nm and 530nm. 
The median response neutrophil Indo-1 ratio of =500-700 events is plotted every second. Cells 
were preincubated for > 15 minutes with lOOpM OAG prior to stimulation with MIP-2 or FMLP. 
Data shown is representative o f 3 independent experiments.
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response in the S100A9 null cells was seen. When the FMLP response was 
considered little effect on wildtype or S100A9 null cells was seen. DAG can have 
numerous effects in the cell, but a major one of these is to activate PKC.
These data along with the DAG kinase inhibitor data seem to indicate that 
the S100A9 null cells have a different response to an elevation of DAG levels. To 
test if PKC is mediating this effect of DAG in the S 100A9 null cells, it was 
decided to assess the effect of PKC inhibition on the calcium signalling in the 
wildtype and null cells.
4.2.11 A role for PKC
Wildtype and S100A9 null cells were preincubated with BIM, a PKC 
inhibitor, then stimulated with FMLP and MIP-2 (figure 4.12). No effect of PKC 
inhibition was seen on the response to MIP-2 at maximal responses or at levels 
where the lesion in S100A9 signalling was evident. No effect of BIM was seen 
on FMLP induced calcium flux in either wildtype or knockout cells. Another 
inhibitor of PKC, Calphostin C, was also tested in the experiment, with similar 
lack of effect. These results show that inhibition of PKC does not rescue the 
lesion in the S100A9 null cells. While the knockout cells have a different 
response to DAG signalling an altered response to PKC is not the cause of the 
lesion seen in MIP-2 signalling.
4.2.12 Another hypothesis: arachidonic acid
S I00A8/9 has been implicated as a major arachidonic acid (AA) binding 
protein in neutrophils (Kerkhoff et al., 1999b; Klempt et al., 1997; Roulin et al., 
1999; Siegenthaler et al., 1997; Sopalla et al., 2002). Arachidonic acid has also
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Figure 4.12 Effect of inhibition of PKC on neutrophil calcium signalling
Bone marrow leukocytes were loaded with Indo-1 and were identified by labelling with mAbs 7/4 
and Ly-6 G. Intracellular calcium concentration was monitored by flow cytometry and was 
expressed as an arbitrary figure, based on the ratio o f Indo-1 fluorescence at 424nm and 530nm. 
The median response neutrophil Indo-1 ratio of ~500-700 events is plotted every second. Cells 
were preincubated for in excess o f 15 minutes with 2pM BIM or Calphostin C prior to stimulation 
with a titration o f MIP-2 or FMLP. Data shown is representative of 3 independent experiments.
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been shown to affect calcium signalling (Mignen and Shuttleworth, 2000; 
Striggow and Ehrlich, 1997). Arachidonic acid has been shown to mediate 
extracellular calcium entry via the arachidonic acid activated calcium (ARC) 
channels (Mignen and Shuttleworth, 2000). It has been shown that arachidonic 
acid can cause inhibition of intracellular calcium release via the IP3 receptor in 
cerebellum microsomes (Striggow and Ehrlich, 1997). It could be speculated that 
in the absence of the major A A binding capacity, more free A A is available in the 
S100A9 neutrophils which could cause an increase in the cytosolic calcium 
concentration as is seen by the increased basal calcium levels in the S100A9 null 
neutrophils. The data showing that the IP3 receptor can be inhibited by 
arachidonic acid could supply a direct route of affecting calcium signalling.
To elevate the levels of A A in the neutrophils, the arachidonic acid 
mimetic ETYA was pre-incubated with the cells. When the effect of ETYA on 
the MIP-2 or FMLP response is considered it can be seen that ETYA causes no 
change to the profile of the responses (figure 4.13).
Another method of altering the AA metabolism in the cells is to inhibit the 
breakdown by cyclooxygenase enzymes to form prostanoid/leukotriene 
derivatives. This can be done by treating the cells with indomethacin. When the 
cells were treated with indomethacin no effect on the response to MIP-2 or FMLP 
could be seen (figure 4.13).
Neutrophils were stimulated with arachidonic acid in the presence and 
absence of extracellular calcium (figure 4.14). In the presence of extracellular 
calcium a robust spike of calcium was seen. This appeared to be of similar 
magnitude and duration in the wildtype and S100A9 null cells. In the absence of
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Figure 4.13 Effect of alteration of Arachidonic Acid metabolism on 
neutrophil calcium signalling
Bone marrow leukocytes were loaded with Indo-1 and were identified by labelling with mAbs 7/4 
and Ly-6 G. Intracellular calcium concentration was monitored by flow cytometry and was 
expressed as an arbitrary figure, based on the ratio of Indo-1 fluorescence at 424nm and 530nm. 
The median response neutrophil Indo-1 ratio of ~500-700 events is plotted every second. Cells 
were preincubated for in excess o f 15 minutes with 50pM ETYA or Indomethacin prior to 
stimulation with a titration o f MIP-2 or FMLP. Data shown is representative o f 3 (2 for 
Indomethacin) independent experiments.
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Figure 4.14 Arachidonic acid stimulates intracellular and extracellular 
calcium signalling in neutrophils
Bone marrow leukocytes were loaded with Indo-1 and were identified by labelling with mAbs 7/4 
and Ly-6G. Intracellular calcium concentration was monitored by flow cytometry and was 
expressed as an arbitrary figure, based on the ratio of Indo-1 fluorescence at 424nm and 530nm. 
The median response neutrophil Indo-1 ratio of -500-700 events is plotted every second. Cells 
were stimulated with lOOpM arachidonic acid in the presence or absence of extracellular calcium. 
Data shown is representative o f 2 independent experiments.
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extracellular calcium the magnitude of the AA induced calcium flux was reduced 
in both wildtype and S100A9 null animals to an equal degree. This data shows 
that AA can cause a combination of extracellular calcium entry and intracellular 
calcium release. The intracellular calcium release seems to be independent of the 
need for extracellular calcium entry.
These data show that arachidonic acid can stimulate calcium signalling but 
attempts to alter arachidonic acid levels in the neutrophils have only minor effects 
on chemoattractant induced calcium signalling. This data does not provide robust 
evidence to support the arachidonic acid theory.
4.3 Discussion
4.3.1 Calcium Homeostasis
The results obtained in this study do not indicate any abnormalities in the 
basic homeostatic calcium parameters in the S100A9 null neutrophils. Most 
interestingly despite the abundance of the dimer in neutrophils there was no 
obvious effect on the calcium buffering potential of the cells, with the magnitude 
of the ionomycin response being identical in S100A9 null and wildtype 
neutrophils. Indeed preliminary experiments carried out by S. Bolsover 
(University College London) to directly measure the calcium buffering potential 
o f the two cell types revealed no significant decrease in calcium buffering 
potential. When calbindin D28k, a highly abundant neuronal calcium buffering 
protein, was deleted in mice the magnitude of synaptically induced calcium 
transients was enhanced by 80% in the mutant mice (Airaksinen et al., 1997). 
Calbindin D28k, like S100A8/9, is startlingly abundant, being 15% of total 
cellular protein in mature Purkinje cells ((Baimbridge et al., 1982)), and it is this
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parallel of high expression levels that lead to the assumption that the S100A8/9 
dimer must be a major neutrophil cytosolic calcium binding protein. The 
evidence from this study fits with the idea that the S I00 family act as calcium 
sensor proteins transducing a signal.
Normal loading of the internal calcium stores in the S100A9 null cells is 
also another key observation of normal calcium homeostasis in these cells. In the 
cardiomyocytes of S100A1 overexpressing transgenic mice the sarcoplasmic 
reticulum, a major calcium storage structure in excitable cells, has increased 
calcium content (Most et al., 2003). In light of this data it was important to 
observe if the loading of the neutrophil internal stores was affected in the S100A9 
null mice. Having established no deficiency or enhancement of ER calcium 
loading it was then logical to evaluate the refilling of these stores. The precise 
mechanism of store operated calcium entry (SOCE) is unclear, but depletion of 
the intracellular stores causes opening of calcium channels on the surface, either 
by direct coupling of the stores to these channels or by production of an 
intracellular messenger. By studying the effects of thapsigargin in the presence of 
calcium and the store operated calcium entry profiles for the S100A9 null and 
wildtype neutrophils it was seen that this process is unaffected by the absence of 
S100A9.
The one aspect of calcium homeostasis that has not been examined in this 
study is the elevated baseline calcium as described previously (Hobbs et al., 
2003). This apparent increased calcium level in the unstimulated S100A9 null 
neutrophils is still evident in this current study. It has been difficult to define and 
investigate its significance due to the size of the difference involved. This 
increase in calcium under basal conditions was not explained by enhanced release
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from intracellular stores or alteration in SOCE. The buffering of acute elevations 
in cytosolic calcium seems to indicate no profound affect on the ability of the cell 
to buffer calcium. A source of intracellular calcium buffering and release not 
explored in this study are the mitochondria (reviewed in (Duchen, 1999; Rizzuto 
et al., 2004)). These are able to both take up and release calcium in the cell and 
could in theory act as a broad compensatory pathway for a lack of calcium 
buffering potential. Whether this would allow the cell however to have perfectly 
identical calcium kinetics in wildtype and S100A9 null cells as seen in this study 
is unclear. Any differences in the number or function of the mitochondria could 
be detected by flow cytometry using mitotracker dyes to assess the number of 
mitochondria present and the ratiometric dye JC-1, that changes fluorescence 
relative to the membrane potential of the mitochondria, to assess their function.
4.3.2 Lesion in chemoattractant-induced calcium flux
Having established that calcium homeostasis as explored in the S100A9 
null cells was normal, the next stage was to examine and confirm the published 
deficiency in chemokine-induced calcium signalling in the S100A9 null mice 
(Hobbs et al., 2003). In this study the lesion was shown to be present in the 
calcium response to a broad range of chemoattractants, chemokines of the CCR 
and CXCR type and other chemoattractants such as C5a and PAF. The lesion was 
localised to intracellular calcium release. Rather than being a generalised 
deficiency in all chemoattractant induced calcium signalling the absence of any 
lesion in the response to FMLP indicated that a specific intracellular release 
mechanism used by some but not all chemoattractants was affected in the S100A9 
null mice. To dissect the lesion, a model system of comparing MIP-2 and FMLP
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mediated signalling was used. Figure 4.15 summarises the generally accepted 
scheme of chemoattractant signalling.
The calcium signalling induced in neutrophils by these two mediators has 
been studied in various ways. The signalling by FMLP and IL - 8  (the human 
homolog of MIP-2) was pertussis toxin sensitive as shown by others (Jiang et al., 
1996; Schorr et al., 1999). The signalling by MIP-2 and FMLP was not 
completely abolished by PTX in this study. This was likely to be due to difficulty 
in loading the cells with PTX, which usually requires an incubation of several 
hours to be fully effective. As neutrophils have a short life-span, much longer 
incubation times were not feasible. Pertussis toxin is a bacterial toxin that 
modifies a set of G-protein a  subunits belonging to the Gi and Go classes (but not 
the Gq, Gs or G 12 classes), preventing receptor coupling to these G-proteins. G- 
proteins consist of three stably associated subunits a ,  p and y. Interaction of a G- 
protein and an activated receptor causes exchange of the GDP bound to the a  
subunit for GTP. The GTP bound a  subunit can then disassociate from the Py 
dimer. Both the a  and Py subunits subsequently transduce the signal into the cell. 
PLCp can be activated by either a i  or by a  or Py subunit of the Gq pathway 
(reviewed in (Neves et al., 2002)). The sensitivity of CXCR1/2 and FMLP 
receptor signalling to PTX shows coupling to the Gi pathway (Jiang et al., 1996; 
Wu et al., 1993).
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Figure 4.15 General scheme of chemoattractant calcium signalling
When chemoattractants such as MIP-2 or FMLP ligate their seven transmembrane spanning 
receptors activation of G-proteins occurs. This causes activation o f PLC, PLC|32/3 in murine 
neutrophils. The hydrolysis of the membrane lipid PIP2 to form IP3 and DAG then occurs. IP3 
acts to ligate the IP3 receptor on the intracellular calcium stores triggering the release of calcium 
into the cytosol. In addition to this standard mechanism FMLP has been shown to activate CD38, 
a surface membrane ecto-enzyme that catalyses the formation and subsequent transport o f cADPR 
into the cell. This molecule can ligate the ryanodine receptor that also sits in the membrane of the 
intracellular stores and cause release o f calcium into the cytosol.
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Members of the Gi class of G-protein can transduce a signal using both the 
a  and py subunits (reviewed in (Neves et al., 2002)). The a  subunit does not 
activate calcium signalling, but the py subunit released by receptor interaction can 
directly activate phospholipase C enzymes of the p class. In mice lacking the 
haematopoietic specific PLCP2 isoform neutrophil signalling by both IL- 8  and 
FMLP was reduced, but not abolished (Jiang et al., 1997). When PLCp2/PLCp3 
double knockout mice were studied, signalling to both IL - 8  and FMLP was 
completely abolished, showing the intracellular calcium release by these 
mediators was entirely PLCp2/3 dependent (Li et al., 2000b). In PLCP3 null 
animals the reduction in calcium flux following FMLP stimulation was minimal 
compared to the reduction in the PLCP2 and double knockout animals (Li et al., 
2000b). This seems to indicate that the PLCp2 isoform is the default isoform in 
wildtype neutrophil signalling, with PLCP3 playing a compensatory role in the 
absence of PLCP2.
The data obtained from the wildtype neutrophils seems to indicate that 
both MIP-2 and FMLP use pertussis toxin sensitive PLCp to hydrolyse PIP2 to 
produce IP3 mediated calcium flux in neutrophils. The MIP-2 induced calcium 
flux was shown to be sensitive to elevation of intracellular DAG levels by 
inhibiting DAG kinase or applying the DAG mimetic OAG. The FMLP induced 
calcium response was unaffected by increasing DAG levels. Both pathways were 
shown to be unaffected by inhibition of PKC signalling, a primary effector of 
DAG. No role for ryanodine receptor mediated calcium release was shown in 
either response in the conditions used for this study. Similarly there was little 
effect of altering arachidonic acid metabolism on the MIP-2 or FMLP induced 
calcium flux. This shows a picture where the basic calcium release pathways
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used by both CXCR2 and the FMLP receptor are similar but that the regulation of 
these pathways is different.
4.3.3 Differential regulation of intracellular calcium release
In the S100A9 null neutrophils the signalling by MIP-2 and FMLP 
appeared to be via PLC and the IP3 receptor, as both are sensitive to 2-APB and 
U73122. Additionally the MIP-2 response was sensitive to inhibition by 
increased DAG levels or OAG. The interesting observation is that the S100A9 
null cells were far more sensitive to inhibition by 2-APB and the DAG kinase 
inhibitor. The increased efficacy of the 2-APB compound on MIP-2 signalling in 
the S100A9 null neutrophils seems to imply that the PLC-IP3 pathway is working 
less efficiently. The data from the U73122 compound seems to indicate the 
opposite, showing that the wildtype MIP-2 response is more compromised. There 
a few possible explanations for this. The compound may have greater efficacy 
against one PLC family member than another, which seems to be indicated in the 
literature (Hou et al., 2004). Here greater potency of the inhibitor against PLCp2 
than PLC|33 is shown in a cell-free system where the ability of U73122 to inhibit 
the hydrolysis of PIP2 by recombinant PLCp isoforms is tested (Hou et al., 2004). 
This could imply that in the S100A9 null cells the signalling is coupled to PLCp3 
in preference to PLCP2 thus being more resistant to inhibition by U73122. What 
is more puzzling about the U73122 data is that it shows a differential effect in 
wildtype and S100A9 null signalling induced by FMLP, a response that is 
unaffected in the S100A9 null mice in all other conditions tested. Attempts to 
confirm this data with other inhibitors of PLC were unsuccessful. That the effect 
produced by this inhibitor does not mirror the lesion seen in the S100A9 null mice
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could imply that its lack of potency against the S100A9 null neutrophils is not 
directly related to the lesion described so far.
One recent paper of interest that may provide a mechanism to identify 
whether the lesion in calcium signalling is at or above the level of PLC activity 
concerns a novel real-time IP3 sensor (Sugimoto et al., 2004). This system uses 
an engineered protein identical to the PH domain of PLC with a fluorescent 
indicator attached. The binding of IP3 to the probe displaces the fluorophore and 
its fluorescence is decreased. The probe is cell-permeable due to the inclusion of 
an arginine-rich tag. The probe was capable of detecting IP3 production in the 
DT-40 B cell-line in response to B cell receptor stimulation. This system should 
be usable by flow cytometry and would thus be suitable to study the production of 
IP3 in neutrophils.
4.3.4 Theories for the mechanism of action of S100A9
The two most attractive explanations for the calcium signalling lesion in 
the S100A9 null neutrophils, given the existing literature, are an effect of altered 
arachidonic acid availability and a direct interaction of S100A9 with the IP3 
receptor. The data presented here does not validate either hypothesis. The lack of 
any effect of the arachidonic acid mimetic or of indomethacin gives no evidence 
for arachidonic acid mediators playing any role in regulating chemoattractant- 
induced calcium flux in neutrophils. The evidence for a direct interaction of 
S100A9 with the IP3 receptor is less robustly ruled out.
Although the data from the IP3 ester shows no constitutive effect of
S100A9 in calcium release from the internal stores, it could be that S100A9 is
only recruited to the receptor upon defined stimuli, thus accounting for the lack of
lesion when the cells are stimulated with IP3 directly. There are several studies
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documenting protein ligands for the IP3 receptor that can enhance or inhibit its 
activity. The prototypical protein of this type is calmodulin (CaM), a highly 
abundant ubiquitous four-EF-hand-containing intracellular protein. The calcium- 
unbound apo-CaM form has been shown to inhibit IP3 binding to the IP3 
Receptor. In its calcium-bound state, Ca-CaM facilitates the calcium-mediated 
inactivation of the receptor (reviewed in (Nadif Kasri et al., 2002; Roderick and 
Bootman, 2003)).
More recent studies have demonstrated a modulatory effect of CaBPl on 
IP3 receptor activation. Two contrasting studies have demonstrated both a 
positive (Yang et al., 2002) and negative role (Kasri et al., 2004) for this protein 
on IP3 receptor activity. In the paper by Kasri et al the inhibitory role of 
overexpressed CaBPl in COS-7 cells on the activity of the IP3 receptor following 
stimulation with HVester was used as proof of concept. In the other report 
CaBPl was shown to interact directly in a calcium dependent manner with the IP3 
receptor both in transfected systems and in rat brain extracts by co- 
immunoprecipitation (Yang et al., 2002). In that study the presence of CaBPl 
was associated with Xenopus IP3 receptor opening measured by individual 
channel patch clamping.
Hypothesis of an interaction of S100A9 with the IP3 receptor requires 
some proof of a physical interaction between the IP3 receptor and S100A9. 
Attempts to gain this evidence were unsuccessful due to the limitations of the 
available antibodies. A biochemical system, such as a yeast two-hybrid screen or 
co-precipitation of tagged proteins could be used to look for a direct in vitro 
interaction of the proteins. Such attempts are warranted given the evidence from 
the study of S100A1. This member of the SI 00 family has been shown to interact
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with both ryanodine receptors type I and II (Most et al., 2003; Treves et al., 1997). 
Furthermore studies with S100A1 overexpressing transgenic mice, or S100A1 
overexpressing cardiomyocytes in vitro, demonstrate an increase in calcium 
release from the sacroplasmic reticulum following cell stimulation (Most et al., 
2004; Most et al., 2003). More tantalizingly the S100A1 knockout mice show a 
slight impairment of calcium release from cardiomyocytes following p i 
adrenoceptor stimulation (Du et al., 2002) that is reminiscent of the magnitude of 
effect seen in the S100A9 null calcium responses. Although in two very different 
cell systems, the principle of the interaction of an S I 0 0  protein with an 
intracellular ligand gated ion channel causing enhancement of calcium release 
following receptor stimulation could be a conserved role for these proteins.
4.3.5 A role for DAG kinase in chemoattractant signalling?
The evidence presented here seems to imply a strong modulatory role for
DAG in MIP-2-induced calcium signalling. That this effect is manifested only
when DAG kinase, rather than DAG lipase, is inhibited indicates that this
molecule is of greater importance in this role. Given that inhibition of PKC has
shown little effect on chemokine stimulation in this model, it is possible that DAG
is exerting its effect through other downstream mediators. Interestingly a very
recent publication has highlighted a modulatory role for DAG in IP3 mediated
signalling (Hisatsune et al., 2005). In this system addition of the DAG mimetic
OAG caused increased IP3 -dependent calcium oscillations in various cell types.
Elevation of endogenous DAG levels by inhibition of DAG lipase caused an
increased calcium response to low levels of agonist stimulation. Whilst this effect
is the opposite of that seen in this system, where DAG is inhibitory, it does
provide proof of concept for non-PKC mediated modulation of calcium signalling
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by DAG. Whether the effect of DAG on chemoattractant signalling is the site of 
the lesion in the S100A9 null neutrophils or whether DAG plays a modulatory 
role in the same pathway is unclear. The DAG kinase a  enzymes contain EF- 
hand motifs that when bound to calcium have been shown to cause translocation 
to the membrane and increased kinase activity (reviewed in (Luo et al., 2004b)). 
Regulation of this molecule by calcium provides a mechanism by which a 
calcium-binding protein such as S100A9 could modulate the activity of this 
enzyme.
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5 Adhesion and migration of S100A9 null neutrophils
5.1 Introduction
The primary role for the neutrophil is as a first line of defence against 
invading pathogens. To perform this activity they must be able to move rapidly 
out of systemic circulation, following a series of directional signals to arrive at the 
site of the infection. It has already been shown that the S100A9 null neutrophils 
have a deficiency in their ability to produce a calcium signal in response to many 
chemoattractant stimuli. It seems possible that this deficiency could impair their 
ability to become activated by and respond to these stimuli both in in vitro and in 
vivo situations. As well as a role in chemoattractant signalling, S100A9 could 
play other roles in the calcium-dependent process of adhesion and migration.
The complex nature of leukocyte recruitment to the site of inflammation in 
vivo requires the neutrophil to respond appropriately to a concert of activating and 
directional signals. Individual steps of this process can be modelled in vitro with 
the phases o f adhesion, chemotactic movement and migratory ability and 
morphology being studied separately. Adhesion can be quantified by assessing 
the ability o f neutrophils to bind to immobilised integrin ligands in response to 
activating stimuli. PMA or chemoattractants cause cellular activation and result in 
“inside-out” integrin activation causing adhesion. Divalent cations activate by 
binding directly to (32 integrin, acting as a model of “outside-in” signalling.
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Assessment o f the directional movement o f cells towards a
chemoattractant stimuli can be undertaken using a range of different methods. 
The most simple of these is the Transwell™ system where cells are placed in a 
well separated from a chemoattractant stimulus by a polycarbonate filter of 
varying pore size to allow specific subsets of cells to migrate through. This assay 
is relatively easy to perform and provides a gross indication as to whether the 
cells are being activated by the chemoattractant stimulus. The assay can be 
extended to investigate the process further by coating the filter with specific 
integrin ligands or an endothelial cell layer should any interesting phenomena be 
observed.
The ability of the cells to migrate normally on integrin ligands can be 
evaluated by allowing the cells to attach and migrate on the LFA-1 ligand ICAM- 
1 , where leukocytes undergo seemingly random migration in physiological salt 
solution in the presence of divalent cations (magnesium and calcium). The speed 
and directionality of the migration can be assessed by video microscopy along 
with any obvious abnormalities in cell morphology. A normal migrating cell 
exhibits an elongated polarised morphology having a narrow un-attached uropod 
at the trailing edge and a fan-shaped attached lamellipodia towards the direction 
of movement. Microscopical studies of the migrating cell can be made to 
examine the organisation of cytoskeletal and signalling molecules.
In this section any role for S100A8/9 in cell adhesion and migration is 
examined using both in vitro and in vivo methods.
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5.2 Results
5.2.1 Integrin mediated adhesion
The function of cell surface integrins can be studied using an adhesion 
assay. This entails activating the cells, or the integrin directly, and monitoring the 
ability of the cells to bind a suitable integrin ligand. In this study the binding of 
the p2 integrin Mac-1 to its ligand fibrinogen is used as a model. To assess cell 
adhesion resulting from an increase in Mac-1 avidity, PdBu was used to stimulate 
bone marrow cells (figure 5.1). Over a titration range of PdBu an increase in 
adhesion to fibrinogen was observed between 0.04pM and lpM. No significant 
difference between wildtype and S100A9 null cells was seen. To test the ability 
of Mac-1 to mediate adhesion following an increase in affinity the cells were 
stimulated with a titration of the divalent cation Mn2+. Mn2+ was shown to cause 
an increase in cell adhesion to fibrinogen. The level of adhesion stimulated in the 
wildtype and S100A9 null cells showed no significant difference with -40%  of 
the bone marrow cells adhering in both populations in response to 500pM Mn2+.
5.2.2 Mac-1 up-regulation
In addition to changes in affinity and avidity Mac-1 expression levels are 
increased in response to neutrophil activating stimuli. This gives an indication of 
the activation state of the neutrophil and its ability to become activated by pro- 
inflammatory stimuli. In this study increased surface expression of Mac-1 was 
detected by performing three-colour flow cytometry to identify the neutrophils in 
a mixed bone marrow cell population and by studying the expression of Mac-1 on 
those neutrophils using a monoclonal anti-M ac-1 antibody. A range of 
chemoattractants that were used in the calcium signalling studies were used to
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Figure 5.1 Integrin-mediated adhesion of bone marrow leukocytes stimulated 
by inside-out and outside-in signalling
Bone marrow cells were flushed out of femurs and tibias o f 6-10 week-old mice. The cells were 
loaded with the fluorescent dye BCECF for 30 minutes at 37°C. The cells were then applied to a 
fibrinogen coated 96 well plate in the presence of a titration o f PdBu or Mn2+. The plate was 
centrifuged briefly and the cells left to adhere at room temperature for 30 minutes. At the end of 
the experiment unadhered cells were removed by gentle washing and the cell-associated 
fluorescence o f each well was assessed using a plate-reading Cyto-Fluor. The percentage of 
adhesion for each samples was calculated by comparing the fluorescence o f each well before and 
after the unattached cells had been removed. The experiment was performed in triplicate and the 
data shown is representative o f 3 independent experiments. The mean values +/- standard 
deviation for the triplicates are shown.
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stimulate the neutrophils at concentrations that gave maximal calcium responses
or sub-maximal concentrations where a deficiency in the calcium response of the
S100A9 null cells was observed (figure 5.2). Increased cell-surface expression of
Mac-1 was observed in response to the higher concentrations of C5a, MIP-2, KC
and FMLP. The increased levels of Mac-1 expression were similar in wildtype
and S100A9 null neutrophils. At the lower concentrations of chemoattractant, up-
regulation of Mac-1 was only seen in response to FMLP, C5a and MIP-2. At
these lower concentrations of stimulation there was still no difference in Mac-1
expression by wildtype or S100A9 null neutrophils.
5.2.3 S100A9 neutrophils can polarise and migrate on ICAM-1
The morphology of migrating neutrophils was examined to look for any
defects in this process. Preliminary studies observed cells from whole bone
marrow attaching and migrating on ICAM-1 coated coverslips in a similar assay
to that published by this lab for human T cells (Smith et al., 2003). Bone marrow
cells were allowed to attach to the coverslips for 15mins in normal HBSS
containing calcium and magnesium, unattached cells were removed by gentle
rinsing. The cells were filmed using time-lapse light microscopy with images
being taken at 10 second intervals. The neutrophils were identified as rapidly
migrating cells with a large lamellapodia and small uropod. Neutrophils were
observed to attach and rapidly migrate at a similar speed. No consistent
abnormalities in the morphology of the S100A9 null population were observed
(figure 5.3). A population of large flattened cells adhere to the ICAM-1 coated
cover slips. These were assumed to be macrophage or monocyte-like cells and
appeared similar in both cell populations. These cells attached, flattened and
underwent membrane ruffling during the course of the experiment. No difference
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Figure 5.2 Chemoattractant-induced Mac-1 up-regulation on neutrophils
Neutrophils from bone marrow of wildtype and S100A9 null mice were identified by staining cells 
with mAbs 7/4 and Ly-6 G. The expression of Mac-1 was determined by flow cytometry after co­
labelling cells with a monoclonal Mac-1 antibody as described in the Materials and Methods. 
Data shown is for pooled samples from 3 independent animals per genotype and is representative 
of 3 independent experiments.
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Figure 5.3 Normal migration of S100A9 null neutrophils on ICAM-1
Bone marrow cells were prepared and applied to ICAM-1 coated coverslips mounted in the bottom 
of Matek dishes. The cells were left to adhere at 37°C for 15minutes. After this time unadhered 
cells were removed by gently washing the dishes. A representative field o f view was selected and 
images o f the cells were taken at 1 0  second intervals using a light microscope and used to compile 
a time-lapse video o f their behaviour. Images shown are images of individual cells taken at one- 
minute intervals. The cells shown are representative of more than 30 cells observed per genotype. 
This experiment was performed in collaboration with Dr Andrew Smith o f the Leukocyte 
Adhesion Lab, Cancer Research UK.
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in the behaviour of the wildtype or S100A9 null cells was seen following the
addition of LPS, FMLP or MIP-2 during the assay (preliminary, data not shown).
When PdBu was added the migrating cells stopped and spread. No difference in
this response was observed comparing wildtype and S100A9 null cells.
(preliminary, data not shown).
5.2.4 Cytoskeletal morphology
In a migrating leukocyte a highly organised cytoskeletal system is formed
and maintained (reviewed in (Pettit and Fay, 1998; Vicente-Manzanares and
Sanchez-Madrid, 2004; Wu, 2005)). Interference with this system using
pharmacological agents such as cytochalasin D causes the cells to stop migrating
or to migrate with compromised morphology. Calcium has been shown to be vital
in forming and maintaining this cytoskeletal machinery. It was decided to
examine the cytoskeleton of the S100A9 null neutrophils to look for any
abnormalities in their morphology.
Wildtype and S100A9 null neutrophils were adhered to ICAM-1 coated
coverslips under similar conditions to the migration assay. The adhered cells
were stained with anti-tubulin antibodies and phalloidin to visualise the
microtubule and actin networks respectively. The neutrophils were identified by
lobed nuclear morphology, with nuclei being visualised using DAPI. Figure 5.4
shows a polarised actin distribution in the polarised neutrophil. Polarised actin
networks were observed in both wildtype and S100A9 null cells. An organised
microtubule cytoskeleton was observed in both wildtype and S100A9 null cells.
This shows that the ability of the neutrophils to form a polarised cytoskeletal
system while migrating on ICAM-1 is not grossly compromised. Attempts to
stain the intermediate filaments using anti-vimentin antibodies were unsuccessful.
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Figure 5.4 Morphology of the actin and microtubule cytoskeleton in wildtype 
and S100A9 null neutrophils
Bone marrow leukocytes were prepared and allowed to adhere to ICAM-1 coated coverslips for 
30min at 37°C. Unattached cells were removed by washing and fixed using 3% formaldehyde 
followed by quenching o f cellular auto-fluorescence using ammonium chloride. The cells were 
permeabilised using 1% Triton and incubated with directly conjugated Alexa 488-phalloidin to 
visualise the actin cytoskeleton (shown in green), Alexa 567-anti-tubulin antibody (shown in red) 
and DAPI to visualise nuclear morphology (shown in blue). Serial sections throughout the cell 
were imaged using a confocal microscope and compiled together to form a composite image. 
Cells shown are representative of the total population observed in 2 independent experiments.
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5.2.5 S100A9 localization
While looking at the cytoskeletal system of the bone marrow leukocytes 
any co-localization o f the S100A9 protein with any particular cellular 
compartment was examined. A monoclonal anti-S100A9 antibody directly 
conjugated to Alexa-488 was used. The specificity o f this antibody was 
confirmed by the absence of staining in the S100A9 null bone marrow cells and 
also by the presence of staining only in myeloid cells (identified by morphology) 
in the wildtype samples. In the adherent cells the distribution of S100A9 
appeared to both cytosolic and membranous (figure 5.5). Co-staining with anti­
tubulin antibody to identify the microtubules revealed no co-localization with 
S100A9. When the cells were stained with phalloidin and the anti-S100A9 
antibody some co-localization was seen, with areas of high actin expression often 
showing intense S100A9 staining (figure 5.6). However, not all the S100A9 
staining was co-incident with actin staining and vice versa, indeed S100A9 
seemed to be excluded from some actin rich areas. The significance of this 
limited co-localization is unclear, and it should be remembered that S100A9 is an 
abundant protein. To look for any alteration of the distribution of S100A9 upon 
cell stimulation, the adhered cells were treated with ionomycin, LPS, PdBu, MIP- 
2 and FMLP (preliminary, data not shown). More flattened cells were observed 
following PdBu treatment, but no change in the distribution of S100A9 was seen 
following any stimuli (data not shown).
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Figure 5.5 No co-localization of S100A9 with micro-tubules
Bone marrow leukocytes were prepared and allowed to adhere to ICAM-1 coated coverslips for 
30min at 37°C. Unattached cells were removed by washing and fixed using 3% formaldehyde 
followed by quenching o f cellular auto-fluorescence using ammonium chloride. The cells were 
permeabilised using 1% Triton and incubated with directly conjugated anti-S100A9 antibody 
Alexa 488-2B10 (shown in green), Alexa 567-anti-tubulin antibody (shown in red) and DAPI to 
visualise nuclear morphology (shown in blue). Serial sections throughout the cell were imaged 
using a confocal microscope and compiled together to form a composite image. Cells shown are 
representative of the total population observed in 2  independent experiments.
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Figure 5.6 Limited co-localisation of S100A9 with actin in neutrophils
Bone marrow leukocytes were prepared and allowed to adhere to ICAM-1 coated coverslips for 
30min at 37°C. Unattached cells were removed by washing and fixed using 3%  formaldehyde 
followed by quenching o f cellular auto-fluorescence using ammonium chloride. The cells were 
permeabilised using 1% Triton and incubated with directly conjugated anti-S100A9 antibody 
Alexa 488-2B10 (shown in green), Alexa 567-phalloidin to visualise the actin cytoskeleton (shown 
in red) and DAPI to visualise nuclear morphology (shown in blue). Serial sections throughout the 
cell were imaged using a confocal microscope and compiled together to form a composite image. 
Cells shown are representative of the total population observed in 2 independent experiments.
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5.2.6 An in  vitro  model of chemotaxis
To combine the previous experiments and further test if  the S100A9 null 
neutrophils are compromised in their ability to respond normally to 
chemoattractant stimuli, given their decreased calcium flux response, an in vitro 
chemotaxis assay was performed. In this experiment a Transwell system is set up 
with the cells in normal media placed in a plastic insert separated by a 3 pm pore 
filter from a well containing media and a chemoattractant stimulus. In this assay 
the panel of chemoattractants tested in the Mac-1 upregulation studies was again 
tested. To ensure that the migrating bone marrow cells were indeed neutrophils, 
the harvested cells were stained with the 7/4 and Ly-6 G antibody cocktail and 
were confirmed to be neutrophils (data not shown). The number of cells 
migrating towards a chemoattractant stimulus was enumerated by performing an 
absolute cell count by flow cytometry.
No significant difference in random, unstimulated migration of the cells 
was observed between wildtype and S100A9 null populations (figure 5.7). 
Migration of the neutrophils to MIP-2, FMLP and KC was seen at both 
concentrations studied (figure 5.7). In the case of MIP-2 and KC the highest level 
of migration correlated with the higher level of chemokine. In the case of FMLP 
the lower concentration tested showed the greater migration presumably showing 
that lOpM is above the maximal concentration, as chemoattractants show a bell­
shaped curve of sensitivity of chemoattractants. When the number of cells 
migrating to the three stimuli are compared no significant differences in the 
number of wildtype or S100A9 null cells migrating is seen (as indicated by the 
overlapping error bars).
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Figure 5.7 Normal in vitro chemotaxis of S100A9 null neutrophils
Migration o f bone marrow neutrophils in a Trans well chemotaxis assay in response to the 
chemoattractants was assessed. Cells were allowed to migrate for 2 hours, then cells in the bottom 
well were stained with mAbs 7/4 and Ly-6 G. The number o f migrated neutrophils was determined 
by flow cytometry. Data are expressed as the mean o f 3 independent samples per genotype +/- 
standard deviation. Data is representative o f 3 experiments.
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5.2.7 S100A9 as a chemokine
There have been several publications indicating a role for S100A8 and 
S100A9 as chemokines. This chemoattractive effect of murine S100A9 has been 
previously investigated by this lab and could not be confirmed (Hobbs, 2003). 
Given the recent publication of several papers by the group of P. Tessier, showing 
evidence of the chemoattractant properties of human S100A9 it was decided to 
briefly re-investigate this role using a sample o f their recombinant S100A9 
(Ryckman et al., 2004; Ryckman et al., 2003a; Ryckman et al., 2003b). One of 
the major artefacts obtained when using a recombinant protein to investigate 
chemoattractant properties of a protein is the contamination of the protein with 
bacterial by-products from its production. Bacterial contaminants can themselves 
exert a potent chemotactic effect in vivo. The Ryckman et al paper states that 
their protein has a low level of endotoxin contamination (Ryckman et al., 2003b). 
Tests in this laboratory using the limulus amoebocyte assay showed the samples 
sent to us contained in excess of lng/pg protein (E. McNeill -  data not shown).
LPS, a major component of bacterial endotoxin, does not exert a 
chemoattractive effect in vitro so although the proteins were contaminated any 
chemoattractant effect of the S100A9 proteins in the Transwell assay could be an 
indication of their activity. When the S100A9 protein was compared to PBS 
alone control no chemoattractant effect of the protein could be seen at InM or 
lpM  concentrations (figure 5.8). As a positive control C5a was included in the 
assay and was shown to be highly chemoattractive. These results were in conflict 
to the published data using the S100A9 protein by Ryckman et al.
To examine the chemoattractive potential of an LPS contaminated protein
in vivo it is not appropriate to use a normal LPS-sensitive mouse as the LPS will
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exert a potent chemoattractive effect itself. We repeated the published air pouch
model of in vivo chemotaxis in the C3H/HeJ LPS-insensitive mice and the control
LPS-sensitive strain C3H/HeN (Ryckman et al., 2003b). The S100A9 sample
exerted a chemoattractive effect in the C3H/HeN mice, but showed no
chemoattractive potential above the dose of LPS equivalent to the contamination
of the protein in the C3H/HeJ mice, indicating that the chemoattractive effect seen
was likely to be due to the LPS contamination of this protein (figure 5.8). This is
again in conflict with the published data. Similar to previous finding by this lab
(Hobbs, 2003) I found no evidence that S100A9 acts as a chemokine either in
vitro or in vivo.
5.2.8 I n  vivo  migration studies
The in vitro chemotaxis assay provides some evidence that the ability of
the S100A9 null neutrophils to chemotax is not severely affected. However, the
process of deforming through a plastic filter to move towards a chemoattractant in
media does not fully replicate the process of responding to a proinflammatory
agent in vivo. While the in vitro assay is useful in allowing the assessment of the
response of the neutrophils to a specific chemotactic agent it is more important to
know if the cells can perform normally under physiological conditions. To test
this a model of peritonitis was used, where inflammation was initiated in the
peritoneum with thioglycollate, IL-1 (3 or TNFa. To respond to the stimuli the
neutrophils need to adhere to the inflamed endothelium, extravasate out through
the vessel wall, pass through the basement membrane and migrate through the
tissue into the peritoneum. Thioglycollate-induced peritonitis has been performed
using S100A9 null mice at backcross generation five (Hobbs et al., 2003). These
experiments did not show any affect of S100A9 deletion on the ability of the
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Figure 5.8 Effect of recombinant murine S100A9 on in vitro and in vivo 
neutrophil migration
A: Migration o f bone marrow neutrophils in a Transwell chemotaxis assay in response to the 
S100A9 and chemoattractants C5a and MIP-2 was assessed. Cells were allowed to migrate for 2 
hours, then cells in the bottom well were stained with mAbs 7/4 and Ly-6 G. The number of 
migrated neutrophils was determined by flow cytometry. The experiment shown was performed 
in triplicate with data displayed as mean +/- standard deviation.
B: Air-pouches were formed on the back o f mice by repeated injection o f sterile air. S100A9, LPS 
or PBS, prepared using endotoxin free reagents, were injected into the air pouches and the cellular 
infiltrate was recovered by lavage with EDTA containing PBS at 6  hours post-injection. The 
recovered cells were stained with mAbs 7/4 and Gr-1 and quantified using flow cytometry. Data 
shown is the mean +/- standard error o f the mean for 5 mice per time point.
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neutrophils to respond in this model. However, as the mice are now fully
backcrossed onto a C57BL/6J background and the cells show a defect in calcium
signalling to chemoattractant stimuli, in vivo migration was examined further.
TN Fa and IL-lp elicit an inflammatory reaction by stimulating endothelial and
resident leukocytes respectively and have been shown to caused neutrophil
extravasation via different mechanisms ((Dahlgren and Karlsson, 1999;
Thompson et al., 2001; Young et al., 2002)). A six hour time point was chosen as
previous work by this lab has shown significant peritoneal myeloid cells influx at
this time point (Henderson et al., 2003). At this time the mice are culled and the
elicited cells harvested by peritoneal lavage. Any mice showing significant blood
in the peritoneum were discarded.
A significant influx of both neutrophils and monocytes was found in 
response to the thioglycollate, TNFa and IL-lp stimuli, but not in the PBS control 
group (figure 5.9). When the numbers of neutrophils migrating to all stimuli were 
compared, no significant difference between wildtype and S100A9 null groups 
was observed. The same was also observed when the numbers of monocytes were 
assessed. This finding is in keeping with the previous work with the S100A9 null 
mice where thioglycollate alone was used as a stimulus ((Hobbs et al., 2003; 
Manitz et al., 2003)). No effect on the influx of other leukocytes was found in 
these previous studies, and as no defect in the initial myeloid cell influx was seen 
it was decided not to extend these experiments to perform a full time course of 
leukocyte recruitment.
This work finds no role for S100A9 in leukocyte migration either in vitro 
or in vivo either by affecting the function of the neutrophils themselves or by 
acting as an in vivo chemoattractant. This work also casts doubt on the published
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Figure 5.9 In vivo migration of myeloid cells into the peritoneum in response 
to inflammatory stimuli
Leukocyte recruitment into the peritoneum was initiated by intra-peritoneal injection o f 
inflammatory stimuli thioglycollate, TNFa, IL-1 (3 and PBS control. Six hours post injection the 
mice are culled and the recruited cells harvested by peritoneal lavage with PBS/EDTA. The cells 
were stained with mAbs 7/4 and Ly-6 G and quantified by flow cytometry.
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reports of chemoattractant properties for both S100A8 and S100A9. This would 
include S100A8 as well as S100A9 as both proteins are missing from the S100A9 
null mice.
5.3 Discussion
5.3.1 Normal Integrin Function in S100A9 null mice
The data presented earlier in this thesis has shown that the expression of a 
number of integrins is normal on the S100A9 null cells. Further experiments 
show that the S100A9 null bone marrow cells demonstrate normal integrin 
activation following “outside in” and “inside out” stimulation showing that the 
function of the |32 integrin Mac-1 is broadly normal. Preliminary experiments to 
use a more relevant chemokine stimuli in this assay showed no obvious difference 
in activity in the S100A9 null cells. However as only 25-35% of the total cells 
studied in these experiments are neutrophils it is hard to assess any subtle effects. 
To extend this part of the study a method of isolating a pure population of 
neutrophils would be required.
Another manner in which the activity of integrin is enhanced in the 
neutrophil is the upregulation of the surface expression of Mac-1. In this study 
upregulation of Mac-1 was seen in response to MIP-2, C5a and FMLP. S100A9 
appears to be dispensable for this function. No manifestation of the decreased 
chemoattractant sensitivity of the S100A9 null neutrophils in the calcium flux 
assay was seen. It was noted that the concentrations at which the Mac-1 up­
regulation was seen were above the levels at which the deficiency in calcium 
signalling is seen. This data shows that although the Ca signalling properties of
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the S100A9 null cell are compromised, the cells can be activated by
chemoattractants.
5.3.2 Migration and Morphology of S100A9 null neutrophils
Using a model of in vitro migration it has been demonstrated that murine 
bone marrow neutrophils can polarise and migrate on murine-ICAM-1 coated 
coverslips with no additional activating stimuli. This random migration on 
ICAM-1 has been recently described in this lab for human T cells (Smith et al.,
2003). In the T cell situation, no autocrine secretion of chemokine could be found 
to provide a directional stimuli for this migration. The migratory pattern was 
therefore assumed to be truly random, or perhaps following undetectable gradients 
of ICAM-1 formed during the coverslip coating process. Neutrophils are more 
sensitive than T cells to signals such as LPS and the products of apoptosis, that do 
not activate T cells and further investigation and validation of this model would 
be required to elucidate the migratory stimuli the cells may be following. It 
should be noted that significant variation between preparations was observed for 
both wildtype and S100A9 null cells, perhaps a facet of how easily these cells can 
be activated. However, it could be seen that the S100A9 null neutrophils were as 
capable of attaching and migrating with a similar morphology to the wildtype 
neutrophils. No gross difference in their speed or directionality could be seen 
although it was hard to judge absolutely due to the intra-preparation differences.
As a preliminary study of the migratory capacity of these cells, it can be 
concluded that S100A9 is dispensable for normal migration of murine neutrophils 
on ICAM-1. In studies on human T cells, profound morphological effects of 
pharmacological inhibition of various parts of the cytoskeleton are seen (Smith et
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al., 2003). None o f these morphologies were present in the S100A9 null
neutrophils, implying no gross failure of the cytoskeleton.
Further investigation o f these features led to the examination o f the 
cytoskeletal by confocal microscopy. Firstly no difference in the formation of 
microtubule networks in the S100A9 null or wildtype neutrophils could be seen. 
Similarly no gross abnormalities in the actin cytoskeleton could be seen. This 
was expected given the normal migratory phenotype of the cells in the video­
microscopy experiments. Further to this, the localization of the S100A9 protein 
was examined in the wildtype neutrophils. It was assumed that all the S100A9 
bright cells were neutrophils. No S100A9 dim cells, that would be assumed to be 
monocytes, were observed. This led to the interesting observation that the 
S100A9 positive cells seemed to exhibit two markedly different morphologies, 
either polarised and migrating or rounded adhered cells, similar to those seen in 
the video-microscopy experiments. Attempts to confirm that both these 
populations were Ly6 G positive, ie neutrophils, were unfortunately unsuccessful. 
It might be interesting to see if these two morphologically different groups 
represent different maturation states of the murine neutrophil. It should be 
pointed out that no differences in the proportion of the different cell types were 
observed between S100A9 null and wildtype samples.
In terms o f cytoskeletal networks it has been reported that S100A9 co- 
localises with micro-tubules in human macrophages(Rammes et al., 1997). No 
observation of a similar feature was seen in murine bone marrow cells. Secondly, 
although staining for vimentin was unsuccessful the S100A9 staining itself did not 
appear to form any fibrous structure, arguing against any interaction with the 
intermediate filaments as has been shown in previous reports (Burwinkel et al.,
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1994; Roth et al., 1993). No evidence of the “polarised micro-filament network”
that has been reported in another line of S100A9 null mice was seen in these 
experiments (Manitz et al., 2003). As with the migration assays the observation 
of several separate neutrophil preparations is required due to the variation in the 
morphology of the cells between different preparations. In this study some co­
localisation of S100A9 with the actin cytoskeleton could be seen. This possible 
interaction requires further investigation as the sheer abundance of this protein in 
the cells makes observation of some irrelevant co-localisation likely. It can be 
said with some certainty that no obvious association of S100A9 with larger 
cellular structures, such as the nucleus, mitochondria, granules, or endoplasmic 
reticulum, is obvious under any of the stimuli tested. Staining the two cell 
populations with probes to identify cellular compartments, such as the 
endoplasmic reticulum, to observe any altered structure could be an interesting 
extension to this work.
5.3.3 No role of S100A9 in neutrophil chemotaxis
It has been reported by another group working with an independently
derived line of S I00A9 null mice that the neutrophils in those mice demonstrate a
higher basal migration in vitro across Bend5 brain endothelial cells and a
decreased migration in response to recombinant human IL - 8  or LTB4 (Manitz et
al., 2003). This difference was apparently significant. No assessment of the
quality of the data can be made as the error bars are absent from the graph shown
(Manitz et al., 2003). In addition, the migration of the S100A9 null cells in a 3D
collagen matrix was quantified and the S100A9 null cells were deemed to have
significantly higher migration rate, velocity o f migration and distance of
migration (Manitz et al., 2003). The degree to which the error bars overlap in the
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data presented in this paper make it highly surprising that the differences are
significant and the statistical tests used to evaluate the data are not stated.
It has been previously described by this laboratory that the bone marrow 
neutrophils from both our S100A9 null mouse lines demonstrate normal 
chemotaxis to the murine homolog of IL- 8  (MIP-2), exhibiting a normal bell­
shaped curve of sensitivity to this mediator (Hobbs et al., 2003). To extend the in 
vitro chemotaxis studies, I have used the stimuli to which the S100A9 null mice 
exhibited a decreased sensitivity in the calcium flux experiments. Due to 
constraints of reagents, full dose response curves were not performed for all these 
mediators, but a high and low dose from the titration range calcium assay were 
used. No deficiencies in the response of the S100A9 null cells were seen. Thus 
we see no defect in in vitro chemotaxis to a range of stimuli.
It is unclear why we obtain different results using cells from our S100A9 
null mice to those published for the other S100A9 null mice although, however, 
no significant differences in myeloid recruitment in an in vivo model of peritonitis 
are seen in either mouse line. This may be the most enlightening data regarding 
any role for S100A9 in cell migration. Specific differences in the preparation of 
the cells may cause the differences between the results obtained by independent 
groups. Differences in genetic background may also play a role in the disparity as 
our mice are fully back-crossed onto a C57BL/6J strain, whilst the other mice are 
on a mixed 129/C57BL/6J background and may demonstrate increased variation. 
Differences in the precise model of in vitro migration used may also be an 
explanation for the different results obtained.
This difference in migratory ability is not the only data I have produced 
that is in direct conflict with published roles for these proteins. There is a
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significant body of work that proposes S100A9 to be a potent chemokine in
mouse. Using samples from the authors of that work we were unable to
demonstrate any chemotactic activity more than could be assigned to
contaminating LPS. An explanation might be the chemotactic activity of the
protein samples was destroyed in the transport process. However, previous
exhaustive examination of recombinant S100A9 in this lab has failed to show any
chemotactic activity other than due to contaminating endotoxin (Hobbs, 2003).
The levels of S100A9 required to produce the chemotactic effect are more than a
thousand fold lower than the peak concentrations reported in an inflammatory site
(Roth et al., 2003). It would be interesting to perform the model of urate crystal-
induced neutrophil influx into the air pouch, that has been shown to be S100A9
dependent, in the S100A9 null mice to observe if S I00A9 truly participates in this
model (Ryckman et al., 2003a).
Final evidence for the function of S100A9 being dispensable in the 
process of leukocyte adhesion and migration comes from an in vivo model of 
leukocyte migration. Normal myeloid cell recruitment into the peritoneum was 
observed following stimulation by thioglycollate, TNFa and XL-1 (3. These stimuli 
have been previously shown to cause leukocyte recruitment dependent on 
different integrin family members (Thompson et al., 2001; Young et al., 2002). 
The lack of any lesion in the S100A9 null mice in recruitment to any of these 
stimuli seems to imply a relatively broad lack o f requirement for S100A9 in 
neutrophil recruitment. This data is in accordance with results published for the 
independent strain of S100A9 mice in which no defect in in vivo migration was 
seen (Manitz et al., 2003).
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The studies presented in this chapter could be extended to involve more in
depth analysis of chemokine-induced adhesion and further investigation of the 
speed and morphology of the S100A9 neutrophils. However given the lack of any 
in vivo phenotype resulting from the loss of S100A9, it seems unlikely any gross 
abnormality will be found. This implies that the calcium signalling deficiency in 
the S100A9 null neutrophils, as shown in chapter 4, does not affect normal 
migration. The role of the affected calcium signal may be critical to a process 
independent of leukocyte recruitment. Indeed PLC(32/3 null neutrophils, that 
produce no calcium flux in response to chemokine stimulation, show normal 
leukocyte migration (Li et al., 2000b). This indicates that the calcium signal is 
dispensable for leukocyte migration.
In conclusion, despite the published data that neutrophils from another 
strain of S100A9 null mice show abnormalities in leukocyte migration due to a 
hyper-polarised micro-filament system (Manitz et al., 2003) and that S100A9 is 
reported to be a potent chemokine in vivo (Ryckman et al., 2003b), I find S100A9 
to be totally dispensable for normal leukocyte adhesion and migration in the 
models tested to date.
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6 Cytotoxic activity of S100A9 null neutrophils
6.1 Introduction
The role of the neutrophil within the body is to combat infection. So far it 
has been shown that, in the S100A9 null mice, the neutrophils have a defect in 
chemokine-induced calcium signalling, yet are able to respond normally to a 
chemotactic stimuli in vitro and in vivo. Therefore we assume that they are 
largely able to arrive normally at the site of infection. To examine any further 
role for S100A9 in the neutrophil other functions relating to their cytotoxic 
abilities were investigated.
As has been discussed in the introduction there is a body of evidence that 
suggests a role for S100A8/9 in the formation of the oxidase machinery. The 
complex co-precipitated with components of the NADPH oxidase machinery and 
was able to activate the oxidase machinery in a cell-free system (Doussiere et al., 
2002; Kerkhoff et al., 2005). Most recently it has been shown that the 
independent line of S I00A9 null mice showed decreased superoxide formation in 
response to PMA stimulation(Kerkhoff et al., 2005). It has already been 
demonstrated that our line o f S100A9 null mice are capable o f normal 
phagocytosis of E. coli and that they are capable of forming an oxidative burst in 
response to PMA (Hobbs et al., 2003). In this experiment the kinetics of the 
superoxide burst was not assessed. The fluorescence of dihydrorhodamine, an 
oxidant sensitive dye, was tested by flow cytometry following a set time interval. 
Given that the published effect of S100A9 deletion on oxidant production
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appeared to be a subtle decrease in the reaction kinetics a more full exploration of 
this phenomenon was required.
Along with the oxidase, granule fusion and trafficking are vital aspects of 
the neutrophil killing mechanism (reviewed in (Faurschou and Borregaard,
2003)). Studying the ability of the S100A9 neutrophils to kill bacteria would 
provide a test of how the whole neutrophil cytotoxic machinery is working. 
However the best test for neutrophil function is an in vivo bacterial infection, this 
will test all aspects of neutrophil function from their ability to adhere and migrate 
to phagocytosis and killing of invading microorganisms.
Streptococcus pneumoniae is a Gram positive human pathogen that is the 
fifth leading cause o f death worldwide (reviewed in (Kadioglu and Andrew,
2004)). This bacterium is responsible for 40-50% of community-acquired 
pneumonia and 20% of meningitis cases in the UK. As such the pathogenesis of 
this disease is widely studied and the murine model well characterised. To test 
the function of the neutrophils in the S100A9 null mice, we require an infection in 
which the innate immune system plays an important role in its control. In 
pneumococcal lung disease the bacteria are thought to be primarily opsonized by 
complement (reviewed in (Kadioglu and Andrew, 2004)). Following 
opsonization the bacteria are phagocytosed and killed by neutrophils recruited to 
the lung by resident macrophages following release of TNFa and IL-8 . The 
initial phase of control of infection is highly dependent on the adequate function 
of neutrophils.
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6.2 R esults
6.2.1 Kinetics of superoxide formation
In the Hobbs et al publication, the production of an oxidative burst by the 
S100A9 null neutrophils was examined. In that study the production of the 
oxidative burst was assessed by flow cytometry, with the change in fluorescence 
of dihydrorhodamine assessed after stimulation of the cells with PdBu (Hobbs et 
al., 2003). While this experiment shows that the S100A9 null neutrophils are 
capable of forming a similar oxidative burst, it did not give any data on the 
kinetics of the response. The kinetics of oxidant production by neutrophils can be 
assessed using a number of different assays. The most simple to perform is 
enhanced chemiluminescence monitored using luminol. This substance is freely 
diffusible through neutrophils and emits a photon of light when it comes into 
contact with oxidants (discussed in (Dahlgren and Karlsson, 1999)). The photons 
of light produced over time can be monitored in a plate-reading luminometer. 
Being freely diffusible, luminol measures the production of oxidants inside the 
cell as well as any released oxidants. Other methods of measuring superoxide 
burst such as cytochrome c reduction rely on the release of oxidant species by the 
cells as they are not cell permeable agents. When wildtype and S100A9 null bone 
marrow preparations were stimulated with PMA, an increase in Relative Light 
Units (RLU) occurred over time in both wildtype and S100A9 samples (figure 
6.1). When the kinetics o f this response was plotted, the two groups had 
overlapping error bars and thus had similar kinetics. A similar result was 
obtained when the experiment was repeated using the cytochrome c reduction test 
(preliminary, data not shown).
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Figure 6.1 Production of oxidant species by wildtype and S100A9 null bone 
marrow cells in response to PMA
Bone marrow leukocytes were applied to a 96-well plate in luminol supplemented HBSS. The 
cells were stimulated with PMA and immediately placed in a plate-reading luminometer. The 
production of oxidants was measured as the production of photons of light by the luminol solution. 
The plate was read every 17 seconds over a period of twenty minutes. The experiment was 
performed in duplicate with 3 independent samples per genotype. Data is shown as mean values 
+/- standard deviation and is representative of 3 experiments.
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These data show that the S100A9 null neutrophils are not compromised in 
their ability to produce an oxidative burst. This conflicts with the published 
biochemical data that speculates a crucial role for S100A9 in the function of this 
machinery ((Doussiere et al., 1999; Doussiere et al., 2002; Kerkhoff et al., 2005)). 
Although the fundamental function of the oxidase machinery is unaffected, the 
ability of the S100A9 null neutrophils to produce an oxidative burst in response to 
a physiological stimulus, such as a bacterium, has not been assessed.
6.2.2 Activation of oxidative burst following phagocytosis
The principal role of the oxidative burst is to participate in microbial 
killing by neutrophils as discussed in the Introduction. Despite the controversy 
over the mechanism of this function, be it as a direct cytotoxic moiety or as part of 
a process of protease activation via internal ion flux, its requirement for neutrophil 
cytotoxicity is clear (reviewed in (Segal, 2005)). Having observed that the 
S100A9 neutrophils are capable of forming an oxidative burst, it next seemed 
logical to examine if  the cells could perform this function normally following a 
physiological stimulus.
To carry out this experiment, opsonized dichlorodihydrofluorescein-
(DCDHF) coupled zymosan particles were obtained (a kind gift from MB
Hallett). As DCDHF becomes fluorescent upon oxidation, the coupled particles
act to indicate if  the oxidase is activated upon phagocytosis of the particles
(preparation and use of particles detailed in (Dewitt et al., 2003)). To monitor this
process neutrophils were mixed with the zymosan particles at 37°C with samples
being taken at regular intervals. The uptake and oxidation of the particles was
monitored by flow cytometry, with the neutrophils being identified using a
myeloid cell identification antibody cocktail. The increase in DCDHF
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fluorescence over time is plotted in figure 6.2. No difference in the increase in 
geometric mean fluorescence over time is seen between the S100A9 null and 
wildtype neutrophils indicating that phagocytosis and oxidation of the particles is 
normal in the S100A9 null neutrophils.
The localisation of the S100A9 protein in the neutrophils following 
phagocytosis was examined by staining with the anti-S100A9 monoclonal 
antibody. The S100A9 protein was seen to be excluded from the phagocytic 
vacuole, containing the green zymosan particles, and to have a cytosolic 
distribution (figure 6 .2 ).
6.2.3 I n  vitro  bacterial killing
Previous work published with the S100A9 null mice highlighted a lack of 
defect in the ability of neutrophils to phagocytose bacteria (Hobbs et al., 2003). 
Work presented in this thesis has shown that the mice are also able to activate the 
oxidase machinery normally upon phagocytosis. The next step in examining the 
ability o f the S100A9 neutrophils to act normally in their anti-microbial role was 
to examine their ability to kill micro-organisms.
Initially a protocol using human neutrophils was undertaken. Human
neutrophils were isolated from fresh human blood. Neutrophils and bacteria were
mixed at a 1:10 ratio. At set time points samples from the experimental tubes
were taken and spun to pellet the cells. The cell pellet and supernatant were
diluted in water and vortexed to lyse the leukocytes. The supernatant and cell
associated samples combine to give the total remaining viable bacteria, and
separately give an idea of whether uptake of the bacteria by the neutrophils is
occurring (figure 6.3). It could be seen that over time the bacteria alone increased
in number in a linear fashion. For the first 30 minutes the number of bacteria in
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Figure 6.2 Activation of the NADPH oxidase machinery upon phagocytosis of 
DCDHF-coupled zymosan particles
A: Bone leukocytes were prepared and mixed with iC3b-opsonized DCDHF-coupled zymosan 
particles. The cells were subjected to intermittent gentle mixing and samples were removed for 
flow cytometric analysis at 20 minute intervals. The sample aliquots were stained with mAbs 7/4 
and Gr-1 to identify the neutrophils and the level of DCDHF fluorescence of these cells assessed 
by flow cytometry.
B: Aliquots o f zymosan containing neutrophils were adhered onto fibrinogen coated coverslips. 
The cells were fixed, permeabilised and stained with mAb anti-S100A9 (2B10) and an Alexa-547 
conjugated secondary antibody. Serial sections throughout the cell were imaged using a confocal 
microscope and compiled together to form a composite image. S100A9 is shown in red and the 
oxidised zymosan particles shown in green. The images shown are representative o f the whole 
population.
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Figure 6.3 Bacterial killing by human neutrophils
Human neutrophils were isolated from blood using a Ficoll gradient. The cells were mixed with 
E.coli K12 at a ratio o f 10:1 in the presence o f heat-inactivated human serum. Aliquots were 
removed from the reaction mixture at the time points indicated. The leukocyte population was 
separated by centrifugation of the samples at 200g. The cell pellet and supernatant samples were 
diluted in water to lyse the leukocytes and plated onto agarose culture plates at 3 different 
dilutions in duplicate. The plates were incubated over night at 37°C and the number of CFUs 
counted. The data shown are mean values +/- standard deviation.
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the cell associated fraction increased and the number of bacteria in the supernatant 
decreased. The total number of viable bacteria recovered from the experimental 
samples was much lower than the number of bacteria recovered from the bacteria- 
alone samples at these time points. Comparing the number of viable bacteria in 
the presence of neutrophils compared to the growth of the bacteria alone at any 
time point it can be seen that bacteria killing has occurred.
While mature neutrophils are abundant in human blood, being 30-40% of 
total leukocytes, they are relatively scarce in murine blood, accounting for only 3 - 
5% of total leukocytes (figure 3.3). Given that only a few hundred microlitres of 
blood can be taken from a mouse by terminal cardiac puncture, the use of murine 
blood neutrophils did not seem a viable approach. Trial experiments using whole 
bone marrow preparations proved unsuccessful, as the immature neutrophils were 
unable to kill. In modifying the human killing assay protocol it was decided that 
it was unnecessary to split the samples into supernatant and cell associated 
bacteria as the total number recovered gives an indication of whether killing has 
occurred. Looking at published protocols for murine neutrophil killing assays it 
was decided to use elicited peritoneal neutrophils as a source o f ‘mature’ 
neutrophils (Roes et al., 2003). These cells are elicited by intra-peritoneal 
injection of thioglycollate, with the cells being harvested 6  hours later. At this 
time point neutrophils are the most abundant leukocyte population in the 
peritoneal lavage sample. As in the published method the unfractionated 
peritoneal population was used (Roes et al., 2003). Following 20min incubation 
with bacteria, killing was observed in wildtype and S 100A9 null groups (figure 
6.4). No significant difference in the ability of the wildtype and S100A9 null 
cells to kill the E. coli K12 was seen.
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Figure 6.4 No difference in bacterial killing by wildtype of S100A9 null 
phagocytes
Mature peritoneal phagocytes were elicited following 6 hours of thioglycollate stimulation and 
recovered by peritoneal lavage. The cells were mixed with E.coli K12 at a ratio of 1:1 in the 
presence of heat-inactivated human serum. Aliquots were removed from the reaction mixture at 
the time points indicated. The samples were diluted in water to lyse the leukocytes and plated 
onto agarose culture plates at 3 different dilutions in duplicate. The plates were incubated over 
night at 37°C and the number of CFUs counted. The experiment was performed with triplicate 
samples. The data shown are mean values +/- standard deviation and representative of 2 
experiments.
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6.2.4 I n  vivo S trep tococcus p n e u m o n ia e  infection
Having seen that in general the ability of the S100A9 null neutrophils to 
perform their cytotoxic function appeared normal, it was decided that it might be 
more productive to evaluate an in vivo model of infection rather than continue to 
work-up new in vitro tests. A model of Streptococcus pneumoniae infection was 
chosen as the control of this infection has been shown to be highly neutrophil 
dependent ((Bergeron et al., 1998; Kadioglu et al., 2000; Takashima et al., 1997)). 
This model was carried out in collaboration with A. Kadioglu at the University of 
Leicester. In this model the bacteria are administered via intra-nasal injection. 
The progression of the disease is followed by harvest of blood and lungs at 24 
hourly intervals over the course of a 72-hour experiment. A C57BL/6J mouse 
generally becomes ill in the first 24 hours showing a peak of bacteria in the lungs, 
and possibly a low level of bacteria in the blood. By 48 hours the mice are 
expected the begin to resolve the infection with any bacteria in blood being 
cleared and a reduction lung infection, this resolution of the infection continues 
with the mice clearing the infection by 72 hours.
This infection model has been carried out several times over the course of 
back-crossing the S100A9 null mice onto the C57BL/6J genetic background at 
generations three, five and ten. The S100A9 null mice are derived from a 
chimaeric mouse of C57BL/6J and 129 strains. In all experiments the S100A9 
null mice were compared to wildtype mice from the same generation of back- 
cross. Confirmation of any difference between S100A9 null and wildtype mice 
was required in high back-cross mice.
At back cross generation 5 the S100A9 null mice were shown to be much
more susceptible to the Streptococcus pneumoniae infection (figure 6.5). The
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Figure 6.5 Time course of S. pneumoniae infection in wildtype and S100A9 
null mice
S. pneumoniae were instilled into the lungs of mice by intra-nasal inoculation. At the time points 
indicated blood was taken by terminal cardiac puncture and the lungs were removed and 
homogenized. Samples from blood and lung were plated onto blood supplemented agar plates and 
incubated over night at 37°C. The number o f colony forming units was assessed in duplicate. 
Data from generation 5 back-crossed S100A9 null mice for blood and lung infection levels. Data 
from generation 10 back-crossed mice for blood infection levels. These experiments were 
performed by Dr Aras Kadioglu at the University of Leicester. The data is shown as mean values 
+/- standard error of the mean.
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S100A9'
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Figure 6 . 6  Myeloid cell influx into the lung during Streptococcus pnuemoniae 
infection
S.pneumoniae were instilled into the lungs of mice by intra-nasal inoculation. Broncho-alveolar 
lavage was performed on euthanised mice using PBS at the time points indicated post inoculation. 
Harvested leukocytes were stained with mAbs 7/4, Ly-6G and anti-F4:80 and the number of cells 
recovered assessed by flow cytometry. Data is shown as the mean value +/- standard error o f the 
mean for 3-5mice per group. This experiment was performed in collaboration with Dr Aras 
Kadioglu at The University of Leicester.
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S100A9 null mice had higher numbers of bacteria in the lungs and blood at late 
time points. When back-cross generation 10 mice were compared against 
commercial C57BL/6J mice this pattern was maintained (data not shown). 
Unfortunately, when compared in a subsequent experiment against in-house 
C57BL/6J from the colony with which they were back-crossed, no difference 
between wildtype and S100A9 null mice was seen in either bacterial numbers in 
the lungs (data not shown -  unavailable at this time) or blood in the number of 
myeloid cells recovered by broncho-alveolar lavage (figure 6.5 and 6 .6 ).
It was observed over the generations of back-crossing that the response of 
the S100A9 null to the bacterial infection remained constant, with the mice being 
highly susceptible to the infection and showing significant septicaemia. When the 
response of the ‘wildtype’ mice was evaluated over the generations, it was seen 
that the mice became more susceptible as they were back-crossed with the in- 
house C57BL/6J strain (data not shown). This is not what would be expected, 
given that the mice were being back-crossed away from the susceptible 129 
genetic back-ground to the supposedly resistant ‘C57BL/6J’ background. It 
appears that the in-house C57BL/6J colony, being a closed colony for 8  years and 
hence around 20-30 generations, has undergone significant genetic drift away 
from the original C57BL/6J background. It is highly unfortunate that this genetic 
drift is manifested as an increase in their susceptibility to this particular infection. 
The earlier data seems to suggest a defect in the ability of the S100A9 null mice 
to control this infection, but this lesion is not evident on the current infection- 
susceptible background. It seems possible that the lack of S100A9 does indeed 
compromise the ability of the mice to control an infection, but this can be neither 
confirmed nor a mechanism evaluated on a genetic background where the mice
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succumb to the infection readily. At this stage it must be concluded that on the 
current susceptible genetic background the S100A9 null mice are not further 
compromised in their response to pneumococcal infection.
6.3 Discussion
The evidence presented in this chapter appears to show no deficiency in 
the ability of neutrophils to form an oxidative burst in the absence of S100A9. 
This conflicts with the evidence published that hypothesises a critical role for the 
S100A8/9 complex in the activation of the NADPH oxidase machinery 
(Doussiere et al., 1999; Doussiere et al., 2002; Kerkhoff et al., 2005). In addition 
the ability of the cells to form an oxidative burst in response to phagocytosis of an 
opsonized particle shows no requirement for the S100A8/9 dimer in coordinated 
activation of the oxidase machinery. This appears to rule out a direct role in the 
oxidase machinery or an indirect role in controlling the signalling required for the 
oxidase burst to happen following phagocytosis. The difference found between 
our data and that already published might be due to differences in the precise 
protocol used or method of isolation and handling of the neutrophils. However it 
should be noted that only one piece of data published to date shows a deficiency 
in oxidase activity in S100A9 null neutrophils and this deficiency appears to be 
relatively subtle (Kerkhoff et al., 2005). The published biochemical studies may 
show a co-incidental effect of the isolated protein that is not physiologically 
relevant.
The in vitro killing assays using murine leukocytes were challenging and 
time-consuming to design and undertake successfully. Although the level of 
killing seen was not very high this data demonstrates that in the conditions used
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the S100A9 null mice were capable of killing bacteria. When published data from 
murine killing assays are studied carefully, it can be seen that the observed level 
of killing is of a similar order to that presented here (Roes et al., 2003). Our 
protocol could possibly be improved by opsonising the bacteria with C3bi or 
serum from mice inoculated with the target pathogen. Should these 
improvements allow more efficient killing, then testing the ability of the 
neutrophils to kill a panel of different micro-organisms could be undertaken. 
However, challenging the S100A9 null mice with pathogens in vivo is likely to be 
the most efficient means of identifying any lesion in the function of the S100A9 
null neutrophils. Should a lesion to a particular pathogen be seen then the kinetics 
of the myeloid response can be studied to ascertain if recruitment or function of 
the neutrophils is compromised. From this data, in vitro stimuli relevant to the 
pathogen could be dissected to define the role of S I00A9 in neutrophil function.
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7 Wound healing and carcinogenesis in S100A9 null
mice
7.1 Introduction
So far the study of the S100A9 null mouse has concentrated on the 
examination of myeloid cell functions. This is logical given the great abundance 
of the protein in these cells. However, other than the defect in calcium signalling 
no clear consistent phenotype has been found either in vitro or, perhaps more 
importantly, in vivo. It seemed reasonable under these conditions to take another 
approach in looking for the function of this protein. Other than the expression of 
S100A9 in myeloid cells, another site for expression o f this protein is in 
keratinocytes of the wounded epithelium (Li et al., 2000a; Thorey et al., 2001). 
As well as a potential role in keratinocytes, neutrophils have also been indicated 
to modulate the healing process (reviewed in (Martin, 1997; Schaffer and Nanney, 
1996; Singer and Clark, 1999)). As such it seemed a reasonable hypothesis that 
the deletion of S100A9 may affect the process of wound healing. Another 
strongly suggestive function for S I 0 0  protein is in the pathogenesis of cancer. 
The S 100A4 null mice have an increased prevalence of cancer and a decreased 
engraftment of an injected syngeneic tumour cells (C'Naaman et al., 2004; Grum- 
Schwensen et al., 2005). These conflicting data make hypothesis of a mechanism 
of action for S100A4 in cancer biology difficult, but clearly demonstrate 
alterations to this pathological condition in the absence of an SI 00 protein.
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7.1.1 S100 proteins in the skin
The expression of S I00 in the skin has largely focussed on the comparison 
of expression patterns in normal and diseased epidermis. Whilst S100A10 and 
S100A11 are expressed in normal skin by basal and supra-basal keratinocytes, 
others are upregulated in inflammatory conditions (reviewed in (Eckert et al.,
2004)). S100A7 has been identified as an anti-microbial protein in human skin 
and to be secreted on the human body surface (Glaser et al., 2005). Secretion of 
S100A7 from cultured keratinocytes in response to bacterial or pro-inflammatory 
challenge has been shown and purified S100A7 from human skin has anti­
microbial activity against E.coli (Glaser et al., 2005). This anti-microbial activity 
was reversed by increased zinc levels indicating the activity of S I00A7 may be to 
bind zinc which is required for bacterial growth (Glaser et al., 2005). In an assay 
of bacterial growth on human skin, use of an anti-S100A7 antibody allowed 
increased bacterial growth compared to isotype control (Glaser et al., 2005). 
S 1 0 0 A2  is expressed by normal human keratinocytes under basal conditions and 
has a nuclear distribution (Zhang et al., 2002). Under oxidative stress S100A2 
translocates to the cytosol and this phenomenon could be reproduced using 
ionomycin to elevate intracellular calcium (Zhang et al., 2002). S100A8 is
reported to be induced in murine keratinocytes by treatment with UVA 
(Grimbaldeston et al., 2003). The induction was shown to be a response to 
oxidant stress. Co-ordinate induction of S100A9 was not seen in that study. 
S100A8 and S100A9 are overexpressed in psoriasis, an inflammatory skin 
condition, along with S100A7 (Broome et al., 2003).
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7.1.2 The wound healing process
Wound healing is a highly orchestrated and organised process. The 
morphology of the healing skin is summarised in figure 7.1. As a crucial part of 
the immune defence, the skin acts as the most important epithelial barrier between 
the body and the outside pathogen filled world. The healing process has three 
over-lapping phases: inflammation, tissue formation and tissue remodelling. The 
immediate issue in wound healing is to prevent haemorrhage from damaged 
vessels by formation of a clot through the action of platelet and clotting factors. 
The disruption to the blood vessels in the skin allows the passage of blood 
leukocytes into the zone of damage. These early arriving leukocytes along with 
resident cells at the site of injury produce pro-inflammatory stimuli to hasten the 
entry of leukocytes into the wound (reviewed in (Martin, 1997; Santoro and 
Gaudino, 2005; Schaffer and Nanney, 1996; Singer and Clark, 1999)).
Leukocytes play a key role in this early phase of healing. Neutrophils are 
responsible for removing foreign particles, bacteria and fibrin matrix from the site 
of the wound, but are not essential for the healing process to occur. Neutrophils 
are later removed from the wound by resident macrophages or by their passage 
into the debris of the forming scab. The neutrophilic infiltration lasts only for the 
first 3-4 days of the wound healing process unless infections occurs, in which case 
continued neutrophil infiltration into the wound retards the healing process (Dovi 
et al., 2003; Martin et al., 2003b).
Monocytes and resident macrophages play a key role at the interface of 
inflammation and the repair stages. Monocytes are recruited to the site of the 
wound where they mature into tissue macrophages. Macrophages, as well as 
playing a role in clearing the wound of apoptotic neutrophils and other debris,
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Figure 7.1 Architecture of the healing epithelium
During the healing process the migratory keratinocytes bisect the wound to reform the epithelial 
barrier. Behind these cells keratinocytes o f the epithelium and adjacent hair follicles become 
hyperproliferative. Initially a fibrin clot fills the wound. Over time this the clot is replaced by 
granulation tissue and shed as a scab. Myeloid cells infiltrate the fibrin clot and granulation tissue 
to protect against infection and also provide cytokine signals to activate local fibroblasts and to 
initiate angiogenesis.
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also secrete a host of cytokines and growth factors such TG F-a, TGF-(3
(Transforming growth factors) and EGF (Epidermal growth factor). They also
produce potent tissue degrading and re-modelling enzymes such as collagenase.
They also produce IL-1 that activates further production of tissue degrading
collagenase by fibroblasts. The crucial role for macrophages in the wound
healing process has been demonstrated by macrophage depletion experiments.
These result in retarded fibroblast proliferation and wound fibrosis resulting in
delayed and abnormal wound healing. When similar experiments are carried out
to deplete neutrophil numbers, no effect on un-infected wounds is seen, implying
that the role of neutrophils in the wound is to control infection (Dovi et al., 2003;
Martin et al., 2003b) and that they have no role in the healing process (wound
healing reviewed in (Martin, 1997; Santoro and Gaudino, 2005; Schaffer and
Nanney, 1996; Singer and Clark, 1999)).
The second overlapping process of epithelialization begins within hours of 
the wound occurring. The epithelial cells (keratinocytes) undergo a dramatic 
phenotypic change. They reduce their attachment to surrounding cells by 
contraction of intracellular tonofilaments, degrade intra-cellular desmosomes and 
form a polarised action cytoskeleton and alter their integrin expression, allowing 
them to become migratory. The migratory keratinocytes bisect the wound 
dividing healthy tissue from wound debris in an integrin dependent process. One- 
two days after the migratory keratinocytes begin to bisect the wound, the 
keratinocytes at the wound edge begin to proliferate responding to local growth 
factors such are IGF and KGF (Insulin-like and Keratinocyte growth factors) 
initially released from fibroblasts and laterally as part of an autocrine signalling 
loop. As the re-epithelialization process completes, the re-expression of normal
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basement membrane proteins occurs in an ordered zip-like fashion. Binding of 
the migratory keratinocytes to the new basement membrane returns them to a 
normal phenotype and marks reformation of the continuous epithelial barrier 
(reviewed in (Martin, 1997; Santoro and Gaudino, 2005; Schaffer and Nanney, 
1996; Singer and Clark, 1999)).
Whilst the epithelial barrier is restored, extensive granulation tissue is 
formed to fill the void left by the wound. Granulation tissue results from the 
proliferation of fibroblasts and the deposition of collagen, allowing macrophages 
to move further into the wound space and supporting angiogenesis. Once 
sufficient granulation tissue has been formed to support the re-establishment of 
the epithelial barrier, the fibroblasts within the wound transform to a contractile 
myo-fibroblastic phenotype. Their tight interaction with the cell-matrix and the 
formation of large cytoplasmic actin bundles enables them to contract the wound. 
The scar tissue is gradually remodelled following contraction over a longer period 
of weeks as normal skin architecture reasserts itself as far as possible from the 
edges of the wound. However skin scars are estimated to gain only 70% of the 
tensile strength of normal skin (reviewed in (Martin, 1997; Santoro and Gaudino, 
2005; Schaffer and Nanney, 1996; Singer and Clark, 1999)).
7.1.3 S100 proteins and cancer
A common feature of many SI 00 family members is their dysregulation in
cancer (reviewed in (Donato, 2001; Emberley et al., 2004)). A potential in vivo
role for S I00 proteins in cancer has been highlighted recently in S100A4
transgenic mice (Ambartsumian et al., 2001; C'Naaman et al., 2004; Grum-
Schwensen et al., 2005). In these studies mice over-expressing S100A4
demonstrated that this protein does not have tumourigenic potential per se, rather
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the metastatic potential of tumours in susceptible strains is increased (reviewed in 
(Helfman et al., 2005)). A possible role in angiogenesis is also indicated from the 
presence of haemagiomas in aged S100A4 overexpressing mice (Ambartsumian et 
al., 2001). In the S100A4 null mice there is a higher incidence of spontaneous 
tumour formation possibly related to destabilisation of p53 in these mice 
(C'Naaman et al., 2004). Additionally engraftment of syngeneic tumours in the 
S100A4 null mice is delayed or reduced demonstrating a role for S100A4 
produced by stromal fibroblasts in the support of tumour growth (Grum- 
Schwensen et al., 2005).
S100A9 is dysregulated in squamous cell carcinoma following UVB 
irradiation and in esophageal squamous cell carcinoma (Dazard et al., 2003; Luo 
et al., 2004a). S100A8/9 expression has been highlighted in keratinocytes and 
infiltrating leukocytes in a skin carcinogenesis model in mice (Gebhardt et al., 
2002). They were identified as being targets for the glucocorticoid sensitive c-fos 
pathway activated during TP A treatment. S100A9 have been associated with 
other aspects of keratinocyte biology, being up-regulated during wound healing 
(Thorey et al., 2001). Here expression was associated with the hyper-proliferative 
population of keratinocytes at the wound edge. The expression of S100A9 
correlated with proliferation rather than an inflammatory stimulus as expression 
by keratinocytes was also shown in activin over-expressing mice that exhibit 
enhanced keratinocyte proliferation in the absence of inflammation (Thorey et al., 
2001).
7.1.4 Skin carcinogenesis
To address a potential role for S100A9 in tumourigenesis a multi-stage
skin carcinogenesis protocol was undertaken (the protocol and typical molecular
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events associated with progression of this model are outlined in figure 7.2). The
basis of this protocol is the application of a subthreshold dose of a carcinogen
(initiation) followed by successive applications of a non-carcinogenic promotor
(promotion). 7,12-dimethylbenz(a)anthracene (DMBA) is a potent carcinogen
and causes an irreversible initiation event. The initiation of skin-tumours has been
linked to the ability of agents such as DMBA to bind covalently to DNA and the
mutagenic activity of this compound. Activation of the H-ras gene is frequently
reported in mouse skin early in the carcinogenesis protocol and is considered a
likely cause of the initiating event. The promotion phase, using TP A in this case,
is initially reversible with benign papillomas arising that can undergo regression.
The production of papillomas is followed by the formation of squamous cell
carcinomas. In the absence of the initiation phase application of TPA alone
typically does not cause tumour formation, not being inherently carcinogenic.
The tumour promoting agents do not bind DNA and are not mutagenic, but are
capable of causing epigenetic changes (such as down regulation of anti-oxidant
enzymes and glucocorticoid receptors), inflammation and epidermal hyperplasia.
The key aspect of the promotion phase is the selective and specific expansion of
initiated cells through hyperplasia into papillomas. The progression phase of skin
carcinogenesis is characterized by high levels of genetic instability and
chromosomal alterations (reviewed in (Slaga et al., 1996)). Loss of p53 is
reported in skin carcinomas, but not in the benign papillomas and is strongly
associated with malignant progression. The final phase of progression is the
formation of aggressive carcinomas with metastatic potential (skin tumourigenesis
model reviewed in (Slaga et al., 1996; Zoumpourlis et al., 2003)).
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Figure 7.2 Mechanism of chemical induced carcinogenesis in mouse
Adapted from (Zoumpourlis et al., 2003). The initiation and promotion of chemical induced 
carcinogenesis is shown along with molecules typically altered during progression.
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This model is highly interesting to consider in the S100A9 null mice.
Aside from any role for S100A9 in the transformation of the keratinocytes recent
studies have highlighted a key role for the immune system in modulation of
tumour formation. Mice over-expressing IL -la , a proinflammatory cytokine,
under control of a keratinocyte specific promoter, are shown to be resistant to skin
papilloma formation in the DMBA/TPA carcinogenesis protocol (Murphy et al.,
2003). Crossing these mice onto a RAG deficient background, in which the
adaptive immune system is absent, did not alter this phenotype (Murphy et al.,
2003). This provides evidence for a role of the innate immune system in skin
carcinogenesis. TN Fa null mice have also been shown to be resistant to
papilloma formation and more advanced carcinoma formation in the DMBA/TPA
protocol (Moore et al., 1999). In these mice the inflammation seen during the
tumour promotion phase in response to TPA treatment is reduced and the heavy
neutrophil and eosinophil infiltration seen in the wildtype animals is absent
(Moore et al., 1999). A similar protection from tumour formation is seen in TNF
receptor knockout animals, where levels o f GM-CSF and matrix-
metalloproteinases were reduced (Amott et al., 2004). Treatment with a TNFa
blocking antibody is similarly protective (Scott et al., 2003). The use of MMP9
null mice has demonstrated that this molecule plays a role in tumour progression
in the multi-stage carcinogenesis protocol (Coussens et al., 2000). The use of
bone-marrow chimaeric mice to re-introduce MMP9 in the bone marrow
compartment alone removes the protection of MMP9 deletion, demonstrating a
role for bone marrow derived leukocytes in pathogenesis in this model (Coussens
et al., 2000). A more speculative role for neutrophils in tumour biology comes
from studies using the Mutatect cell line, which acts as a reporter system for
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genetic instability and forms subcutaneous tumours in mice. In this system
expression of IL- 8  correlated with increased neutrophil influx and an increase in
genetic instability in the tumour cells (Haqqani et al., 2000).
Differences in susceptibility in female and male mice are not without
precedence, with MMP8  (collagenase 2) null mice showing an increased tumour
incidence in male mice alone (Balbin et al., 2003). This effect could be reversed
by transplantation of neutrophils from wildtype mice, showing that production
MMP8  by neutrophils is protective in a model of multi-stage skin carcinogenesis
(Balbin et al., 2003).
These data show the importance of inflammation and the innate immune
system in carcinogenesis, although the potential role played may be complex.
7.2 Results
7.2.1 Wound healing assay
A wound healing assay was performed in wildtype and S100A9 null mice. 
A 3mm biopsy punch was used to make a pair of wounds through the skin on the 
back of the mice. To reduce the possibility of damaging the underlying tissue of 
the body cavity, the skin on the back was gently stretched away from the 
anaesthetised mice positioned on one side. This allowed the punch to be made 
cleanly through the skin alone, with no damage to the underlying tissues. Mice 
were sacrificed at four and seven days post wounding, with fresh wounds made 
post-mortem as a zero time point.
Sections cut through the midpoint of the wounds were stained with 
Haematoxylin and Eosin to visualise the morphology of the skin (figure 7.3). 
Low magnification images were taken of all the wounds and were used to assess
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Figure 7.3 Wound healing assay in wildtype and S100A9 null mice
Full thickness skin wounds were formed using a 3mm biopsy punch in duplicate on wildtype and 
S100A9 null mice to give wounds at day 4 and 7 at the point o f experiment termination. The skin 
time zero wounds were formed post-mortem and the individual wounds excised and fixed. The 
wounds were bisected and embedded in paraffin blocks. Sections were cut and stained with 
Haematoxylin and Eosin to visualise morphology. HF: Hair Follicle, E: Epithelium, W: Wound, 
HE: Hyperproliferative Epithelium, GT: Granulation Tissue, ML: Migrating Lip. Sections shown 
are representative of 3 duplicate wounds per genotype. Immunohistochemistry was performed by 
George Elia at Cancer Research UK.
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the degree of healing at the difference time point. At day zero a clean break in the
organised architecture of the skin could be seen. At day 4 post wounding the
wounds showed substantial scabbing with fibrous granulation tissue filling the
void of the wound. The epithelium had begun to close in all samples, shown by
the presence of a migrating lip of keratinocytes beginning to bisect the wound
between dead and live tissue. At day 7 all the wounds had closed and greatly
reduced in size with much of the normal skin architecture restored.
Studying the histology of the healing wound we can see that at the zero 
time point the epithelial layers consists of a single layer of nucleated cells, 
covered in layer of anucleated heavily fibrous cells, called the comified envelope. 
The surface of the skin is interrupted at regular intervals by hair follicles. It is in 
bulbous structures within the hair follicle that many of the skin stem cells exist 
(not shown). On day 4 post-wounding an organised population of migrating 
keratinocytes can be seen. This migrating lip bisects neatly between debris of the 
scab and the live fibrous tissue. Examination of the location and morphology of 
this migrating lip of keratinocytes revealed no obvious difference between 
S100A9 null and wildtype samples. This indicates that the speed of the 
epithelialization process and activity of this group of cells appears unaffected. At 
this time point, dramatic thickening of the epithelium behind the migrating lip can 
be observed. This hyper-proliferative population is located at the wound edge and 
behind, again the size and morphology of this population appears unaffected. By 
day 7 post wounding, the keratinocytes have fully re-established the epithelial 
barrier in all samples. The wound has also contracted significantly and the 
breadth of the wound is shown by the thickened layer of keratinocytes at the site
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of the wound. In most cases the scab over the wounded area had been shed by
this time.
7.2.2 Neutrophil influx into the wounded epithelium
Neutrophils act in the wounded epithelium primarily to control any 
infection, but their persistent presence can retard wound healing. The influx of 
myeloid cells into the skin was assessed by immunohistochemistry, using the 7/4 
antibody (figure 7.4). When examining skin samples, it is necessary to take into 
account that any apparent positive staining of the hair shaft, comified layer and 
scab may be artefact. In the day zero skin samples, no infiltration of myeloid cells 
into the skin could be seen, this was expected as neutrophils and monocytes are 
not resident in the skin. As would be expected from the literature on wound 
healing, infiltrating myeloid cells were seen in the wound in the day 4 post 
wounding sample. These cells could be seen around what appear to vascular 
structures at the base of the skin in both S100A9 null and wildtype samples. 
Myeloid cells that had migrated into the skin were observed in both S100A9 null 
and wildtype samples. When the day 7 samples were examined no infiltration of 
myeloid cells was observed. No difference in the myeloid cell influx into the 
wildtype and S100A9 null wounds could be seen.
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Figure 7.4 Myeloid Cell influx into the wounded epithelium
Full thickness skin wounds were formed using a 3mm biopsy punch in duplicate on wildtype and 
S100A9 null mice to give wounds at day 4 and 7 at the point o f experiment termination. The time 
zero skin wounds were formed post-mortem and the individual wounds excised and fixed. The 
wounds were bisected and embedded in paraffin blocks. Day 4 skin sections were cut and stained 
with mAb 7/4 to identify myeloid cells. HF: Hair Follicle, W: Wound, HE: Hyperproliferative 
Epithelium. Immunohistochemistry was performed by George Elia at Cancer Research UK.
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7.2.3 Expression of S100A8 and S100A9 in the wounded epithelium
Gene array data has previously identified S100A8 and S100A9 as being 
up-regulated during the wounding process (Li et al., 2000a). This could be due to 
the influx of myeloid cells that express high levels of these proteins during this 
process. More careful studies on keratinocytes alone have shown that these cells 
begin to express S100A8 and S100A9 in response to wounding stimuli (Thorey et 
al., 2001). To confirm any expression of S100A8 and S100A9 in the murine 
epithelium sections from all time points were stained with monoclonal anti- 
S100A8 (6A4 -  IgG2b) and monoclonal anti-S100A9 (2B10 -  IgG2b) antibodies 
and relevant isotype controls (PyLT -  IgG2b and Y13 -  IgG2a) (figures 7.5 and 
7.6).
No expression of S100A8 or S100A9 was seen at any time point in the
S100A9 null samples. No expression of S100A8 or S100A9 was seen in the
normal unwounded epithelium. On day 4 post wounding staining for both
S100A8 and S100A9 could be seen in a defined population of keratinocytes
located at edge of the wound in the wildtype samples (figure 7.5 and 7.6). No
staining was seen in the migrating lip. The population of keratinocytes expressing
the proteins is a portion of the hyperproliferative epithelium situated at the wound
edge. In addition to this expression of S100A8 and S100A9 small positively
stained cells within the dermis and granulation tissue could be seen. It would be
assumed that these are infiltrating neutrophils or monocytes, although to confirm
this co-staining sections with anti-SlOO antibodies and other leukocyte marker
antibodies would be required. By day 7, when the wounds had contracted
significantly and the epithelial barrier completely reformed, the defined
population of S100A8/9 positive keratinocytes could no longer be seen, instead a
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Figure 7.5 Expression of S100A9 in the wounded epithelium
Full thickness skin wounds were formed using a 3mm biopsy punch in duplicate on wildtype and 
S100A9 null mice to give wounds at day 4 and 7 at the point o f experiment termination. The time 
zero skin wounds were formed post-mortem and the individual wounds excised and fixed. The 
wounds were bisected and embedded in paraffin blocks. Sections were cut and stained with mAb 
2B10 to identify S100A9 or isotype control mAb Y13. HF: Hair Follicle, E: Epithelium, W: 
Wound, HE: Hyperproliferative Epithelium, GT: Granulation Tissue. Immunohistochemistry was 
performed by George Elia at Cancer Research UK.
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Figure 7.6 Expression of S100A8 in the wounded epithelium
Full thickness skin wounds were formed using a 3mm biopsy punch in duplicate on wildtype and 
S100A9 null mice to give wounds at day 4 and 7 at the point o f experiment termination. The time 
zero wounds skin were formed post-mortem and the individual wounds excised and fixed. The 
wounds were bisected and embedded in paraffin blocks. Sections were cut and stained with mAb 
6A4 to identify S100A8 or isotype control mAb PyLT. HF: Hair Follicle, E: Epithelium, W: 
Wound, HE: Hyperproliferative Epithelium, GT: Granulation Tissue. Immunohistochemistry was 
performed by George Elia at Cancer Research UK.
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small number of isolated S100A8/9 expressing cells could be seen within the
keratinocytes at the wound site. None of the small S I00 positive cells were
evident in the day 7 skin samples, nor were there any 7/4 positive myeloid cells
(figure 7.4)
Expression of S100A8 and S100A9 has been reported in the cells of the 
hair follicle in humans. Examination of the hair follicles shows no expression of 
these proteins in the hair follicle in the mouse or in the stem cells resident in the 
hair follicle. Some staining of the hair itself is seen, but as this is also seen in the 
isotype controls, it is assumed to be non-specific.
7.2.4 Syngeneic tumour engraftment model
Given the reduced growth of injected tumours cells in the S100A4 null 
mouse ((Grum-Schwensen et al., 2005)), it seemed logical to evaluate this model 
in the S100A9 null mouse. Two cell lines of syngeneic C57BL/6J tumours were 
examined: B 1 6 g a l v  melanoma and 3LL Lewis Lung Carcinoma. Expression of 
S100A8 and S100A9 is reported in various cancers and it was first important to 
ascertain whether the two cell lines expressed either protein. As the mature 
animal does not express either S100A8 or S100A9, it is possible that the immune 
system may recognise these proteins as antigens in the S100A9 null mouse, 
potentially causing a difference in tumour growth due that is not due to a function 
of S100A9 per se. Western blotting of a lysate produced from the B16 GALV 
and 3LL cell lines did not show any expression of S I00A9 or S100A8 (data not 
shown). Similarly a lysate produced from a B16 tumour grown in the S100A9 
null animal did not show any S100A8 or S100A9 expression (data not shown).
When the growth of the 3LL and B 1 6 g a l v  tumours was monitored by
measurement of tumour size no difference in the kinetics of growth of either
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tumour was observed when the S100A9 null and wildtype mice were compared
(figure 7.7). The mass of the tumours was also assessed at the end point of the
experiment. The end point was taken as the time when the first tumour passed the
critical size threshold at which point the experiment was terminated and all the
tumours from both S100A9 null and wildtype groups were weighed. There was
no difference in the mass of either 3LL or B 1 6 g a l v  tumours when S100A9 null
and wildtype tumours were compared. In addition to measurement of the tumour
size the mice were examined for any obvious metastatic spread or other
abnormalities. No obvious metastasis or other sign of ill health was found in the
mice (data not shown).
The number of lymphocytes present in the tumour-draining lymph nodes 
was assessed at the end of the experiment as an indication of immune activation in 
the mice (figure 7.8). No difference in the lymphocyte populations was seen 
when S100A9 null and wildtype mice were compared. The extent of angiogenesis 
supporting the tumour growth was assessed by eye and no gross difference in the 
extent of vessel growth was seen when S100A9 null and wildtype mice were 
compared (figure 7.9).
This data seems to indicate that unlike S100A4, S100A9 has no role in 
support or retardation of tumour growth in this model. This may be correct as the 
only stromal tissue likely to express S100A9 would be infiltrating neutrophils. 
Preliminary histochemistry performed on the 3LL tumour samples revealed only a 
low level of neutrophil infiltration and no expression of S100A8 or S100A9 by 
other cells at the site of tumour (data not shown).
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Figure 7.7 Growth of syngeneic tumours in wildtype and S100A9 null mice
B 1 6 g a l v  or 3LL cells were cultured and injected sub-cutaneously into the right flank o f  
anaesthetized mice. Tumour growth was followed by measurement o f the tumours in two 
dimensions every two days. All mice were culled once tumour size reached the legal limit and the 
tumours were excised. A: Tumour progression monitored by measurement o f tumour size. B: 
Tumour growth assessed as tumour mass at the end-point o f the experiment. Data shown as mean 
value +/- standard error o f the mean for groups of 7 animals per genotype. The experiment was 
performed 3 times.
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Figure 7.8 Lymphocyte numbers in the tumour-draining lymph nodes
B 1 6 q a l v  or 3LL cells were cultured and injected sub-cutaneously into the right flank of 
anaesthetized mice. All mice were culled once a single tumour reached the legal limit and the 
tumours were excised. The inguinal lymph nodes were removed at the end o f the experiment and 
mechanically disrupted. The resulting cell suspension was labelled with antibodies recognising 
B220 (B cells), CD4 and CD8  (T cells). The number o f cells was assessed by flow cytometry. 
Data shown is the mean +/- standard error o f the mean for 5-7 animals per group.
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Figure 7.9 Tumour induced angiogenesis
B 1 6 g a l v  or 3LL cells were cultured and injected sub-cutaneously into the right flank of  
anaesthetized mice. All mice were culled once tumour size reached the legal limit and the tumours 
were excised. The growth of blood vessels supplying the tumours was assessed visually. T: 
Tumour, B: Body cavity, V: Vessel. Representative images o f mice from each group are shown, 
with 5-7 animals per group. The experiment was repeated 3 times.
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7.2.5 Skin carcinogenesis in S100A9 null mice
Multi-stage induced carcinogenesis promotes the immortalization of cells 
within the murine epithelium. These cells form benign papillomas that can in 
time progress to form squamous or spindle cell carcinomas as illustrated in figure 
7.2. At the time of writing, this experiment is in progress and so data up to week 
18 is shown. Following treatment with DMBA, the tumour initiating agent, the 
mice are treated weekly with TPA to promote carcinogenesis.
Papillomas were first observed in the female wildtype and S100A9 null 
mice around week 8  of the TPA tumour promotion phase. Papillomas arose 
slightly later in both male groups (around week 11). By week 13 all female 
S100A9 null mice had papillomas, with all wildtype female mice having 
papillomas by week 15. Time to 50% of the female mice having papillomas was 
approximately 2 weeks earlier (week 8.5 compared to week 10.5) in the S100A9 
null mice. The incidence of papillomas in the male mice was lower with 50% of 
male S100A9 null mice having tumours by week 7.5 and the wildtype mice not 
reaching that level by week 18 (figure 7.10).
Observing the mean number of papilloma per mouse in the different
groups showed that the female knockout mice had more papillomas than the
wildtypes (figure 7.11). The mean number of papillomas present in the S100A9
null mice was significantly different from the wildtype mice at various time points
as shown in figure 7.11. At maximum the female S100A9 null group had 3-4
times as many papillomas as the wildtype group. The male mice have a lower
number of papillomas to date. The mean number of papillomas is elevated in the
male S100A9 null group as in the female group and was also significant at certain
time-points. By week 16 the first transformed skin carcinoma had arisen in the
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female S100A9 null group. A more comprehensive statistical evaluation will be 
performed later in the experiment when an ‘area under curve’ analysis will be 
performed and used to assess any significant differences (using a Mann-Whitney 
test) between wildtype and S100A9 null mice over the duration of the experiment.
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Figure 7.10 Chemical induced carcinogenesis -  Papilloma incidence
The backs o f mice were shaved and painted with DMBA at the 8  weeks of age. TPA was applied 
topically to the shaved area weekly for 15 weeks. The development of papillomas was recorded 
weekly. The incidence o f papillomas per group is shown.
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Figure 7.11 Chemical induced carcinogenesis -  Papilloma multiplicity
The backs of mice were shaved and painted with DMBA at the 8  weeks of age. TPA was applied 
topically to the shaved area weekly for 15 weeks. The development o f papillomas was recorded 
weekly. Data shown is mean values per group of 15 mice +/- standard error o f the mean. 
Significance between wildtype and S100A9 null data at each time point was assessed using a 
Student’s T-Test: * P<0.05; ** P<0.01.
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7.3 D iscussion
The evidence presented here gives the most promising data to date for an 
in vivo difference between the S100A9 null and wildtype mice. The enhanced 
level of papilloma formation in the S100A9 null mice could indicate a regulatory 
role in protecting the body in this model of skin carcinogenesis. In the absence of 
histochemistry data, we can speculate that this may be an as yet undefined role for 
the neutrophil in this process, or a role for this protein in the keratinocyte. The 
first stage in evaluating this model will be to study the morphology of the 
papillomas/carcinomas arising and assessing cellular proliferation and apoptosis 
in these structures. To dissect a role for S100A9 immunohistochemistry should 
be performed to look for expression of S I00A8  and S100A9 during the initiation, 
promotion and progression phases of the experiment in initiated and uninitiated 
skin. Also given the prominent modulatory role of leukocytes in this process, 
evaluation of the presence of lymphocytes and myeloid cells in S100A9 null and 
wildtype mice should be made. To evaluate a role for these proteins in the 
inflammatory processes linked to tumour promotion, levels of key mediators such 
as MMP9 and TNFa could be made using a gene array or by RT-PCR.
The preliminary wound healing data does not show a role for S100A9 in 
wound closure. This does not rule out a role for this protein, either in neutrophils 
or keratinocytes, in protection o f the wound site from microbial attack. 
Keratinocytes are known to produce a range of anti-microbicidal proteins thus 
participating in the innate host defence during this vulnerable time. S100A7 is 
secreted and possibly plays a role of this type (Glaser et al., 2005). Another 
family of mediators that are expressed in the hyper-proliferative epithelium are 
anti-oxidant enzymes. Increased expression of these enzymes (including haem-
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oxygenase 1, catalase and superoxide dismutase) occurs within the first 3 days of
injury and declines by day 7, a similar pattern to that seen for S100A9
(Hanselmann et al., 2001; Steiling et al., 1999). Given that the other major site of
expression of these proteins is in the neutrophil, a cell that is exposed to high
levels of oxidant, and indeed produces large quantities o f oxidant, this could
imply some role for this protein in the response to oxidants.
An extension of this study would be to see if  the S100A8/9 expressing 
keratinocyte population is proliferating, this could provide some insight into the 
role of S100A9. Work previously published has indicated that the expression of 
S100A9 in the wounded epithelium may be linked to hyper-proliferation rather 
than an inflammatory response, demonstrated by expression in hyperproliferative 
keratinocytes of the non-inflamed epithelium of activin over expressing mice 
(Thorey et al., 2001). Examination of earlier time points may also give interesting 
information as to the time period over which S100A9 protein is induced. The 
time-points examined so far do not reveal the kinetics of S100A9 expression and 
the expression seen at day 4 could be at either the beginning or end of this 
process, given that little expression remains at day 7.
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8 General discussion
One feature of S100A8/9 that has been of abiding interest to leukocyte 
biologists is the abundance of this protein in neutrophils. That this protein can be 
entirely deleted and the cells are able to perform their fundamental roles 
apparently normally is surprising. To date in this study and in the previous 
publication (Hobbs et al., 2003) the ability of the neutrophils to develop, mature, 
adhere, migrate, chemotax, phagocytose, produce an oxidative burst, kill bacteria 
and apoptose has been shown to be broadly normal in the assays tested. This 
seems to be in conflict with the published literature on this protein that has 
speculated key roles for this protein in most neutrophil functions. The published 
chemoattractant properties of S100A8/9 (Ryckman et al., 2003b) could not be 
reproduced in this work and no defect in migration in a model of peritonitis could 
be seen. The antimicrobicidal properties o f S100A8/9 (Sohnle et al., 2000; 
Steinbakk et al., 1990) are not evident in the in vivo model of Streptococcus 
pneumoniae infection or the in vitro killing assay. The reported association of 
S100A8/9 with the cytoskeleton (Burwinkel et al., 1994; Roth et al., 1993) could 
not be seen in murine neutrophils and no defect in cytoskeleton function relating 
to cell migration or phagocytosis has been detected to date (this study and (Hobbs 
et al., 2003)). Given that the potential functions outlined in the literature have not 
yielded a clear neutrophil phenotype in the mice to date other than a calcium 
signalling defect, it seems future studies should concentrate on less biased in vivo
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models of general innate immune function. The lack of correlation between 
functions ascribed to recombinant proteins and real in vivo functions underlines 
the necessity of in vivo functional studies.
8.1.1 Differences in phenotype between S100A9 null mouse strains
The differences in phenotype of our S100A9 null mice and the Manitz et 
al strain of S100A9 null are perplexing. To date no gross phenotype for these 
mice have been published. All differences in the function of the S100A9 null 
neutrophils have been relatively subtle and little difference in any in vivo model 
has been shown (Hobbs et al., 2003; Manitz et al., 2003). The only reported in 
vivo lesion is the preliminary observation of decreased neutrophil recruitment to 
the site of wound healing in the independent strain of S I00A9 null mice (Vogl et 
al., 2004). The mechanism of this phenotype is unclear and is not reproducible in 
our line of S100A9 null mice (see Chapter 7). The mechanism published 
implicates the phosphorylation of S100A9 by the MAP kinase p38 and the 
polymerisation of the S100A8/9 dimer and interaction with micro filaments (Vogl 
et al., 2004). The published human S100A9 data shows a role for phosphorylation 
of S100A9 causing its translocation to microfilaments after which cell migration 
is enhanced (Kerkhoff et al., 1999a). This explanation is not fully satisfactory as 
phosphorylation of murine S100A9 has never been demonstrated and the 
mechanistic data presented shows biochemical studies using human S100A9 and 
in this instance a correlation in the activity of the human and murine protein 
cannot be assumed. Indeed the only confirmed phosphorylation site in the human 
S100A9 protein (Edgeworth et al., 1989) is not conserved in the murine homolog 
(E. M ^ e ill - data not shown). To confirm this phenomenon in murine
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neutrophils, evidence for any phosphorylation of this protein, and in particular, in 
this model, would have to be obtained.
To further consider reasons for the different data reported for the two 
S100A9 null mice strains it should be pointed out that the mice have been 
produced using different targeting strategies. Rather than an insertional strategy 
(Hobbs et al., 2003), the second strain of mice was produced using a deletional 
strategy (Manitz et al., 2003). It is possible that, given the different targeting 
strategies, effects on the transcription of other proteins has been affected, although 
in our extensive investigation we have found no evidence for this (Hobbs et al., 
2003). Also the mice presented in this study are fully back-crossed onto a 
C57BL/6J background and the back-cross status of the Manitz et al mice is 
unclear in their publication. Having mice on a mixed background can increase the 
variation between mice as they may not all exhibit the same level of C57BL/6J or 
SvJ background and these two strains exhibit different responses in various 
models. It could also be that differences in the technique used to isolate 
neutrophils by the different groups may have lead to differences in the activation 
state of the cells. Given the ease with which this cell type can be activated by 
bacterial products and mechanical stimulation, differences in how the cells are 
handled maybe masking/revealing differences in the biology of these cells or 
leading to false results.
8.1.2 S100A9 and calcium signalling
The data presented in this thesis indicates that specific calcium signalling
pathways are altered in the absence of S100A9 (see chapter 3). The significance
of the lesion with regard to physiological levels of chemoattractant stimulation is
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unclear. The relationship between the levels of chemoattractant used here and the 
levels found in vivo are difficult to interpret as chemoattractants are presented on 
glycoasminoglycans in vivo rather than in a soluble state. It may be that the sub- 
maximal levels at which the lesion is seen in the in vitro assays presented here 
indicate that calcium signalling is profoundly affected in the absence of S100A9 
in vivo. While not appearing a profound lesion in vitro, this deficiency could give 
a clue to the fundamental role of this protein family. That this lesion bears some 
similarity to the subtle alterations in calcium signalling seen in the S 1 0 0 A 1 null 
mice (Du et al., 2002) could indicate that the role of these proteins is in the fine 
tuning of cellular calcium responses. I have already outlined in chapter 3 that key 
extensions of this work are to find exactly the point in the IP3-mediated pathway 
that is compromised in S100A9 null mice. A piece of evidence needed is to find 
out if the levels of IP3 are normal in these mice, which would allow the lesion to 
be placed prior to or after phospholipase C activation. Another key experiment is 
to look further for any direct interaction of S I00A9 with the IP3 receptor or any 
other part of the calcium signalling machinery under various conditions, in a 
similar manner to the reported interaction of S 1 0 0 A 1 with the ryanodine receptor 
(Du et al., 2002; Most et al., 2003).
8.1.3 I n  vivo  infection studies
It seems perplexing that given the abundance of these proteins, we can 
detect no consistent obvious defect in neutrophil function. Although the results 
from the Streptococcus pneumoniae infection study are tantalising, currently we 
can demonstrate no effect of the lack of S100A9 on the progress of this infection. 
There are several neutrophil functions, such as production of cytokines and de­
granulation, which we have not yet analysed. However, given that in a model of
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infection no gross phenotype can be seen implies no critical non-redundant un­
compensated role for S100A9 in neutrophil function. To extend the study of the 
S100A9 mice with respect to neutrophil function, developing further in vitro 
assays seems unlikely to be a productive avenue until an in vivo effect of deletion 
of this protein can be successfully documented. Challenging these mice with 
other pathogens and assessing the progress of the infection is likely to be the most 
productive way forward. This may yield a defined pathogenic stimulus that will 
reveal the function of this protein in neutrophils. The function that is defective in 
vivo can be dissected by directed in vivo and in vitro experiments. Until that time, 
the limits imposed by the difficulty of working with primary murine neutrophils 
in a mixed bone marrow cell population are too great.
The work presented in this thesis almost entirely deals with the 
functioning of the innate immune system. The innate immune system plays a role 
initiating the function of the adaptive immune system through the production of 
cytokines and the presentation of processed antigen. The delayed-type 
hypersensitivity reaction tests the function of the adaptive immune system to 
respond to immunization with antigen. Mice are inoculated with antigen and 
adjuvant, and following a lag period the lymph nodes are removed, disaggregated 
and put into culture. The cultures are then restimulated with the antigen and the 
local lymph node APCs present the antigen to the resident lymphocyes and the 
degree of proliferation induced in assessed. Preliminary experiments using this 
protocol have shown no difference in the response to ovalbumin immunization to 
date, but require further investigation to confirm this (E. McNeill -  data not 
shown).
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8.1.4 Carcinogenesis
The data produced by the carcinogenesis study provides the most exciting 
in vivo phenotype to date. This model seems to show a real difference in the 
formation of benign papillomas. There are two possible sites at which S100A9 
deletion could be playing a role, both in keratinocyte function or in innate 
immune function. There is evidence for upregulation of S100A9 in the skin 
carcinogenesis model (Gebhardt et al., 2002) and in this study we have also seen 
expression by the hyperproliferative keratinocyte population during wound 
healing as has been reported previously (Thorey et al., 2001). Inflammation and 
the innate immune system have been shown to play a crucial role in the promotion 
phase of this model (Moore et al., 1999; Murphy et al., 2003). If it is an alteration 
in the function of neutrophils that is responsible for this phenotype this will 
provide the first evidence o f a specific role for this leukocyte subset in skin 
carcinogenesis. To define the phenotype we see in this model the first task will be 
will be key to perform histology to look for expression of S100A9 by both 
keratinocytes and cells of the innate immune system in the affected area in 
wildtype mice. Histology will also provide the opportunity to look for gross 
changes in the S100A9 null mice such as altered leukocyte infiltration or 
epithelial morphology.
Additional experiments could include examination of cytokine production 
such as TNFa that are central to the inflammatory component of the promotion 
phase (Moore et al., 1999). Examination of the keratinocytes could include 
measurements of proliferation using BrdU or Ki67. Should any differences be 
seen in the incidence of carcinomas in the S100A9 null mice, this can be further 
investigated using a complete carcinogenesis protocol that consists of repeated
228
Chapter 8: General discussion
treatment with the initiating agent DMBA and does not include a promotion 
phase. To absolutely confirm a role for either the keratinocytes or neutrophils 
bone marrow chimearas could be produced to replace the immune system in an 
S100A9 null animal with wildtype cells and vice versa. Once the cell type/s 
affected by the deletion of S I00A9 have been identified then further investigation 
of the mechanism of action of S100A9 in induced skin carcinogenesis should be 
carried out. If a role for the immune system is highlighted the role of the adaptive 
immune system can be assessed by observing papilloma formation in lymphocyte 
deficicent S100A9 null RAG-2 null animals. To further characterise any role for 
neutrophils in the wildtype and S100A9 null situation neutrophils could be 
depleted during the experiment by repeated injection of a neutrophil-depleting 
antibody such as RB6 .
8.1.5 Chronic inflammation
High levels of S100A8/9 are reported in chronic inflammatory conditions 
such as rheumatoid arthritis (Odink et al., 1987) and inflammatory bowel disease 
(Fagerhol, 2000). Inflammatory bowel disease can be modelled in mice using a 
model of TNBS-induced colitis. This causes inflammation in colon similar to that 
seen in ulcerative colitis. Rheumatoid arthritis can be modelled using a collagen- 
induced arthritis protocol, although this would require the mice to be bred onto a 
susceptible background, such as the CBA strain. Studying these conditions in the 
S100A9 null mice may give some indication if S100A9 plays a role in the 
pathogenesis of inflammatory conditions or whether the levels seem are simply a 
marker of myeloid cell based inflammation in these conditions.
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8.1.6 Compensation
Whilst the function of S100A9 in neutrophil function may not have been 
revealed by the assays performed to date another less appealing prospect is that 
the neutrophils have managed to compensate for the lack of this protein. 
Although no alterations in protein expression levels has been seen they may have 
compensated in a manner that does not require altered protein expression. It may 
be that the alterations in calcium signalling and altered basal calcium levels are all 
that remains of the effect of deletion of S100A9 on calcium homeostasis and 
signalling. If this in indeed that case, then a conditional S100A9 knockout mouse, 
for example produced using the Cre-Lox system, would allow cells to develop 
normally and undergo deletion of the protein in mature cells. Such a model would 
reduce the likelihood of any compensation occurring during cell development and 
allow the function of S I00A9 to be reassessed. These experiments would need to 
be performed using a conditional knockout animal as, even with the advent of 
siRNA and primary leukocyte transfection strategies, knockdown of S100A9 in 
primary neutrophils would be problematic. Neutrophils have a short half-life and 
as a terminally differentiated cell type do not divide and cannot be maintained in 
culture. The only available cell-lines are leukaemic progenitor cell lines that 
require differentiation to a neutrophil-like phenotype. These lines then stop 
dividing and develop the short life span associated with neutrophils. This makes 
any deletion of S I00A9 in a relevant cell or cell-line difficult.
8.1.7 Conclusions
To date it can be concluded from the studies of the S100A9 null mice that
S100A8/9 appears to play a redundant role in neutrophil development and many
aspects of their function. The complex appears to play a non-redundant role in
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intracellular calcium release in response to some but not all chemoattractant 
signalling. S100A9 null neutrophils show reduced calcium signalling in response 
to MIP-2 but not FMLP. This deficiency appears to be in the IP3 -mediated 
calcium release pathway. S100A8/9 plays a non-redundant role in a model of 
skin carcinogenesis with S100A9 null mice showing increased rate and incidence 
papilloma formation and increased tumour multiplicity.
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